1997

Primary care of the HIV/AIDS patient. [computer file]: Stamford, CT : Appleton & Lange, New Media, c1997- computer laser optical discs : sd., col. ; 4 3/4 in. + 1 guide (21 p.) + 1 poster Unique Identifier : AIDSLINE MED/9712582; Henderson JV; (Producer) This virtual clinic allows the user to experience a hands-on environment and gain a sense of first-hand longitudinal care, along with the long-term physical and emotional impact on individual patients. In just a few hours you follow the progress of the disease in your simulated patient--a process normally
al- Idz : marad naqs al-mana'ah al-muktasab, wa-hiwar hawla ijra' ikhtibar al-dam lil-kashf 'an al-isabah bi-fayrus al-idz.: al-Dawhah, Qatar : [s.n.], 1988 50 p. : ill Unique Identifier : AIDSLINE MED/9709357; 'Abd Allah H'
Women and AIDS. 2nd ed.: [Harare] : Zimbabwe Women's Resource Centre and Network, [1993] 28 p (ZWRCN bibliography ; no. 5) Unique Identifier : AIDSLINE MED/9707950
Strategic plan, 1994-1998 : a time to act, a time to care.: [Lusaka, Zambia] : Zambia National AIDS/STD/TB & Leprosy Programme, [1993?] 35 p Unique Identifier : AIDSLINE MED/9709169
HIV/AIDS and sexual health papers. 14-: London : Health Education Authority, c1993- v Unique Identifier : AIDSLINE MED/9612034
National Conference on AIDS 1993 : theme, the role of Indian medicine in search of a remedy to cure AIDS.: Madras : Conference Secretariat, Indian Medical Practitioners' Co-operative Pharmacy and Stores Ltd., 1993 256 p. : ill Unique Identifier : AIDSLINE MED/9714611; Venkatesan K
Phuying kap wikrittakan et. Phim khrang raek.: Krung Thep : Samnakphim Soithong, 2537 [1994] 222 p. : ill Unique Identifier : AIDSLINE MED/9711397; Mayuri Yuphawan
Guidelines for hospitals for notification of transfusion recipients of possible transfusion-related HIV infection.: Don Mills, Ont. : The Association, 1994 21 p Unique Identifier : AIDSLINE MED/9711466
HIV molecular immunology database. 1995- Group T-10: Los Alamos, N.M. : Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, [1995- v. : ill Unique Identifier : AIDSLINE MED/9611415
La corona di nemesi : sul morire e la cultura della morte nell'epoca dell'AIDS.: Como : Filo, c1995 203 p. : ill Unique Identifier : AIDSLINE MED/9709545; Lorenzini M
HIV/AIDS : aspekty medyczne i spoleczne : materialy z konferencji naukowej uniwersytetow Gdanskiego, Yale i Akademii Medycznej w Gdansku, 23.03, 1993 = HIV/AIDS : social and medical aspects. Wyd. 1.: Gdansk : Wydawn. Uniwersytetu Gdanskiego, 1995 265 p. : ill Rozprawy i monografie) Unique Identifier : AIDSLINE MED/9611448; Kmiecik-Baran K
On the margins : men who have sex with men and HIV in the developing world.: London : Panos, c1996 112 p (Special reports) Unique Identifier : AIDSLINE MED/9710899; McKenna N
Resource manual for providing hospice care to people living with AIDS.: Arlington, Va. : National Hospice Organization, c1996 iv, 109 p Unique Identifier : AIDSLINE MED/9707973
Assistenza ai malati terminali in ospedale e a domicilio : aspetti relazionali, organizzativi, formativi.: Milano, Italy : FrancoAngeli, c1996 175 p (IREF/ricerche ; ISSN 752.2.6) Unique Identifier : AIDSLINE MED/9708045; Ranci Ortigosa E
Cancer, SIDA : la qualite de vie. 1. ed.: Le Plessis-Robinson : Synthelabo groupe, c1996 284 p (Collection Les Empecheurs de penser en rond) Unique Identifier : AIDSLINE MED/9705814; Jasmin C
Infezione da HIV e gravidanza : con una nota sull'epatite C.: Milano : Lauri edizioni, c1996 vii, 127 p. : ill (Collana "Le infezioni in gravidanza") Unique Identifier : AIDSLINE MED/9708020; Ippolito G
Sexual behaviour and AIDS in India.: New Delhi : Vikas Pub. House, 1996 xix, 157 p Unique Identifier : AIDSLINE MED/9706330; Nag M
The demographic impacts of HIV/AIDS perspectives from the world population profile : 1996.: Washington, D.C. : International Programs Center, Population Division, U.S. Bureau of the Census, 1997 ix, 43 p. ; ill (IPC staff paper ; no. 86.) Unique Identifier : AIDSLINE MED/9709182; Stanecki K; Way PO
Abstracts of papers presented at the 1997 meeting on retroviruses : May 20-May 25, 1997.: Cold Spring Harbor, N.Y. : Cold Spring Harbor Laboratory, [1997] lxxvii, 394 p Unique Identifier : AIDSLINE MED/9711823; Hughes SH; Coffin JM
AIDS as an apocalyptic metaphor in North America.: Toronto ; Buffalo : University of Toronto Press, c1997 199 p Unique Identifier : AIDSLINE MED/9710913; Palmer SJ
In changing times : gay men and lesbians encounter HIV/AIDS.: Chicago : University of Chicago Press, c1997 xii, 313 p. : ill Unique Identifier : AIDSLINE MED/9713333; Levine MP; Nardi PM; Gagnon JH
Acquired immune deficiency syndrome : biological, medical, social, and legal issues. 3rd ed.: Upper Saddle River, N.J. : Prentice Hall, 1997 Unique Identifier : AIDSLINE MED/9715822; Stine GJ
Medical management of HIV infection. 1997 ed.: [Baltimore, Md.?] : J.G. Bartlett, c1997 ix, 296 p. : ill. ; Unique Identifier : AIDSLINE MED/9711467; Bartlett JG
Manual of HIV therapeutics.: Philadelphia : Lippincott-Raven, c1997 xv, 254 p. : ill Unique Identifier : AIDSLINE MED/9714772; Powderly WG
Sex at risk : lifetime number of partners, frequency of intercourse, and the low AIDS risk of vaginal intercourse.: New Brunswick, N.J. : Transaction Publishers, c1997 ix, 222 p. : ill Unique Identifier : AIDSLINE MED/9715291; Brody S
Illustrated handbook of respiratory disease in HIV infection.: New York : Parthenon, c1998 Unique Identifier : AIDSLINE MED/9715377; Lipman MC; Gluck TA; Johnson MA
Oxidative stress in cancer, AIDS, and neurodegenerative diseases.: New York : M. Dekker, c1998 xiii, 558 p. : ill (Oxidative stress and disease ; 1) Unique Identifier : AIDSLINE MED/9714866; Montagnier L; Pasquier C; Olivier R
A mental health practitioner's guide to the neuropsychiatric aspects of HIV/AIDS.: New York : Guilford Press, c1998 Unique Identifier : AIDSLINE MED/9715676; Van Gorp WG; Buckingham SL
Cardiology in AIDS.: New York : Chapman & Hall, c1998 Unique Identifier : AIDSLINE MED/9715590; Lipshultz SE
HIV and the pathogenesis of AIDS. 2nd ed.: Washington, D.C. : ASM Press, c1998 Unique Identifier : AIDSLINE MED/9716299; Levy JA
What works. AIDS application enhances case managers' productivity and proactivity.: Health Manag Technol. 1997 Aug;18(9):27. Unique Identifier : AIDSLINE MED/97456042; Milakovich P; AIDS Resource Center of Wisconsin, Milwaukee 53202, USA.
Telecare for HIV/AIDS patients.: Caring. 1997 Jul;16(7):42-5. Unique Identifier : AIDSLINE MED/97437922; Kinsella A; Information For Tomorrow, Sunriver, OR, USA.; Telecare--or health care services delivered via telecommunications--can be a valuable adjunct to conventional home care service delivery, particularly to chronic care patients. Technological advances have made it possible for providers to deliver cost-effective telecare to the in-home HIV/AIDS patient.
A note on co-ordinating the AIDS crisis: issues for policy management and research.: Int J Health Plann Manage. 1997 Apr-Jun;12(2):149-57. Unique Identifier : AIDSLINE MED/97459503; Anand P; Templeton College, Oxford, UK.
Charges and charge coverage in the treatment of HIV/AIDS patients in a rural southern state.: J Health Soc Policy. 1997;9(1):77-82. Unique Identifier : AIDSLINE MED/97439351; Strahan ND; Gandy MJ; Mississippi State Department of Health, Jackson 39215, USA.; In Mississippi it was not known where Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Disease Syndrome (AIDS) persons receive care, what type of care is available to them, and how care is financed. To ascertain inpatient treatment charges of HIV/AIDS patients, a medical record review was conducted at 1
EMS and HIV: understanding the CDC's provisional guidelines for HIV post-exposure prophylaxis.: Emerg Med Serv. 1997 Jul;26(7):44-6, 63, 67. Unique Identifier : AIDSLINE MED/97456020; West K; Infection control/emerging concepts, Springfield, VA, USA.
The role of computed tomography in community-acquired pneumonia.: Adm Radiol J. 1997 Jun-Jul;16(6-7):30-3. Unique Identifier : AIDSLINE MED/97456011; Hofmann LV; Beall DP; Department of Radiology and Radiological Sciences, Johns Hopkins; Hospital, Baltimore, MD, USA.
Hepatitis C. New guidelines on precautions, follow-up.: OR Manager. 1997 Sep;13(9):38-9. Unique Identifier : AIDSLINE MED/97456124; An OR team has a greater chance of operating on a patient infected with hepatitis C than on a patient with HIV or hepatitis B. Many patients with HCV aren t critically ill, and the team may not know a patient is infected. HCV is more common than many think--an estimated 3.5 million people in the US are infected. The c
Impact of a longitudinal community HIV intervention targeting injecting drug users' stage of change for condom and bleach use.: Am J Health Promot. 1997 Sep-Oct;12(1):15-24. Unique Identifier : AIDSLINE MED/97448548; Jamner MS; Wolitski RJ; Corby NH; Center for Behavioral Research and Services, California State; University, Long Beach, USA.; PURPOSE: To evaluate the impact of the Long Beach AIDS Community Demonstration Project, a community-based HIV-prevention intervention incorporating principles from the Transtheoretical model in its design and evaluation. DESIGN: Repeated cross-sectional sampling with matched intervention and comparison communities. SE
May I ask you a personal question? The right to privacy and HIV testing in the European Community and the United States.: Fordham Law Rev. 1997 May;65(6):2775-824. Unique Identifier : AIDSLINE MED/97623501; Stanley AE
Providers need not disclose HIV status to third parties. Lemon v. Stewart.: J Healthc Risk Manag. 1997 Spring;17(2):45-6. Unique Identifier : AIDSLINE MED/97459518; West JC
European School of Oncology, Second Educational Convention, Vienna, Austria, 1996.: Eur J Cancer; 32A(Suppl 1):S1-S38 1996. Unique Identifier : AIDSLINE MED/97621845; Anonymous; No affiliation given; This supplement consists of the proceedings of the Second Educational Convention of the European School of Oncology held in Vienna, Austria , June 27-29, 1996. Session topic areas were molecular oncology; new drug development; lung cancer; leukemias and lymphomas; breast cancer; ga
Protection against HIV-1 induced apoptosis by inhibition of CPP32beta-related proteases (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A792 1997. Unique Identifier : AIDSLINE MED/97622045; McKenna KA; Dropulic B; Akhtar AJ; Thoburn C; Fuchs EJ; Hess AD; Bedi A; Johns Hopkins Oncology Center, Baltimore, MD 21287; Acquired immunodeficiency syndrome (AIDS) involves the depletion of CD4+ T cells through apoptosis mediated by the Fas surface receptor. Because Fas-induced apoptosis requires activation of the CPP32beta protease, we studied its role in HIV-induced apoptosis. We examined the effect of the HIV-1 Tat protein on apoptosi
The transforming gene product of the t(2;5) translocation of anaplastic large cell lymphoma transactivates the HIV-LTR in CD4+ T-cells (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A948 1997. Unique Identifier : AIDSLINE MED/97622089; Doseeva V; Butscher W; Wellmann A; Stetler-Stevenson M; Gardner K; Laboratory of Pathology, National Cancer Institute, National; Institutes of Health, Bethesda, MD; Anaplastic large cell lymphomas (Ki-1 Lymphoma) are a subclass of human malignant lymphomas with a highly characteristic morphology. These tumors have also been found to occur as an uncommon subtype of AIDS associated lymphomas. Anaplastic large cell lymphoma is associated with a chromosomal translocation [t(2;5)(p23;
Mobilization and collection of peripheral blood progenitor cells PBPC) from AIDS patients (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A157 1997. Unique Identifier : AIDSLINE MED/97622148; Law P; Schwarz L; Looney D; Gervaix A; Young D; Wong-Staal F; Ho AD; Lane TA; University of California, San Diego, CA; Hematopoietic stem cells are ideal vehicles for gene therapy because of their capacities of self-renewal and differentiation into all lineages of mature blood cells. In this study, we evaluated the possibility of mobilizing PBPC in AIDS patients by administration of G-CSF (10 mg/kg/dx6d). Leukapheresis product LP) of
HIV-related non-Hodgkin's lymphoma: centroblastic lymphoma (CL) is associated with better outcome than other histological subtypes (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A161 1997. Unique Identifier : AIDSLINE MED/97622152; Vaccher E; Nasti G; Simonelli C; Santarossa S; Tirelli U; Division of Medical Oncology and AIDS, Aviano Cancer Center, PN),; Italy; HIV-NHL represent an heterogeneous group of diseases, characterized by the presence of distinct molecular-pathological entities, but overall considered associated with a poor outcome. Controversy, however, exists concerning the outcome of CL. In this study we examined the relationship between pathological and clinical
Doxil in patients with pretreated metastatic breast cancer (MBC): a dose-schedule finding study with pharmacokinetics (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A516 1997. Unique Identifier : AIDSLINE MED/97622343; Gabizon A; Uziely B; Lotem M; Yehoshua Z; Tzemach D; Nathan S; Ganelin B; Brufman G; Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel; Doxil is a formulation of polyethylene-glycol coated liposomal doxorubicin used for the treatment of AIDS-related Kaposi s sarcoma. The aims of this study were to optimize the dose-schedule of Doxil and examine its pharmacokinetics in patients (pts) with MBC and previous chemotherapy. Four dose-schedules were investig
The possible role of soluble IL-6R in growth of AIDS-Kaposi's sarcoma cells (Meeting abstract).: Proc Annu Meet Am Assoc Cancer Res; 38:A791 1997. Unique Identifier : AIDSLINE MED/97622044; Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S; Huntington Memorial Hospital, Pasadena, CA 91105; Kaposi s sarcoma (KS) is most frequently associated with HIV-infected individuals. We found that the soluble IL-6R binding subunit (sIL-6Ralpha) functions as a potent growth factor for AIDS-KS cells, while IL-6 alone has no effect on KS cell growth. KS cells express considerable amounts of the signal transducing subun
Interleukin-12 (IL-12) secretion in Hodgkin's disease (HD) Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A138 1997. Unique Identifier : AIDSLINE MED/97622129; Viviani S; Notti P; Bonfante V; Camerini E; Santoro A; Ravagnani F; Pellegris G; Valagussa P; Bonadonna G; Istituto Nazionale Tumori, Milan, Italy; Recently, it has been suggested that cancer-related immunosuppression may depend at least in part on a Th1/Th2 cytokine imbalance, consisting of a decreased Th1-like, and increased type-2 cytokine secretion (Clerici M, J Natl Cancer Inst; 88:461 1996). In particular, IL-2
Evidence of activity of vinorelbine (VNR) in patients (pts) with previously treated epidemic Kaposi's sarcoma (KS) (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A146 1997. Unique Identifier : AIDSLINE MED/97622137; Errante D; Spina M; Tavio M; Vaccher E; Landonio G; Pagani L; Bottura P; Fasan M; Tirelli U; For the Italian Cooperative Group on AIDS and Tumors (GICAT), C.R.O.; Aviano, Italy; VNR is a new semisynthetic vinca alkaloid that seems to disorganize microtubules of the mitotic figure at a lower concentration than other vinca alkaloids. Moreover it does not affect the axonal microtubules. Vinca alkaloids are active agents in the treatment of KS and form the basis for combination regimens, but ther
Palliation of AIDS-related Kaposi's sarcoma of the head and neck mucosa using radiotherapy with altered fractionation to avoid local toxicity (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A159 1997. Unique Identifier : AIDSLINE MED/97622150; Jagetia R; Kiel KD; Von Roenn J; Dutta S; Northwestern Memorial Hospital and Northwestern University Medical; School, Chicago, IL; AIDS related Kaposi s Sarcoma (KS) frequently involves the oral cavity and can cause pain, difficulty swallowing, altered speech, and obstruction. Radiotherapy (generally 20 Gy in 2 Gy fractions daily) reduces tumor bulk but is frequently associated with severe mucositis, more than observed in non-AIDS patients. We ev
Phase I-II evaluation of Panretin (ALRT1057; LGD1057; AGN192013; 9-cis-retinoic acid) topical gel for AIDS-related cutaneous Kaposi's sarcoma (Meeting abstract).: Proc Annu Meet Am Soc Clin Oncol; 16:A160 1997. Unique Identifier : AIDSLINE MED/97622151; uvic M; Friedman-Kien AE; Miles SA; Looney DJ; Stevens V; Truglia J; Yocum R; University of Texas, Houston, TX; PANRETIN topical gel applied to Kaposi s sarcoma (KS) index lesions 1-4 times daily was evaluated for safety and efficacy in controlled Phase I-II studies. 115 AIDS patients with biopsy-proven KS were enrolled at nine centers. 752 treated index and 264 intrapatient control cutaneous KS lesions were evaluated. The cont
Long awaited HIV treatment guidelines released for public comment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):1, 9-14. Unique Identifier : AIDSLINE MED/97702721; The long-awaited AIDS treatment guidelines were published on June 19, replacing the obsolete guidelines written in 1993. The earlier guidelines, written before the development of viral load testing and protease inhibitors , recommended sub-optimal treatment using one
The turning point in the AIDS epidemic: new hope, new choices, but little hard data and lots of unanswered questions.: Crit Path AIDS Proj. 1997 Summer;(No 32):1, 15-8. Unique Identifier : AIDSLINE MED/97702722; Kuromiya K; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researcher David Ho s paper, published in a British journal in 1995, marked a turning point in the AIDS epidemic. Some of Dr. Ho s revolutionary findings in the pathogenesis of HIV are discussed, including the discovery that HIV does not lie dormant in the body for several years, that it reproduces constantly, and tha
Drug interactions: trials and tribulations and cocktails. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):4-9. Unique Identifier : AIDSLINE MED/97702723; People being treated for HIV frequently face drug reactions and interactions that can be unpleasant, severe, and unpredictable. Combinations of antiretrovirals and prophylactic medications can cause symptoms that negatively impact quality of life or alter the effectiveness of some of the medications. In addition, peop
Compassionate release in California.: Crit Path AIDS Proj. 1997 Summer;(No 32):20-2. Unique Identifier : AIDSLINE MED/97702724; Greenspan J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Catholic Charities of the East Bay, HIV/AIDS in Prison Project,; Oakland, CA.; Several States have instituted compassionate release programs to allow terminally ill inmates to be released early. The programs are politically sensitive, and the California program is highlighted. Early release, called recall of sentence under the State penal code, is a lengthy and cumbersome process that has result
PWA prisoner resources. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):23-4. Unique Identifier : AIDSLINE MED/97702725; The incarcerated population of the United States is the only one with a constitutional right to health care, but most care is substandard. A list of resource agencies is included, with brief descriptions of their audience group. It includes a number of prominent AIDS organizations with
A reportback from the Third National Conference on Women and HIV.: Crit Path AIDS Proj. 1997 Summer;(No 32):25-7. Unique Identifier : AIDSLINE MED/97702726; Russell A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS Coalition To Unleash Power Philadelphia, Philadelphia, PA.; The Third National Conference on Women and HIV addressed a number of important issues related to infection rates, treatments, and research specific to women. While overall death rates for infected men decreased 15 percent in 1996, the rate for women increased 3 percent. The men s decrease is widely attributed to poten
Health advisory: high blood sugar and diabetes seen in protease inhibitor users. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):28. Unique Identifier : AIDSLINE MED/97702727; The Food and Drug Administration ( FDA ) has warned physicians that protease inhibitors may contribute to increased blood sugar or diabetes in HIV-positive patients, and recommends closely monitoring their glucose levels. These events
Medical alert: hemolytic anemia in Crixivan cohort. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):28-9. Unique Identifier : AIDSLINE MED/97702728; Merck is adding a warning label to indinavir ( Crixivan ) as a result of 20 cases of hemolytic anemia reported among the 140,000 people currently using the drug. The disease causes a pr
DMP 266 study opens at Jefferson. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):30-1. Unique Identifier : AIDSLINE MED/97702730; Dupont Merck announced that its experimental non-nucleoside reverse transcriptase inhibitor DMP 266 has shown viral load reductions to undetectable levels in eighty percent of study subjects. CD4 counts also increased among the study group. Other studies are underway to study DMP 266 at higher dosages and in combinati
Nelfinavir: fourth protease inhibitor approved. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):31-2. Unique Identifier : AIDSLINE MED/97702732; The Food and Drug Administration ( FDA ) has granted accelerated approval to nelfinavir in both adult and pediatric formulations. Agouron , the manufacturer, used innovative computerized drug design techniques to discover, design, and refine the nelfi
Philadelphia area AIDS/HIV clinical trials. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):35-44. Unique Identifier : AIDSLINE MED/97702733; This listing of all currently active clinical trials in the Philadelphia area attempts to be an exhaustive list. Contact information, including web sites and phone numbers, are included for each. Participation in trial is extremely limited, and most trials do not require hospitalization. The purposes of each phase of
Expanded access and patient assistance programs for other experimental drugs from their manufacturers. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):44-64. Unique Identifier : AIDSLINE MED/97702734; The cost of prescription drugs for AIDS treatment is high, and many people have inadequate insurance to cover them. Several pharmaceutical companies have set up hotlines and patient assistance programs to help people get the drugs. Most programs require a physician to do the actual enrollment of patients into the prog
The buyers' clubs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):64-6. Unique Identifier : AIDSLINE MED/97702735; Buyers clubs exist to help people with AIDS obtain substances that are normally unavailable to them for a variety of reasons: the substances are illegal, the drugs are not FDA-approved, or the substances are alternative medicines that are generally unavailable in the United States . Co
Want children? Cum clean.: Posit Aware. 1997 Mar/Apr;8(2):9. Unique Identifier : AIDSLINE MED/97702737; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researchers are cautiously optimistic that HIV-positive men with undetectable viral loads may be able to have children with HIV-negative women, without infecting either their partner or their baby. A Spanish study showed that 70 percent of the people transmitting the virus had viral loads greater than 15,000 copies. U
Preparing for the future.: Posit Aware. 1997 Mar/Apr;8(2):10-1. Unique Identifier : AIDSLINE MED/97702738; Cox S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Several new anti-HIV drugs show great promise in future treatments. Nelfinavir, especially effective in combination with AZT and 3TC , is a new protease inhibitor with fewer and milder
New protease inhibitor for children.: Posit Aware. 1997 Mar/Apr;8(2):11. Unique Identifier : AIDSLINE MED/97702739; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; At the International Conference held in Vancouver, ritonavir Norvir ) and indinavir (
Thalidomide trial to begin. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Posit Aware. 1997 Mar/Apr;8(2):15. Unique Identifier : AIDSLINE MED/97702741; Celgene Corporation is enrolling 84 patients living with AIDS, including children, in a trial of thalidomide (Synovir). Thalidomide caused severe birth defects decades ago, however, it has been shown to be effective in treating AIDS-related aphthous ulcers and wasting syndrome.
Nelfinavir (Viracept) moves up the ranks.: Posit Aware. 1997 Mar/Apr;8(2):16-7. Unique Identifier : AIDSLINE MED/97702742; Grodeck B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The anticipated approval of the protease inhibitor nelfinavir Viracept ) will be good for those patients who cannot tolerate the other drugs in that class. Nelfinavir has milder and fewer side effects, and is effective in
The psychology of compliance.: Posit Aware. 1997 Mar/Apr;8(2):18-20. Unique Identifier : AIDSLINE MED/97702743; Condor B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Chicago Tribune, Chicago, IL.; There is no single personality trait, psychological condition, socioeconomic factor or stage of disease that can reliably be used to predict drug compliance. Missing doses of protease inhibitors can lead to drug resistance, so complying with a treatment regimen is c
Whole body health.: Posit Aware. 1997 Mar/Apr;8(2):28-35. Unique Identifier : AIDSLINE MED/97702745; Austin E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Alternative therapies, widely used by Americans, include yoga, relaxation techniques, and herbal medications, as well as less conventional and more experimental treatments. The AIDS Research Center in Seattle is conducting the largest study of alternative therapies. Many alternative therapies are used as complements t
Needle exchange: why don't the feds get the point?: Posit Aware. 1997 Mar/Apr;8(2):36-40. Unique Identifier : AIDSLINE MED/97702746; Beaubien G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; There is no doubt that needle-exchange programs can reduce the incidence of HIV and other blood-borne diseases, however, the issue remains contentious and controversial in the United States . At least half of all new HIV infections in the United States can be traced to risky injection d
Resources for prisoners.: Posit Aware. 1997 Mar/Apr;8(2):46-9. Unique Identifier : AIDSLINE MED/97702747; Bejlovec R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Resources for inmates to use to educate themselves on HIV/AIDS are provided. Contact information and a description of the services that are available are detailed for each group, including whether the group accepts collect phone calls. Also included is a listing of journals and newsletters specific to the prison popul
Major pediatric study stopped early: combination treatment better.: AIDS Treat News. 1997 Jul 4;(No 274):5-6. Unique Identifier : AIDSLINE MED/97702751; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The National Institute of Allergy and Infectious Diseases (NIAID) stopped a clinical trial (ACTG 300) of more than 600 children because of obvious benefits of the combination of zidovudine AZT ) plus lamivudine (
Saquinavir: major study shows survival benefit in treatment-naive patients.: AIDS Treat News. 1997 Jul 4;(No 274):6. Unique Identifier : AIDSLINE MED/97702752; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The largest trial ever on AIDS treatment (3,400 volunteers with little or no prior antiviral treatment) reveals that triple drug treatment using saquinavir plus zidovudine ( AZT ) plus zalcitabine
Internet free speech upheld.: AIDS Treat News. 1997 Jul 4;(No 274):7-8. Unique Identifier : AIDSLINE MED/97702753; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Now that the U.S. Supreme Court has ruled the key provisions of the Communications Decency Act as unconstitutional, AIDS organizations are freer to publish safer-sex information on the Internet without fear of being prosecuted. More information on the Supreme Court decision can be obtained through the following organi
Pediatric trial of 141W94, Vertex protease inhibitor. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jul 18;(No 275):3. Unique Identifier : AIDSLINE MED/97702755; A new trial of the experimental protease inhibitor 141W94 VX-478) is being conducted with protease inhibitor-naive patients aged between 6 months and 18 years, and with viral loads of at least 10,000 copies. The trial is testing antiviral effect at 16 weeks and durability at 48 weeks. A phase III study of adult patien
Pediatric 1592 compassionate use program begins. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Jul 18;(No 275):3. Unique Identifier : AIDSLINE MED/97702756; Glaxo Wellcome is running a compassionate use program for pediatric users of its experimental antiretroviral, 1592 1592U89). The program is open to patients 6 months to 14 years old who are at high risk of disease progression or death despite current treatments. Physicians
World wide web AIDS medical information.: AIDS Treat News. 1997 Jul 18;(No 275):4-8. Unique Identifier : AIDSLINE MED/97702757; Tobias TT; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Current high-quality medical information is becoming more accessible via the Internet. Some of the timely and valuable information is from professional conference reports and research databases such as MEDLINE and AIDSLINE. Other information available in this format includes very current standards of medical care, ful
Of clades and quasispecies: making sense of the HIV population census.: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):13-25. Unique Identifier : AIDSLINE MED/97702758; Mascolini M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A great debate over the genetic evolution of HIV is under way. This article examines the many attempts to trace this evolution and includes discussions on how selection may drive HIV s evolution, and the controversy surrounding the effect of virion population and the difficulty in measuring it. Reasons clinicians shou
Focus on fungal infections.: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):27-32. Unique Identifier : AIDSLINE MED/97702759; MacDougall DS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New approaches to the diagnosis, treatment, and prevention of fungal infections were discussed at Focus on Fungal Infections in 1997. This article examines the use of early presumptive treatment for candida fungemia, the cause of and treatment for recurrent vulvovaginal candidiasis, and the treatment and prevention pr
Resistance, recombination, evolution--and chance: an interview with Andrew J. Leigh Brown, PhD. [interview by Mark Mascolini]: J Int Assoc Physicians AIDS Care. 1997 Jul;3(7):34-7. Unique Identifier : AIDSLINE MED/97702760; Brown AJL; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Andrew J. Leigh Brown, Ph.D. provides his insights on the transmission of drug-resistant virus, the role of chance in viral evolution, how often recombination might influence viral evolution in an individual, and moving from theory to practice in the fight against HIV. Dr. Brown states that no data currently exist
Guidelines shed light on identifying failed regimens. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):87-8. Unique Identifier : AIDSLINE MED/97702761; The new Federal guidelines for HIV treatment address the issues related to failed drug regimens, whether due to compliance, interruption, or drug interactions. The guidelines also distinguish between changing therapy for drug failure and drug toxicity. Doctors are urged to modify elements of the program if viral loads
Training centers gear up to teach new standards. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):89-90. Unique Identifier : AIDSLINE MED/97702762; Public health officials have designed a series of training programs to give primary care providers access to information from the new Federal guidelines for HIV treatment, and to insure that physicians receive adequate training to apply the recommended treatment effectively. The new guidelines demonstrate the complexi
New treatment a cure? Moment of truth draws nigh. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):90-2. Unique Identifier : AIDSLINE MED/97702763; A group of patients who have been treated aggressively has remained clear of HIV infection for two years. Biopsies of their lymph nodes, spinal fluid and semen also indicate that they are free of infection. Theoretically, these patients are cured, and they will soon have treatment terminated to test whether that is tr
Protease inhibitors linked to drop in CMV retinitis. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):92-4. Unique Identifier : AIDSLINE MED/97702764; Several studies suggest that protease inhibitor therapy is linked with a decrease in cases of cytomegalovirus ( CMV ) retinitis, as high as 50 percent at one institute. CMV retinitis afflicts about 40 percent of AIDS patients,
PCR could help screen patients for CMV treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):94-5. Unique Identifier : AIDSLINE MED/97702765; Polymerase chain reaction (PCR) testing is an effective and economical means to screen patients at high risk of cytomegalovirus ( CMV ) retinitis. Current guidelines recommend ophthalmological reviews every three or four months
Patients should know principles behind new guidelines. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Aug;12(8):suppl 1-4. Unique Identifier : AIDSLINE MED/97702766; The principles behind the new Federal HIV treatment guidelines are described for patients. The benefits and side effects of the new antiretroviral treatments are described. Testing options, preferred treatments, considerations for changing failing drug regimens, and guidelines for treating pregnant women are also disc
Postexposure prophylaxis for HIV.: AIDS Clin Care. 1997 Aug;9(8):59-61, 66. Unique Identifier : AIDSLINE MED/97702767; Daily JP; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Brigham and Women's Hospital, Boston, MA.; Postexposure prophylaxis represents an advance in the management of percutaneous exposure to HIV in the workplace, but its efficacy in other settings needs further study. Three types of occupational exposure, percutaneous, mucous membrane, skin contact or loss of skin integrity, the postexposure prophylaxis to be used
Pursuing a diagnosis in a Caribbean man.: AIDS Clin Care. 1997 Aug;9(8):62-3. Unique Identifier : AIDSLINE MED/97702768; Gulick RM; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New York University, Medical Center, New York, NY.; A case study of an HIV-infected Caribbean male with extrapulmonary tuberculosis details his diagnosis, treatment regimens, and follow-up. His presenting symptoms included epigastric pain and fever. Endoscopy and gastric biopsy showed gastritis and helicobacter infection, which were treated symptomatically, and TMP-SMX
CMV trial enrolling.: Posit Aware. 1997 Jul/Aug;8(4):13. Unique Identifier : AIDSLINE MED/97702769; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A clinical trial is enrolling HIV patients who are newly diagnosed with cytomegalovirus ( CMV ) retinitis in pill form. The study will compare intravenous ganciclovir (Cyotvene) to ganciclovir prodrug, a chemically altered vers
Is it safe to suck?: Posit Aware. 1997 Jul/Aug;8(4):15. Unique Identifier : AIDSLINE MED/97702771; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; At a recent HIV workshop held in Chicago, IL, researcher David G. Ostrow discussed the results of four clinical studies on oral sex that yielded a range of conclusions. Of the 548,102 AIDS cases that have been recorded in the United States , between 3 and 17 cases occurred because of or
A growing threat: cancer.: Posit Aware. 1997 Jul/Aug;8(4):21-3. Unique Identifier : AIDSLINE MED/97702772; Altman LK; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Malignant tumors, particularly Kaposi s sarcoma and certain cancers of the lymph system, have been common in AIDS patients since 1981. The array of cancers is broadening and researchers are looking for insight into the increases in frequency. An emerging theory is that most AIDS-related cancers are linked to viral inf
Why the old saquinavir (Invirase) may be bad for your health.: Posit Aware. 1997 Jul/Aug;8(4):28-31. Unique Identifier : AIDSLINE MED/97702774; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS activists argue that the original formulation of saquinavir may be damaging to people s health and urge those who are considering using saquinavir to wait until the new version of the drug is available. Saquinavir s manufacturer, Roche Laboratories , is being criticized for aggr
Resistance testing.: Posit Aware. 1997 Jul/Aug;8(4):35-7. Unique Identifier : AIDSLINE MED/97702775; Munk B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Clinical resistance, phenotypic resistance, genotypic resistance, and drug resistance are a few of the terms used to define resistance. Drug resistance refers to HIV s ability to live and multiply even when it is exposed to a lethal dose of antiviral drugs. Clinical resistance occurs when a patient s HIV disease gets
A new game plan.: Posit Aware. 1997 Jul/Aug;8(4):41-50. Unique Identifier : AIDSLINE MED/97702776; Cox S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Office of AIDS Research (OAR) at the National Institutes of Health (NIH) and the US Public Health Service (PHS) assembled committees to recommend a new standard of treatment for HIV infection. Treatment guides designed in response to the recommendations are provided. The guides include recommendations for viral lo
[The Fourth Retroviruses Conference: good news with precautions]: Sidahora. 1997 Apr/May;:14-7. Unique Identifier : AIDSLINE MED/97702778; Arboleda CH; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Gay Men's Health Crisis, New York, NY.; The Fourth Conference on Retroviruses and Opportunistic Infections was held in Washington, D.C. in January 1997. Topics that were presented at the conference include reduced AIDS mortalities in New York, reduced hospitalizations for opportunistic infections, clinical advances in antiretroviral therapies, and treatment
[New knowledge and new challenges: 4th National Conference on Retroviruses & Opportunistic Infections]: Sidahora. 1997 Apr/May;:18-21. Unique Identifier : AIDSLINE MED/97702779; Agosto M; Ehara R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; National Minority AIDS Council, Washington, DC.; While complete viral suppression of HIV and the use of new combination therapies are quickly becoming the standard for HIV treatment, many questions about this new knowledge are being raised. The Fourth National Conference on Retroviruses and Opportunistic Infections in 1997 began addressing many of these questions. A
[How to go on vacation with HIV]: Sidahora. 1997 Apr/May;:22-5. Unique Identifier : AIDSLINE MED/97702780; Jensen J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; People living with HIV must be careful about what they eat, especially while on vacation. Recommendations to ensure a safe and enjoyable trip are provided. Some of the recommendations include getting immunized, carrying preventive drugs, and being selective about ordering meats. Guidelines are given on how to pack foo
[How to reveal to children that they are infected with the HIV virus]: Sidahora. 1997 Apr/May;:26-31. Unique Identifier : AIDSLINE MED/97702781; Lipson M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Harlem Hospital Center, New York, NY.; Revealing to a child his or her positive HIV status is not only a clinical dilemma, it is also an ethical dilemma. Parents question when to tell the child, when the child is mature enough to understand, who should tell the child, and whether not telling would protect the child. A number of situations must be considere
[Straight jacket]: Sidahora. 1997 Apr/May;:39-41. Unique Identifier : AIDSLINE MED/97702782; Vasquez D; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Living with HIV in today s prisons can be devastating. Issues such as lost hope, an uncertain future, inequality, and survival are discussed. A comparison is made between the conditions within prison versus the conditions outside of prison for HIV-infected persons. How these prisoners survive within prison is discusse
[HIV infection and vision problems]: Sidahora. 1997 Jun/Jul;:8-13. Unique Identifier : AIDSLINE MED/97702783; Arboleda CH; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Gay Men's Health Crisis, New York, NY.; Visual manifestations of HIV infection and AIDS can present in a variety of ways. Different types of ocular infections are classified and factors that affect diagnosis and treatment are explained. Complications to the eyelids and anterior and posterior parts of the eye are addressed. Steps to determine the presence of
[More color in life: interview with Jairo Pedraza, an activist living with CMV]]: Sidahora. 1997 Jun/Jul;:14-9. Unique Identifier : AIDSLINE MED/97702784; Pedraza J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Jairo Pedraza, who is HIV-positive and living with cytomegalovirus ( CMV ), responds to questions on how he has dealt with the disease. Jairo tells how he reacted to learning that he is HIV-positive, and explains the steps that
[Fighting with humor: interview with Enrique Andino, an activist living with CMV]: Sidahora. 1997 Jun/Jul;:20-6. Unique Identifier : AIDSLINE MED/97702785; Andino E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Enrique Andino, who is HIV-positive and living with cytomegalovirus ( CMV ), discusses his personal experiences of living with the disease. Enrique discusses his CMV symptoms, the types of treatments he used, and the results of
[Detecting changes in your vision] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:27-8. Unique Identifier : AIDSLINE MED/97702786; Sudden changes in vision, an increase of floating particles in the eye, and blurry vision are signals that it is time to visit an ophthalmologist. Ways to assess central and peripheral vision, such as focusing on a word on paper and moving the paper, are explained. Using this method daily makes it easier to notice vis
[Ocular troubles and HIV/AIDS] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:29-32. Unique Identifier : AIDSLINE MED/97702787; People living with HIV/AIDS are more prone to ocular conditions due to their weakened immune systems. The symptoms of HIV-related ocular conditions, such as cotton wool spots from cytomegalovirus infections, ocular hemorrhage, Kaposi s sarcoma (KS), keratitis, conjunctivitis, ocula
[Crisis in Puerto Rico - Regulation 87] Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Sidahora. 1997 Jun/Jul;:33. Unique Identifier : AIDSLINE MED/97702788; On February 22, 1997, the Puerto Rico Health Department passed Regulation 87, requiring doctors to disclose all HIV-positive cases to the Health Department. A coalition of gay and lesbian activists and organizations claim that Regulation 87 is an invasion of privacy. The direct
[Crisis in Puerto Rico - Project 325]: Sidahora. 1997 Jun/Jul;:34-5. Unique Identifier : AIDSLINE MED/97702789; Vargas JA; Torres A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Project 325, a needle-exchange program for injection drug users, began in 1995 in Puerto Rico . Opinions on the successes, failures and contradictions of the project, and ways to fight the ban on the distribution of drug paraphernalia are presented. The similarities of Project 3
[Advances and obstacles in the fight against AIDS in Venezuela]: Sidahora. 1997 Jun/Jul;:41-2. Unique Identifier : AIDSLINE MED/97702790; Moreno-Uribe EA; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Panos Institute, Washington, DC.; It is no secret to the Venezuelan authorities that hundreds of citizens living with HIV/AIDS left the country (mainly to Canada and the United States ) in search of treatment to prolong their lives. People who received treatment got better but were f
[The letters of my AIDS]: Sidahora. 1997 Jun/Jul;:47. Unique Identifier : AIDSLINE MED/97702792; Gutierrez J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; On March 15, 1997, members of the National Organization of Latino Gays and Lesbians (LLEGO) and the HIC Community Coalition (HCC) gathered together to present a program on HIV/AIDS education and prevention. The program brought together various communities in Maryland who are infected or affected by HIV/AIDS. The thoug
Government urges early, aggressive treatment of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):1, 12-3. Unique Identifier : AIDSLINE MED/97702794; June 19, 1997 marked the issuance of clinical guidelines for HIV treatment. The guidelines, issued by a panel convened by the Department of Health and Human Services (HHS) and the Henry J. Kaiser Foundation, recommend treating the infection at an earlier stage and using a three-drug regimen that includes a protease in
Accused stabber need not submit to HIV test, court says. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):2. Unique Identifier : AIDSLINE MED/97702795; A Florida Court of Appeals overturned a judge s order directing a woman charged in a stabbing to submit to an HIV test because there was no evidence that the defendant s body fluids touched the victim. The court said the scope of mandatory HIV testing is limited to cases in which the defendant exposes the victim to bo
ADAPs remain in crisis as demand grows for new drugs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):3. Unique Identifier : AIDSLINE MED/97702796; Many State-run AIDS drug assistance programs (ADAPs) remain in perilous financial situations despite an infusion of government funds. Between 1996 and 1997 the amount of money that Federal and State governments spent on the programs rose 85 percent, yet 35 States have had to enact emergency measures within that time f
Illinois court seeks new course in AIDS phobia cases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):4-5. Unique Identifier : AIDSLINE MED/97702798; The Illinois Court of Appeals ruled that plaintiffs cannot be compensated for negligent infliction of emotional distress unless there is a substantial, medically-verifiable possibility of contracting HIV. The new standard will impact a growing body of case law requiring plaintiffs to show that the fear of AIDS was pre
Recent rulings by other courts in AIDS phobia claims. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):6-7. Unique Identifier : AIDSLINE MED/97702799; Local, State, and Federal courts have not responded uniformly to fear-of-AIDS claims. The majority of the Supreme and Appeals courts have limited recovery of emotional distress to situations in which the plaintiff was exposed to HIV and faced a realistic prospect of contracting the virus. In California, a shopper who
Court overturns verdict favoring gay lawyer who was fired. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):8-9. Unique Identifier : AIDSLINE MED/97702801; The Colorado Supreme Court ruled that a lower court misapplied a smoker s right law meant to stop employers from penalizing workers for legal conduct outside of the office. A new trial has been ordered for Robert P. Borquez, who received a jury award for more than $90,000. Borquez was considered a highly-regarded atto
Report outlines State-run insurance continuity programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):9. Unique Identifier : AIDSLINE MED/97702802; The National Alliance of State and Territorial AIDS Directors NASTAD) issued a brief that analyzes States responses to health insurance continuity programs for people with HIV. The government makes premium payments for individuals who cannot afford to maintain their existing private health insurance in at least 35 St
Home test kit for HIV fails to capture public's interest. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):14. Unique Identifier : AIDSLINE MED/97702804; Direct Access Diagnostics, a subsidiary of Johnson & Johnson , announced on June 26, 1997 that it was discontinuing its Confide kit due to lack of consumer demand. It took nine years for Direct Access Diagnostics to be approved, followed by a legal battle between Johnson & Joh
Court affirms conviction for peddling phony AIDS cure. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):15. Unique Identifier : AIDSLINE MED/97702805; In 1996, Charles R. Pixley was convicted on charges of conspiracy and introducing an unapproved drug into interstate commerce and the 2nd U.S. Circuit Court of Appeals upheld the conviction. Pixley s company, Writers and Researchers Inc. sold a drug called 714X to individuals and physicians, promoting it as a nontoxic
Funeral home settles. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):16. Unique Identifier : AIDSLINE MED/97702806; Michael s Funeral Home in Schaumburg, ILL settled an AIDS discrimination claim after a judge and a county human rights agency both determined that the survivor in a gay relationship has the legal standing to file an AIDS discrimination complaint. Brian Rabe filed complaints with the Cook County Human Rights Commission
HIV charge dropped. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):16. Unique Identifier : AIDSLINE MED/97702807; Guilford County Superior Court Judge James Webb ruled there was not enough evidence to convict HIV-positive Andrew Lee Monk on charges of attempted murder and assault with a deadly weapon in connection with the rape of a 12-year-old girl. Prosecutors argued Monk knew he was HIV-positive when the rape occurred and defe
1592 adult compassionate-use program announced. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Aug 1;(No 276):1. Unique Identifier : AIDSLINE MED/97702808; Few patients will be able to enroll in the newly announced 1592 open-label protocol due to the limited drug supply. To be eligible for this Protocol CNAA/B3008, patients must be over 13 years of age, have a CD4 count lower than 100, and a viral load of at least 30,000 copies within 60 days of registration. Potential p
Federal AIDS policy issues today.: AIDS Treat News. 1997 Aug 1;(No 276):2-8. Unique Identifier : AIDSLINE MED/97702809; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Congress and the White House are currently grappling with a range of AIDS-related issues, including funding, treatment, and health care access. An outline of the current Federal AIDS issues is provided, including information regarding a significant decline in the AIDS-related death rate, antiviral medications and
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.: BETA. 1997 Mar;:3-4. Unique Identifier : AIDSLINE MED/97702810; Baker R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A 3-drug AIDS treatment trial, ACTG 320, was halted early after it became clinically evident that the therapy was superior to 2-drug combinations in reducing death rates and new AIDS-related illnesses. The study demonstrates the superiority of indinavir
Nelfinavir (Viracept).: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702811; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Food and Drug Administration ( FDA ) is expected to grant accelerated approval for nelfinavir ( Viracept ) by mid-March 1997. Nelfinavir, a potent inhibitor of HIV replication when used in 3-drug therapies with
141 (Vertex-478).: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702812; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Glaxo Wellcome s (GW) second generation protease inhibitor Vertex-478 (141) is now in Phase II studies. Vertex-478 is being combined with either AZT / 3TC or 1592 (a new nucleoside anal
Ritonavir and ecstasy.: BETA. 1997 Mar;:5. Unique Identifier : AIDSLINE MED/97702813; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; An overdose death from ecstasy (MDMA) is reported on the Internet. It is believed that the high blood concentration of MDMA in the deceased s body was caused by an interaction with ritonavir , making the liver unable to break down MDMA.
Needle exchange.: BETA. 1997 Mar;:6. Unique Identifier : AIDSLINE MED/97702814; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dozens of needle-exchange programs across the country have concluded that needle-exchange programs work, thus leading to the endorsement by the National Academy of Sciences, the Centers for Disease Control and Prevention (CDC), and the General Accounting Office. It is believed that 10,000 lives could have been saved i
Medical marijuana.: BETA. 1997 Mar;:6. Unique Identifier : AIDSLINE MED/97702815; Baker R; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Grassroots AIDS activist groups denounce the Clinton Administration s stance on banning medicinal use of marijuana due to the lack of clinical evidence supporting its benefits. The 1997 meeting of the San Francisco Medical Society and the New England Journal of Medicine both agreed, following a review of 75 scientific
Hydroxyurea.: BETA. 1997 Mar;:9-11. Unique Identifier : AIDSLINE MED/97702816; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Hydroxyurea, an inhibitor of ribonucleotide reductase in cells, is among the strategies being used to reduce HIV levels. Hydroxyurea disrupts DNA synthesis in rapidly dividing cells and reduces the number of deoxyribonucleotides available to make functional viral products. The combination of hydroxyurea and ddI have s
Psychiatric aspects of HIV.: BETA. 1997 Mar;:12-3, 17. Unique Identifier : AIDSLINE MED/97702817; Romeyn M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Andrew Ziegler Foundation, San Francisco, CA.; HIV-positive men and women have unique psychiatric needs that need to be addressed by medical professionals. Some of the latest developments in the study of psychiatric manifestations of HIV disease are summarized, including an examination of each of the manifestations, the potential for drug interactions, and treatme
Peripheral neuropathy.: BETA. 1997 Mar;:14-7. Unique Identifier : AIDSLINE MED/97702818; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; As HIV and AIDS patients live longer, more neurologic disorders are being reported that require prompt identification and treatment. Neuropathies can be caused by nutritional deficiencies, antiretroviral or chemotherapy drugs, certain toxins such as alcohol, and coexistance of other illnesses such as diabetes. Each of
New studies of methods for preventing perinatal HIV transmission.: BETA. 1997 Mar;:20. Unique Identifier : AIDSLINE MED/97702819; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A number of AIDS clinical trials group studies are investigating the prevention of perinatal HIV transmission (PHT) using triple regimens. Each study generally requires that pregnant women begin prophylactic regimens during the latter part of their pregnancy. Dosing during delivery will involve intravenous infusions o
NIH reaffirms support for perinatal AZT despite cancer findings. National Institutes of Health.: BETA. 1997 Mar;:21. Unique Identifier : AIDSLINE MED/97702820; Highleyman L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Although two studies have potentially linked cancer in children of HIV-positive women to those who use AZT to prevent perinatal HIV transmission, the National Institutes of Health (NIH) recommends that the current U.S. Public Health Service guidelines
Chemokines and HIV.: BETA. 1997 Mar;:22-7. Unique Identifier : AIDSLINE MED/97702821; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Chemokines are being studied to better identify new ways to treat HIV disease, including the development of a vaccine. Chemokine studies have suggested that a cell antiviral factor, a soluble factor secreted by CD8 cells that appears to slow or halt HIV progression in some people, exists. Three chemokines from CD8 cel
Selected highlights from the 4th Conference on Retroviruses and Opportunistic Infections.: BETA. 1997 Mar;:29-38, 41-51. Unique Identifier : AIDSLINE MED/97702822; Bartnof HS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; San Francisco AIDS Foundation, San Francisco, CA.; The 1997 Fourth Conference on Retroviruses and Opportunistic Infections explored the benefits of newer combination therapies and their effect on HIV in lymphoid tissues, HIV-related drug interactions, HIV therapies that are in the pipeline, chemokine research, and recent insights into HIV/AIDS pathogenesis. Highlights
Open clinical trials for HIV/AIDS treatments.: BETA. 1997 Mar;:52-6. Unique Identifier : AIDSLINE MED/97702823; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; New or changed information is presented concerning the goals and protocols of ongoing HIV/AIDS treatment clinical trials. Clinical trials for treatment of HIV infection, opportunistic infections, malignancies, wasting syndrome, immune enhancement, children and adolescents, and women are highlighted. Also included are
The 1592 controversy.: BETA. 1997 Jun;:6-10. Unique Identifier : AIDSLINE MED/97702824; Baker R; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Activists are urging Glaxo Wellcome to make 1592 ( abacavir ) more readily available in the United States . It is in Phase III trials and there is a compassionate use program
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS). Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: BETA. 1997 Jun;:11-22. Unique Identifier : AIDSLINE MED/97702825; The draft Federal guidelines on the use of antiretrovirals in treating adults and adolescents are reprinted. References, panel members names, and some charts and graphs have been left out, ordering information for the full report is included. The guidelines were issues in June 1997 by the U.S. Department of Health an
Nausea and vomiting.: BETA. 1997 Jun;:23-6, 58. Unique Identifier : AIDSLINE MED/97702826; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Nausea and vomiting are frequent, distressing symptoms in HIV and AIDS patients, who are susceptible at any stage of treatment to these debilitating and sometimes life-threatening conditions. A common adverse consequence is that nausea and vomiting can interfere with a patient s ability to follow a prescribed drug reg
Food safety guidelines.: BETA. 1997 Jun;:27, 58. Unique Identifier : AIDSLINE MED/97702827; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Symptoms of nausea, vomiting, and diarrhea to a nonspecific food poisoning can be life-threatening for people with AIDS, particularly for those in the later stages of the disease. Recurrent bouts can lead to additional immune suppression, wasting, and death. Guidelines are provided for insuring that food purchasing an
Diarrhea.: BETA. 1997 Jun;:28-32, 58. Unique Identifier : AIDSLINE MED/97702828; Bowers M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Diarrhea is the greatest single cause of illness and death worldwide, and can be fatal to people with AIDS, 80 percent of whom suffer from diarrhea. There are many causes of diarrhea: bacterial and parasitic infections, opportunistic infections, and contact with contaminated water and food supplies. The physiology of
Selected highlights from the National Conference on Women & HIV, Pasadena, CA, May 4-8, 1997.: BETA. 1997 Jun;:38-45. Unique Identifier : AIDSLINE MED/97702829; Hanna L; Bartnof HS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Major findings from the National Conference on Women and HIV are presented. Topics include advances in immunology and virology, studies on gender and pain perception, candidiasis in women, chronic endometriosis in acute pelvic inflammatory disease, wasting syndrome, HIV-related cancers, and prevention technologies. Ti
Back to the future: survival, uncertainty, and hope.: Focus. 1997 Jun;12(7):1-4. Unique Identifier : AIDSLINE MED/97702831; Rose A; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Tri-City Health Center, Fremont, CA.; The HIV/AIDS epidemic is compared to the World War II-era Holocaust during which millions of people were persecuted. Those infected and affected by HIV/AIDS are described as undergoing a form of post-traumatic stress disorder. People who provide physical, social, and mental health care services to HIV/AIDS clients are
Clearinghouse: hope and uncertainty. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Focus. 1997 Jun;12(7):4-5. Unique Identifier : AIDSLINE MED/97702832; The field of post-traumatic stress syndrome, as it relates to disease survival and HIV/AIDS, is the subject of books, papers, and research. This reference section lists material related to patient outlook and despair, living with uncertainty, loss and grief, and survival mechanisms. Research contacts in Fremont, CA an
A history of hope: the HIV roller coaster.: Focus. 1997 Jun;12(7):5-7. Unique Identifier : AIDSLINE MED/97702833; Shernoff M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Hunter College, School of Social Work, New York, NY.; The introduction of combination therapies has changed HIV/AIDS from a terminal illness to a chronic manageable condition. The evolution of hope and hopelessness in the HIV/AIDS arena is tracked and related to the current treatment paradigm. Hope is often the essential element for patients coping with a diagnosis of HI
Florida court rejects assisted suicide for AIDS patient. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):1, 5. Unique Identifier : AIDSLINE MED/97702837; A 5-1 Florida Supreme Court ruling reversed a circuit court judge s decision granting a man with AIDS the right to physician-assisted suicide. There are no further options left for Charles E. Hall, who had sought the judge s permission in January 1997 to have his doctor administer a lethal dose of painkillers. In June
New Jersey allows lawsuits based on reasonable fear of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):1, 10-1. Unique Identifier : AIDSLINE MED/97702838; The New Jersey Supreme Court ruled that a fear of HIV transmission lawsuit may proceed even though no actual exposure occurred. The court added that the suit may be brought only if the fear is justified by state of the art knowledge about the mechanisms of HIV transmission. Most State supreme courts that have consider
Court grants pianist's ex-partner chance to amend suit. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):2. Unique Identifier : AIDSLINE MED/97702839; The Texas Court of Appeals issued rulings in favor of the renowned pianist, Van Cliburn, in the breach-of-contract suit brought against him by his ex-domestic partner, Thomas E. Zaremba. Zaremba alleged that he and Cliburn had an unwritten understanding that they could share Cliburn s income in exchange for the manage
Supreme Court strikes down Montana's sodomy law. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):3. Unique Identifier : AIDSLINE MED/97702840; The Montana Supreme Court struck down the State s sodomy law and ruled that the law violates the State constitutional right to privacy. Until this ruling, all homosexual relations were labeled deviate sexual conduct, punishable by a $50,000 fine and 10 years in prison. No one had been prosecuted under the law since it
Two States sanction needle-exchange programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):4. Unique Identifier : AIDSLINE MED/97702841; The Maine and New Hampshire State legislatures authorized the regulation of needle-exchange programs. In Maine, the State Bureau of Health will regulate the distribution, tracking, and disposal of hypodermic needles. The measure is designed to prevent HIV transmission. In New Hampshire, a two-year pilot program within
Most parents are hesitant to tell school about child's HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):4. Unique Identifier : AIDSLINE MED/97702842; The results of a study conducted by researchers at the Massachusetts Department of Public Health indicate that 53 percent of families did not inform schools about a child s HIV status. Among children between the ages of 5 and 10, two-thirds had not been told that they were HIV-positive. Although 99 percent of all chil
Appeals panel reverses ruling favoring life insurer. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):5. Unique Identifier : AIDSLINE MED/97702843; A three-judge panel of the 9th U.S. Circuit Court of Appeals reversed a ruling that favored the Minnesota Mutual Life Insurance Company. The court reinstated a lawsuit brought by the estate of an HIV-positive policy holder, Paul Preston. The suit demands that the insurance company honor a life insurance policy issued
No evidence of impairment, no reduction in sentence. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):11. Unique Identifier : AIDSLINE MED/97702845; The 1st U.S. Circuit Court of Appeals rejected an appeal brought by HIV-positive prison inmate Jose Ivan Montanez-Anaya, who argued that his defense counsel rendered ineffective assistance at trial. Montanez-Anaya bases this claim on the fact that his defense counsel did not invoke Section 5H1.4, a compassionate Feder
Charges dropped. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):12. Unique Identifier : AIDSLINE MED/97702846; Clortis Roberts took care of Lawrence White, an AIDS patient, and inappropriately used White s money for her own use. White sued Clortis and won a jury verdict in a civil suit in 1994. Roberts will not face felony charges for misappropriation of fiduciary property since White passed away and the only evidence the Stat
Home testing. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):12. Unique Identifier : AIDSLINE MED/97702847; Home Access Health Corporation, manufacturer of the Home Access HIV test kit, conducted a survey to determine whether or not people would purchase HIV test kits if they were placed behind a pharmacy counter. Results indicate that 85 percent of those surveyed would look for the kits if they were placed on store shelves
Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly." Interview with Lisa Capaldini, M.D. [interview by John S. James]: AIDS Treat News. 1997 Aug 15;(No 277):1-4. Unique Identifier : AIDSLINE MED/97702848; Capaldini L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Lisa Capaldini, an AIDS physician in San Francisco, discusses her experiences with the use of protease inhibitors and their metabolic side effects on cholesterol, triglycerides, blood sugar, and Crix Belly. The ways that these metabolic effects alter the use of
San Francisco: changes at Conant Medical Group. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Aug 15;(No 277):5. Unique Identifier : AIDSLINE MED/97702849; San Francisco s Conant Medical Group was disbanded due to a series of disputes primarily from medical organizations. This closure highlights the need for more public and professional attention to managed care and other issues in medicine today. Because of capitation, physicians treating HIV and/or cancer patients are
Consensus letter: Peter Duesberg.: AIDS Treat News. 1997 Aug 15;(No 277):6-8. Unique Identifier : AIDSLINE MED/97702850; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Project Inform is circulating a consensus letter concerning Peter Duesberg s campaign to convince the public that HIV is harmless and that accepted medical treatments are useless. The concerns about Duesberg s teachings are being used to justify rejecting all medical care for HIV infection, and ignoring guidelines for
One lump or two.: Notes Undergr. 1997 Jun/Jul;(No 35):1, 7. Unique Identifier : AIDSLINE MED/97702851; Low H; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The Food and Drug Administration ( FDA ) is warning physicians that their patients who are taking any of the four protease inhibitors are at increased risk for developing hyperglycemia or diabetes. Diabetes and hyperglycemia are serio
1592 - where are you? Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Notes Undergr. 1997 Jun/Jul;(No 35):1. Unique Identifier : AIDSLINE MED/97702852; Relatively small-scale clinical trials of Glaxo Wellcome s new drug 1592 ( abacavir ) will be introduced to 2,500-5,000 patients worldwide in the near future. The drug will also be made available for children. To qualify, patients must have less than 10
Whatever happened to expanded access? Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Notes Undergr. 1997 Jun/Jul;(No 35):2-3. Unique Identifier : AIDSLINE MED/97702853; People living with AIDS (PWAs) have dramatically changed the way new pharmaceuticals are introduced and researched in the United States . Expanded access is the general term for pharmaceutical company programs that distribute new drugs prior to formal approval from the Food and Drug Adm
My first major choice--hope or hype? (a conversation with myself).: Notes Undergr. 1997 Jun/Jul;(No 35):4-7. Unique Identifier : AIDSLINE MED/97702854; Niedzolkowski M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A question and answer format is presented to provide information about the efficacy of protease inhibitors in the treatment of HIV/AIDS. Patients who qualify and can tolerate these pharmaceutical cocktails have a 60-to-80 percent chance of lowering the amount of vir
The coming sunset on AIDS funding programs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):1-2. Unique Identifier : AIDSLINE MED/97702856; AIDS treatments have entered the long-term, planned strategy phase that could involve many years of therapy, whereas political thinking and the funding that it generates for patient care have not evolved as successfully. Whether or not the patchwork of AIDS funding can be sustained becomes increasingly unclear and les
New Federal guidelines for the use of antiretroviral agents. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):3-6. Unique Identifier : AIDSLINE MED/97702857; The U.S. Department of Health and Human Services (DHHS) issued a new set of guidelines for the treatment of HIV disease. The guidelines acknowledge that the pace of HIV disease progression is tightly linked to a patient s individual level of HIV replication. The guidelines suggest that the best treatment is one that s
Update on antivirals. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):7-9. Unique Identifier : AIDSLINE MED/97702858; Recent studies are indicating that the standard version of saquinavir is not an appropriate anti-HIV regimen protease inhibitor for beginning therapy. In addition, the new soft gel capsule formulation of saquinavir shows better activity than the available hard gel formulation (HGC), warranting its classification as a
Controlling diarrhea. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):9-10. Unique Identifier : AIDSLINE MED/97702859; Diarrhea, a common problem in people living with HIV, has a number of causes and steps to control it. It is important to diagnose the cause(s) of diarrhea as soon as possible, followed by appropriate treatment and replenishment of body fluids. Causes can include diet, lactose intolerance, or the antiviral regimen itse
HIV drug side effects. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):10-1. Unique Identifier : AIDSLINE MED/97702860; A guide is provided to help identify the possible causes of side effects when using a particular HIV drug. Side effects and the drugs most commonly used in HIV treatment are both listed. The percentage of people who report each side effect for each drug is given. A contact number is provided for a more extensive versi
HIV neuropathy. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):12-3. Unique Identifier : AIDSLINE MED/97702861; Peripheral neuropathy, a potential side effect of many anti-HIV therapies and HIV itself, can adversely affect quality of life. The most effective management of peripheral neuropathy starts with identifying the cause, such as the use of certain HIV drugs, alcohol drin
Hopeful CMV drug stalled. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):13. Unique Identifier : AIDSLINE MED/97702862; Although cytomegalovirus ( CMV ) disease, CMV retinitis in particular, is one of the most difficult opportunistic infections to treat, a hopeful new oral form of ganciclovir (proGan) is being stalled. CMV cases have decreased a
Study of GM-CSF enrolling. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):14. Unique Identifier : AIDSLINE MED/97702863; A study to determine if GM-CSF (Leukine), in addition to standard therapies, will delay HIV disease progression and death by enhancing immune function is in clinical trials around the United States . Participants can be on any standard anti-HIV and anti-opportunistic infection regimens.
Thalidomide study. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):14-5. Unique Identifier : AIDSLINE MED/97702864; Preliminary findings from a study on the effects of thalidomide on HIV-related wasting syndrome are encouraging. The study shows that at least half of the weight gained by participants was in the form of lean body mass. Side effects included declines in neutrophil counts and pain or tingling in the hands and/or feet.
Ethnicity and treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):15-6. Unique Identifier : AIDSLINE MED/97702865; CPCRA 007, a study on ethnic/minority groups including African Americans, reveals no significant differences in disease progression, death rates, or the ability of different ethnic groups to tolerate HIV treatments. This contradicts a 1991 study showing that African Americans and Latinos had greater side effects with
Gynecologic conditions and HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):18-9. Unique Identifier : AIDSLINE MED/97702867; Studies are reinforcing the need for HIV-infected women to continue getting regular gynecologic examinations so that gynecologic complications can be detected early and monitored regularly. HIV-infected women who also have the human papillomavirus are more likely to progress to cervical cancer than their HIV-negative
Adherence to HAART. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):20-3. Unique Identifier : AIDSLINE MED/97702868; The problems of adhering to highly active antiretroviral therapy HAART) are addressed and recommendations on initiating and maintaining therapy regimens are provided. Triple-drug therapy strategies are highlighted, including integrating the regimen into one s life rather than the other way around, counting out medicat
1592 update. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):23. Unique Identifier : AIDSLINE MED/97702869; Glaxo Wellcome s 1592 has now been approved for a modest-sized compassionate use program for adults in July 1997 followed by a much larger expanded program in early 1998. Caution is advised. Simply adding 1592 to a failing treatment regimen is not likely to help, and it is less likely to be effective in people who pre
CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):97-100. Unique Identifier : AIDSLINE MED/97702870; Guidelines for post-exposure prophylaxis (PEP) for occupational exposures and sexual and injection drug use exposures continue to be controversial. Occupational exposures are usually single exposures, whereas sexual and drug use exposures may be the result of repeated exposures. Occupational exposure risk is unavoidab
Experience with PEP finds most patients stop early. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):101-2. Unique Identifier : AIDSLINE MED/97702872; Intolerance to antiretrovirals is a primary reason for patients to abandon post-exposure prophylaxis (PEP). No Federal guidelines currently exist for PEP in health-care workers, but many hospitals regularly provide early preventive care in cases of occupational exposure. Most hospital-based programs limit the treatmen
Numerical benefits low for non-occupational PEP. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):102-3. Unique Identifier : AIDSLINE MED/97702873; The costs associated with post-exposure prophylaxis (PEP) for non-occupational HIV exposure would only benefit a relatively low number of people, making it unlikely that wide-scale PEP programs will be initiated. PEP is used now in sexual assault cases where the assailant is known to be HIV-positive or be at high risk
Study shows STDs increase risk of HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):103-4. Unique Identifier : AIDSLINE MED/97702874; HIV-positive patients receiving antibiotics for other sexually transmitted diseases show lower levels of HIV in their semen, resulting in decreased risk of HIV transmission. An African study confirms that sexually transmitted diseases impact the probability of acquiring and transmitting HIV. Treating sexually transmit
Health officials argue that generalists can treat HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):104-5. Unique Identifier : AIDSLINE MED/97702875; AIDS experts continue to debate who is most qualified to care for HIV-positive patients: specialists or generalists. The Federal policy is that HIV is a primary care disease and that primary care physicians can adequately prescribe treatments, but many AIDS specialists say that the complexity of treatments means that
Study shows Avanti breaks more than latex condoms. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):105-7. Unique Identifier : AIDSLINE MED/97702876; The Avanti polyurethane condom had a higher failure rate than latex condoms in a clinical trial, although pregnancy rates were favorable. According to the National Institute of Child Health and Human Development (NICHD) findings, the Avanti condom broke more often than latex control condoms, but pregnancy protection w
Exercise, wellness take on added weight for patients. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):107-8. Unique Identifier : AIDSLINE MED/97702877; An exercise video for HIV-positive people has been developed by Positive Moves, Inc., an Atlanta non-profit company. New studies show that AIDS patients benefit greatly from wellness and exercise programs. Exercise not only makes patients feel better, but may lead to increases in the immune system as well. Patients pa
Preventive therapy isn't a magic pill for exposures. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):suppl 1-2. Unique Identifier : AIDSLINE MED/97702878; The risks and costs associated with HIV-related post-exposure treatment make it unlikely that it will become a standard anti-HIV intervention. Exposure types, Federal guidelines for preventive therapy, and potential drawbacks to treatment are outlined.
AIDS web sites face censorship under new rating schemes. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):3. Unique Identifier : AIDSLINE MED/97702881; The American Civil Liberties Union (ACLU) issued a position paper regarding the software industry s proposed rating standards that will block and rate information judged unsuitable for minors. Following the U.S. Supreme Court s overturning of the Communications Decency Act, a ruling that maintains a high level of free
Doctor can't make lab pay damages for false-positive HIV test. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):3. Unique Identifier : AIDSLINE MED/97702882; The Texas Court of Appeals ruled that physician Afsa Meredith was not eligible for damages from a laboratory that misreported HIV test results for one of her patients. Meredith sued Pathlab, Inc., a laboratory that had a policy of performing an ELISA test and a Western blot test, but that only reported the ELISA resul
Guidelines for post-exposure treatment not likely soon. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):4-5. Unique Identifier : AIDSLINE MED/97702883; Post Exposure Treatment (PET) guidelines are being developed by the Centers for Disease Control and Prevention (CDC), but a clear-cut consensus among experts who gathered to develop these guidelines has not been reached. At issue is whether or not PET is effective in cases of rape, unprotected sex, condom leakage, or
Viral DNA test allowed in trial of Louisiana doctor. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):5. Unique Identifier : AIDSLINE MED/97702884; The Louisiana Court of Appeals voted to uphold a decision to allow use of DNA testing in the criminal trial of a physician charged with intentionally injecting his former girlfriend with the blood of an HIV-positive patient. Dr. Richard J. Schmidt of Lafayette will be tried for the attempted murder of Janice Trahan. M
Court sees no basis to void policy issued to man with HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):6-7. Unique Identifier : AIDSLINE MED/97702885; The Massachusetts Supreme Judicial Court found that Protective Life Insurance Company cannot rescind a policy if it failed to detect fraud within a two-year contestability period. The court ruled that the insurer should have exercised reasonable diligence when conducting the medical exam of Dennis J. Sullivan one year
Plaintiff must show a 'channel for infection' to recover damages. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):9. Unique Identifier : AIDSLINE MED/97702887; A spouse of a St. Frances Cabrini Hospital employee has been barred from recovering emotional distress damages for fear of AIDS unless she alleges that there was a channel for infection. Terry Steward sued the Alexandria, LA hospital for negligent infliction of emotional distress after her husband, Cedric Steward, suf
Snafu in Texas prenatal testing to remain on the books. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):10. Unique Identifier : AIDSLINE MED/97702889; The 1997-98 session of the Texas Legislature closed without the passing of several HIV-related bills. In particular, a 1995 law that requires healthcare providers to test pregnant women and provide HIV counseling during prenatal care was allowed to stand. The law is flawed because it requires testing for sexually tran
Driver can't escape alcohol test by claiming AIDS phobia. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):11. Unique Identifier : AIDSLINE MED/97702890; A Pennsylvania appeals court ruled that a suspected drunk driver could not refuse blood alcohol content testing because he feared needles and HIV. The case involves a motorist who refused to take a blood test to determine whether or not he was driving under the influence of alcohol; his license was revoked. The driver
Inmate to remain jailed so he won't sell drugs. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):11. Unique Identifier : AIDSLINE MED/97702891; An HIV-positive defendant sentenced to 60 months in Federal prison for aiding and abetting interstate racketeering was not granted the home confinement that he sought. The 4th U.S. Circuit Court of Appeals refused to overturn the sentencing judge s decision not to initiate compassionate sentencing for defendant Marcus
Confidentiality breach. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):12. Unique Identifier : AIDSLINE MED/97702892; A former Pinellas County, FL public health worker, William B. Calvert III, is charged with using a government AIDS surveillance database for his own personal dating scheme. He kept the county health department records on his own laptop computer and used the information to screen potential dates for himself and his fri
Murders and HIV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):12. Unique Identifier : AIDSLINE MED/97702893; Investigators have dismissed the previously reported HIV diagnosis links in two prominent homicide cases. Serial murderer Andrew Cunanan, who shot renowned fashion designer Gianni Versace and four other men, was thought to have killed out of rage because his own life was doomed by HIV. Tests conducted during Cunanan s
HIV/AIDS treatment guidelines released.: NIAID AIDS Agenda. 1997 Aug;:1-2, 12. Unique Identifier : AIDSLINE MED/97702894; Randall P; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Guidelines for the use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, a publication created by the U.S. Department of Health and Human Services, have been released after months of anticipation. According to these guidelines, treatment should begin with three antiretroviral agents including one protea
New phase II HIV vaccine study opens.: NIAID AIDS Agenda. 1997 Aug;:3-4. Unique Identifier : AIDSLINE MED/97702895; Doepel LK; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A new National Institute of Allergy and Infectious Disease NIAID)-sponsored HIV vaccine study will determine if combining two experimental HIV vaccines can stimulate the immune system to fight HIV. The two vaccines, vCP205 and rgp120, are genetically engineered and do not contain HIV; rather, the former contains four
NIAID HIV/AIDS vaccine research. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:4. Unique Identifier : AIDSLINE MED/97702896; The status of the National Institute of Allergy and Infectious Diseases (NIAID) HIV/AIDS vaccine research is briefly summarized. To date, seventeen potential HIV vaccines have been tested in humans. In the last two years, HIV vaccine research funding from the National Institutes of Health (NIH) has increased thirty pe
CD4+ T cell diversity not immediately restored by therapy.: NIAID AIDS Agenda. 1997 Aug;:5, 9. Unique Identifier : AIDSLINE MED/97702897; Folkers G; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; One of the arguments for treating early HIV infections lies in the depletion of diverse types of CD4+ T lymphocytes that are not all immediately restored by therapy. The diversity in these cells lies in variations in T-cell receptors that bind to HIV. Variations in the beta chain of the T-cell receptor (V-beta) are of
Gene therapy may restore immune systems.: NIAID AIDS Agenda. 1997 Aug;:8. Unique Identifier : AIDSLINE MED/97702898; Bowersox J; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Researchers are examining an experimental treatment to restore the immune system in HIV-infected persons by using gene therapy based on ribozymes. Ribozymes are forms of RNA that can cleave to other RNA molecules. Cells would be genetically modified to carry anti-HIV ribozymes that could attack HIV RNA when the virus
Combination therapies improve outlook for children with HIV disease. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10. Unique Identifier : AIDSLINE MED/97702899; Results of the ACTG 300 clinical trial show that infants and children with symptomatic HIV infection are treated more successfully when given AZT plus either 3TC or ddI, than with ddI
Low-dose oral alpha interferon trial closes. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10. Unique Identifier : AIDSLINE MED/97702900; A National Institute of Allergy and Infectious Diseases NIAID)-sponsored trial of low-dose alpha interferon to alleviate symptoms associated with AIDS has been closed due to the lack of direct effect on weight loss and severity of opportunistic infections. One major concern was that patients were choosing to go into t
NIAID evaluates N-9 film as microbicide. National Institute of Allergy and Infectious Diseases. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: NIAID AIDS Agenda. 1997 Aug;:10-1. Unique Identifier : AIDSLINE MED/97702901; Results of a two-year National Institute of Allergy and Infectious Diseases (NIAID)-sponsored study on a nonoxynol-9 spermicide film showed that the agent had no effect on transmission of HIV/AIDS, gonorrhea or chlamydia infections. Female sex workers in Cameroon received instruc
NIAID funds studies of early HIV infection. National Institute of Allergy and Infectious Diseases.: NIAID AIDS Agenda. 1997 Aug;:11. Unique Identifier : AIDSLINE MED/97702902; Parrott C; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Studies on early HIV infection funded by the National Institute of Allergy and Infectious Diseases (NIAID) are reported. Four-year awards were made to researchers at six different institutions to pursue studies on immune functions of cytotoxic T-lymphocytes in HIV infection, distribution of virus between blood and tis
Methadone, adherence and protease inhibitors. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):2-3. Unique Identifier : AIDSLINE MED/97702903; Protease inhibitors and methadone are both metabolized by the liver, and there is some concern that patients cannot tolerate both treatments simultaneously. Additionally, many question whether methadone patients can even follow the restrictive drug regimen necessary with
Herpes study and resources. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):5. Unique Identifier : AIDSLINE MED/97702904; Herpes is caused by a virus that causes recurring bouts of cold sores or genital lesions. The differences between herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) are explained. Herpes outbreaks can become harder to treat when the immune system is damaged by HIV. Ac
Saquinavir update. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702905; ACTG 333 tested the effectiveness of other protease inhibitors in patients who had been on saquinavir for two years. Early data showed that neither indinavir (
Stress and therapy study for women. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702906; A new study is looking at how non-drug therapies affect quality of life in women with AIDS. Participants will receive either cognitive behavioral stress management (CBSM) or expressive supportive therapy (EST) in group sessions. Participants will be followed for a year, and will receive compensation for being in the s
1592U89 (abacavir) compassionate use. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):6. Unique Identifier : AIDSLINE MED/97702907; Early studies of 1592U89 ( abacavir ), a new nucleoside analog, suggest that it may have the strongest anti-HIV effect of any drug in its class. 1592U89 is now available via two compassionate use programs for adults and children. Study qualifications an
Pill treatment for CMV. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702908; Oral ganciclovir is the only approved pill treatment for cytomegalovirus ( CMV ) retinitis. However, it is poorly absorbed by the body, so patients may need to take 12 pills a day for it to be effective. A clinical trial will c
Combo therapy for children and adolescents. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702909; A pediatric study showed combination anti-HIV treatment to be effective in children. In a comparison trial of AZT / 3TC to ddI, AZT/3TC reduced the chance of disease progression by 70 p
DHEA for depression. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Treat Rev. 1997 Aug;(No 25):7. Unique Identifier : AIDSLINE MED/97702910; A clinical trial is underway in New York City to examine the effect of DHEA on mood and energy levels in men and women with HIV infection. DHEA is a hormone essential to the production of testosterone. The trial involves giving all participants DHEA for an initial eight weeks. In the second four weeks, participants wi
HMOs and quality care for HIV -- interview with Stephen Becker, M.D. Part 1 of 2. [interview by John S. James]: AIDS Treat News. 1997 Sep 5;(No 278):1-4. Unique Identifier : AIDSLINE MED/97702911; Becker S; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Dr. Steven Becker, an HIV specialist in private practice in San Francisco, offers his appraisal of HIV and HMO quality of care. Becker states that the quality of HMO care is determined by a set of standards called the Health Plan Employer Data and Information Set (HEDIS). If health organizations do not do well with HE
DMP 266 trials recruiting, many cities -- protease inhibitor naive.: AIDS Treat News. 1997 Sep 5;(No 278):5-6. Unique Identifier : AIDSLINE MED/97702912; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; DMP 266, a non-nucleoside reverse transcriptase inhibitor (NNRTI) in the same general class as nevirapine or delavirdine , is undergoing clinical trials. Potential advantages of DMP 26
Adefovir dipivoxil trials: CD4 100-500, protease inhibitor naive. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Treat News. 1997 Sep 5;(No 278):6. Unique Identifier : AIDSLINE MED/97702913; Two trials for adefovir dipivoxil combined with other antiretroviral treatments, GS-96/411 and GS-97/417, are currently recruiting in cities throughout the United States . Adefovir dipivoxil is taken once daily; it has shown modest activity against HIV; and it is known to be active agai
Virologic failure; managed care; treatment rejectionists; medical research: GLMA Achievement Award. Gay and Lesbian Medical Association.: AIDS Treat News. 1997 Sep 5;(No 278):7-8. Unique Identifier : AIDSLINE MED/97702914; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Four HIV treatment issues are addressed by John S. James, the author and a recent recipient of the Achievement Award from the Gay and Lesbian Medical Association (GLMA). Issues addressed are: what should be done when viral load rebounds after treatment, whether people with HIV can receive quality care in the age of ca
Substance use and the puzzle of adherence.: Focus. 1997 Aug;12(9):1-4. Unique Identifier : AIDSLINE MED/97702915; Barthwell AG; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Encounter Medical Group, Oak Park, IL.; The issues of HIV resistance and its relation to patient adherence to treatment are discussed. Non-compliance or misuse of combination therapy fears are usually directed at a single group, substance abusers. There are differences in the availability and use of HIV trea
Clearinghouse: drugs and adherence. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Focus. 1997 Aug;12(9):4-5. Unique Identifier : AIDSLINE MED/97702916; A list of twelve references on HIV drug treatment and adherence is provided. A list of four research contacts is also given.
Immunologic pathogenesis of disease.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 100.1). Unique Identifier : AIDSLINE MED/97927191; Landay AL; Rush Presbyterian-St. Luke's Medical Center, Chicago, IL.; Over the past 10 years, we have gained significant insights in terms of the host immune response to HIV. We now better understand the importance of immunoregulatory molecules cytokines) in modulating the course of HIV disease and in turn have used this information in designing new therapeutic strategies. In addition,
Blood and genital HIV load.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 100.2). Unique Identifier : AIDSLINE MED/97927192; Kovacs A; University of Southern California Medical Center, Los Angeles, CA.; With the availability of assays to detect HIV RNA in blood and body fluids, HIV-1 RNA levels are utilized in the day to day management of patients. Methods of detection of RNA in plasma and cervical fluid will be presented. The utility of various assays and clinical correlations will be discussed.
Topical microbicides: the pathway to female-controlled HIV prevention strategies.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 101.1). Unique Identifier : AIDSLINE MED/97927194; Rosenberg ZF; National Institute of Allergy and Infectious Diseases, National; Institutes of Health, Bethesda, MD.; Heterosexual transmission of HIV presently accounts for the vast majority of new HIV infections worldwide. Women who are at greatest risk of acquiring HIV infection often are unable to negotiate condom use, which is under the control of the male sexual partner. Thus, it is urgent that more acceptable, affordable, fema
The future of community activism.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 102.1). Unique Identifier : AIDSLINE MED/97927196; Lucey MK; Los Angeles City Office of AIDS Policy, Los Angeles, CA.; The goal of this state of the art is to explore advocacy approaches and life prolonging strategies. This session will look at the definition and direction of community activism. A feasible plan of action will be presented along with techniques on how to advocate for women in the AIDS epidemic and save lives.
Living with HIV inside prison walls: a patient and her doctor speak out.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 102.3). Unique Identifier : AIDSLINE MED/97927197; De Groot AS; Cuccinelli D; Brown University School of Medicine, International Health Institute,; Providence, RI.; A patient and her physician will describe access to HIV testing, counseling, education, preventive measures, and treatment inside prison walls. The dimensions of the HIV epidemic behind prison walls will be discussed, as will barriers to HIV care and the great need for gender-specific models for HIV prevention in the
Epidemiology and natural history of cytomegalovirus in HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 103.1). Unique Identifier : AIDSLINE MED/97927198; Chandler S; Bakotic J; Verral S; Pitrak D; Cohen M; Hershow R; Benson C; Garcia P; University of Illinois, Chicago, IL.; Objectives: Cytomegalovirus ( CMV ) is a major cause of morbidity and mortality in AIDS patients. CMV in the context of AIDS has primarily been studied in homosexual men. Our goal has been to define the epidemiology and natural history of CMV infection in HIV-infe
Fluconazole resistance among oral and vaginal Candida isolates, the HER study.: Natl Conf Women HIV. 1997 May 4-7;:107 (abstract no. 103.2). Unique Identifier : AIDSLINE MED/97927199; Schuman P; Sobel J; Ohmit S; Mayer K; Klein R; Rompalo A; Duerr AU; Smith D; Wayne State University, HIV Epidemiology Research Study, Detroit, MI.; Objective: To evaluate in vitro fluconazole resistance (FR) among Candida albicans (CA) and non-C. albicans (NAC) species from oral and vaginal isolates in HIV+ and HIV- at-risk women at the baseline HERS visit and one year later. Methods: Fungal isolates from oral and vaginal specimens obtained at visits 1 and 3 were
Predictors of mucosal candidiasis among HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:107 (abstract no. 103.3). Unique Identifier : AIDSLINE MED/97927200; El-Sadr W; Schuman P; Peng G; Capps L; Neaton J; Harlem Hospital Center, New York, NY.; Introduction: Vaginal candidiasis is a common complication among HIV-infected women. Few studies have defined risk factors for vaginal and other mucosal candidiasis among these women. Methods: HIV-infected women with CD4 less than or equal to 300 were enrolled from 14 CPCRA units in a prospective randomized trial of w
Oxandrolone: anabolic steroid use in HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:107 (abstract no. 103.4). Unique Identifier : AIDSLINE MED/97927201; Pharo AN; Vergel N; Carroll E; Sauer L; New Concept Health Center, Houston, TX.; Objective: The primary objective is to evaluate the efficacy of two dosage levels, (10/20 mg/day), of oxandrolone in conjunction with resistance training and nutritional support for the treatment of weight loss and alterations in body composition characteristic of the Wasting syndrome in HIV positive women. Secondary
Gender differences in the pain experience of AIDS patients.: Natl Conf Women HIV. 1997 May 4-7;:107 (abstract no. 103.5). Unique Identifier : AIDSLINE MED/97927202; Breitbart W; McDonald M; Rosenfeld B; Passik S; Kaim M; Thaler H; Portenoy R; Memorial Sloan-Kettering Cancer Center, New York, NY.; Objectives: To compare pain experience, pain-related functional impairment, and psychological distress in women with AIDS to that of men with AIDS. Method: 451 ambulatory AIDS patients were assessed with the following measures: 1) Brief Pain Inventory BPI); 2) Pain Management Index (PMI); 3) Analgesic Medication Recor
Influence of HIV infection on the relationship of endometritis and endometrial pathogens among women with acute pelvic inflammatory disease.: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 103.6). Unique Identifier : AIDSLINE MED/97927203; Moorman AC; Schwartz D; Irwin K; O'Sullivan MJ; Sperling R; Brodman M; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: To examine the effect of HIV infection on the relationship between pathogens recovered from the endometrium and endometrial histopathology among patients with acute PID. Methods: During 1992-1995, we studied 44 HIV-infected (HIV+) and 163 uninfected (HIV-) women diagnosed with PID by standard clinical crite
Immunomodulator effects of interleukin-2 in HIV-infected patients.: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 104.1). Unique Identifier : AIDSLINE MED/97927204; Kovacs JA; National Institutes of Health, Bethesda, MD.; This presentation will briefly review approaches to immunomodulator therapy for HIV infection and then will focus on studies of IL-2 , a cytokine that plays an important regulatory role in the proliferation and differentiation of lymphocytes, including CD4 T cells. Stud
Hormonal contraception and STD/HIV: what do we know?: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 105.2). Unique Identifier : AIDSLINE MED/97927206; Cates W Jr; Emory University, School of Public Health, Research Triangle Park, NC.; Short Description: To review evidence on the efficacy and safety of hormonal contraception used to prevent pregnancy for its effects on sexually transmitted diseases (STD) and human immunodeficiency virus (HIV). Level I and II scientific evidence U.S. Prevention Services Task Force) was compiled from the scientific li
AIDS incidence in women: recent trends.: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 106.2). Unique Identifier : AIDSLINE MED/97927208; Wortley PM; Fleming PL; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: To describe AIDS incidence trends among women. Design: We analyzed national surveillance data on 78,654 women greater than or equal to 13 years of age reported with AIDS through 6/96. Data were adjusted for reporting delay, unreported risk, and the 1993 change in the AIDS surveillance case definition. Resul
Characteristics of and HIV seroprevalance among medically underserved women utilizing a mobile testing and outreach van in Los Angeles County.: Natl Conf Women HIV. 1997 May 4-7;:109 (abstract no. 106.5). Unique Identifier : AIDSLINE MED/97927211; Smith L; UCLA School of Public Health, Epidemiology Department, Los Angeles,; CA.; Introduction: Nationally women represent the fastest growing population infected with HIV. On a national level, African American women have the highest rates of HIV infection as well as reported cases of AIDS. AIDS is currently the leading cause of death for African American men aged 25 to 44 and the second leading ca
Assessment of quality of life in women with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:110 (abstract no. 107.1). Unique Identifier : AIDSLINE MED/97927212; Coons HL; Harwell TS; Witek J; Spence MR; Striepe MI; Health Federation of Philadelphia, Philadelphia, PA.; Objectives: Assessment of quality of life in women living with HIV/AIDS has been limited by conceptual and methodological constraints of available instruments. Widely used measures: frequently evaluate the impact of physical symptoms on activities of daily living and not on psychosocial, relational and economic status
Social support systems of mothers with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:110 (abstract no. 107.2). Unique Identifier : AIDSLINE MED/97927213; Bauman LJ; Camacho S; Weiss ES; Albert Einstein College of Medicine, Bronx, NY.; Objectives: To describe the relationship of social support to depressive symptoms among women with HIV/AIDS. Methods: Pilot study of a convenience sample of 53 NYC mothers with late stage HIV or AIDS. All had at least one child less than or equal to 12 years of age. Support was measured using a revised version of the
Health related quality of life among women living with HIV.: Natl Conf Women HIV. 1997 May 4-7;:110 (abstract no. 107.3). Unique Identifier : AIDSLINE MED/97927214; McDonnell K; Gielen A; Faden R; Wu A; O'Campo P; Johns Hopkins University, School of Hygiene and Public Health,; Baltimore, MD.; The purposes of this paper are to examine the utility for women s health of a measure of quality of life (QOL) developed specifically for persons infected with HIV, and to describe correlates of poor QOL outcomes among a sample of 322 women living with HIV. The sample was recruited from primary care clinics serving HI
Me first.: Natl Conf Women HIV. 1997 May 4-7;:110 (abstract no. 107.4). Unique Identifier : AIDSLINE MED/97927215; Martell J; AIDS Volunteers of Cincinnati, Cincinnati, OH.; In our on-going struggle to halt or slow the spread of HIV/AIDS, efforts to prevent heterosexual transmission of HIV have thus far focused on modifying sexual behaviors and the use of the male condom. However, underlying gender inequalities severely limit the ability of many women to protect themselves from HIV infect
Post AIDS survivor syndrome.: Natl Conf Women HIV. 1997 May 4-7;:110 (abstract no. 107.5). Unique Identifier : AIDSLINE MED/97927216; Broun SN; Southwestern Medical Center, Dallas, TX.; With the introduction of protease inhibitors and combination therapies, and the dramatic health improvements related to these drugs, as a psychologist, I expected to see an equally dramatic improvement in HIV impacted persons with regard to their feelings of hopeles
Stress and well-being among Latina family AIDS care-givers: moderating effects of self-esteem.: Natl Conf Women HIV. 1997 May 4-7;:111 (abstract no. 107.6). Unique Identifier : AIDSLINE MED/97927217; Land H; Hudson SM; University of Southern California, School of Social Work, Los Angeles,; CA.; Objectives: The primary objective of this project was to examine general well-being in Latinas caring for a family member with AIDS. Specifically, the major objectives were: to analyze models of care-giver stress and role strain on mental and physical well-being; and to examine models of stress mediation including the
On the margin or out of care: an exploration of episodic careseeking behavior for women at risk or infected with HIV.: Natl Conf Women HIV. 1997 May 4-7;:111 (abstract no. 108.2). Unique Identifier : AIDSLINE MED/97927219; Herbert B; Great Brook Valley Health Center, Worcester, MA.; Introduction: Efforts to intervene with women identified as HIV infected or at risk for HIV disease are often concentrated on reaching women in the communities where they live, or focused on women enrolled in primary care settings or speciality practices. Even in fully capitated systems, between 10 and 20% of patients
WomensCare Center/a work in progress: looking at women specific services in a male dominated realm.: Natl Conf Women HIV. 1997 May 4-7;:112 (abstract no. 108.3). Unique Identifier : AIDSLINE MED/97927220; Carreon G; Rodrigues A; Los Angeles County Office of AIDS Programs and Policy, Los Angeles,; CA.; Issues: Epidemiological trends have shown a disproportionate growth of AIDS cases among African-American women and Latinas. They comprise 14.5 and 12.7 percent, respectively, of the adult AIDS cases in Los Angeles County. Disenfranchised women discover their HIV status at a later stage of disease progression. Thus, ad
National data on services to women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:112 (abstract no. 108.4). Unique Identifier : AIDSLINE MED/97927221; Lopez C; Powell A; Eichler A; Marconi K; Health Resources and Services Administration, Department of Health and; Human Services, Rockville, MD.; Objectives: This paper will discuss new data, soon to be published, on the experiences of women with HIV/AIDS who receive services under Titles I and II of the Ryan White CARE Act. The paper will describe highlights from the report s findings which cover a two year period, 1994 - 1995, and reflect the experience of 10
Barriers to treatments for women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:112 (abstract no. 108.5). Unique Identifier : AIDSLINE MED/97927222; Lawless S; Women and AIDS Project, AIDS Council of New South Wales (ACON),; Sydney, NSW, Australia.; Introduction: The following paper considers barriers to accessing treatments by women living with HIV/AIDS. During the process of documenting the experiences of women living with HIV/AIDS, via in-depth, loosely structured interviews, it become evident from women s accounts that they were experiencing various barriers
Violence against women and HIV risk: implications for action.: Natl Conf Women HIV. 1997 May 4-7;:112 (abstract no. 109.1). Unique Identifier : AIDSLINE MED/97927223; Morrill AC; Robbin D; New England Research Institutes, Watertown, MA.; This workshop will consider the direct and indirect ways in which violence against women is related to HIV risk. Three main forms of violence against women will be considered: childhood sexual abuse, sexual assault, and partner violence. Conducted jointly by a research scientist and a community service activist, the w
Community AIDS prevention programs.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 110.1). Unique Identifier : AIDSLINE MED/97927224; Kelly JA; Center for AIDS Intervention Research, Milwaukee, WI.; Short description: This presentation will describe two types of HIV prevention interventions for at-risk women shown in controlled research trials to be effective: (1) small-group workshop programs conducted in inner-city primary health care settings; and (2) community mobilization interventions conducted with women i
Substance abuse and prevention science.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 110.2). Unique Identifier : AIDSLINE MED/97927225; Fullilove M; New York State Psychiatric Institute, New York, NY.; Women are at risk for HIV infection because of their own or their partner s use of drugs. This presentation will review three areas of research bearing on HIV and drugs: needle exchange, psychiatric comorbidity among drug users, and childcare. The presentation will emphasize the need for woman-centered, comprehensive
AIDS prevention with adolescents.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 110.3). Unique Identifier : AIDSLINE MED/97927226; Rotheram MJ; University of California, Department of Psychiatry, Los Angeles, CA.; In addition to prevention activities with uninfected youths, adolescents are influenced in two ways: infected youths and youths whose families have an infected parent. Intensive interventions for each of these adolescent groups will be presented, as well as outcome data for these populations.
Young women and HIV.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 110.5). Unique Identifier : AIDSLINE MED/97927227; Hodgins A; Bay Area Young Positives, San Francisco, CA.; Why have we missed the mark , as a society, when it comes to young women and HIV? This plenary session will show data collected about the needs of young women living with HIV/AIDS. Anecdotal information will also be used to describe some common experiences that young women have with medical and service providers. How
Cervicovaginal HIV-1 secretion and plasma viral load in HIV seropositive women.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 111.1). Unique Identifier : AIDSLINE MED/97927228; Cu-Uvin S; Caliendo A; Flanigan TP; Costello S; Murphy D; Grande R; Farrar DJ; Mayer KH; Carpenter CC; Brown University, Providence, RI.; Objective: To evaluate HIV-1 RNA burden in matched plasma and cervicovaginal lavage (CVL) specimens from HIV (+) women. Methods: Matched plasma and CVL specimens were collected from 72 HIV (+) women. HIV-1 RNA was quantitated using NASBA assay Organon Teknika). One ml of plasma or CVL was added to 9 ml of lysis buffer
Detection of HIV-1 RNA in genital secretions of HIV seropositive women who have undergone hysterectomy.: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 111.2). Unique Identifier : AIDSLINE MED/97927229; Farrar DJ; Cu-Uvin S; Caliendo A; Costello S; Murphy D; Mayer KH; Flanigan TP; Carpenter CC; Brown University, Providence, RI.; Objective: To determine the presence of HIV-1 RNA shedding in the vaginal vault of HIV infected women who have previously undergone hysterectomy. Methods: In a cohort of 72 HIV infected women who had paired plasma and cervicovaginal viral load measurement quantitated by NASBA assay (Organon Teknika). 4 patients had pr
Does antiretroviral therapy reduce the amount of HIV in vaginal secretions of HIV-infected women?: Natl Conf Women HIV. 1997 May 4-7;:113 (abstract no. 111.3). Unique Identifier : AIDSLINE MED/97927230; Palmore MP; Ellerbrock T; Lennox JL; Hart C; Schnell C; Bush T; Evans-Strickfaden T; Conley L; Clancy K; Emory University, Grady Infectious Disease Program, Atlanta, GA.; Objective: To determine the effect of antiretroviral therapy on HIV RNA levels in vaginal secretions of HIV-infected women. Methods: Nonpregnant HIV-infected women who were on no antiretroviral therapy or had been on a stable antiretroviral regimen for greater than or equal to 3 months were selected from an ongoing co
Quantification of HIV RNA in plasma and vaginal secretions using a QC-PCR/microtiter detection assay: preliminary results from the Emory Vaginal Ecology (EVE) Study.: Natl Conf Women HIV. 1997 May 4-7;:114 (abstract no. 111.4). Unique Identifier : AIDSLINE MED/97927231; Hart C; Palmore M; Wright T; Lennox JL; Evans-Strickfaden T; Schnell C; Bush T; Clancy K; Conley L; Ellerbrock T; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: The Emory Vaginal Ecology (EVE) Study is a prospective cohort study to determine when and how much HIV is present in the female genital tract and to compare the amount and characteristics of HIV in the genital tract with that in plasma. The objective of this analysis was to correlate the amount of HIV RNA i
Studies of HIV-1 in the genital tract and blood as part of the Women's Interagency HIV Study.: Natl Conf Women HIV. 1997 May 4-7;:114 (abstract no. 111.5). Unique Identifier : AIDSLINE MED/97927232; Kovacs A; University of Southern California, Los Angeles, CA.; Objective: In order to gain an understanding of the pathogenesis of HIV disease in women the Women s Interagency HIV Study (WIHS) has undertaken multiple focused studies to determine factors which may influence the presence of and type of HIV in various compartments-especially blood and genital tract. Methods: Since O
Studies of the immune response in the female genital tract.: Natl Conf Women HIV. 1997 May 4-7;:114 (abstract no. 111.6). Unique Identifier : AIDSLINE MED/97927233; Landay AL; Baumb L; Sha B; Benson C; Spear GT; Rush Medical College, Department of Immunology and Microbiology,; Chicago, IL.; Over the past 5 years, there has been an increase in the proportion of women who have acquired HIV infection, predominantly through heterosexual contact. Several factors are known to contribute to HIV transmission through sexual contact including the presence of local infections, sexually transmitted diseases and chan
Identification of HIV in the lower genital tract of HIV-infected women: methodology and clinical correlates.: Natl Conf Women HIV. 1997 May 4-7;:114 (abstract no. 111.7). Unique Identifier : AIDSLINE MED/97927234; Tuomala R; Buck A; Tucker L; Cohen A; Pender D; Xu C; Wang Y; Cai W; Anderson D; Brigham and Women's Hospital, Boston, MA.; Objectives: Cervicovaginal Lavage (CVL) specimens were obtained from HIV-infected women in order to characterize HIV in the lower genital tract. Pertinent laboratory and clinical characteristics were correlated with the presence and quantity of cell-free and cell-associated virus detected. Methods: Ten-cc CVL specimen
Chinese medicine and alternative therapies.: Natl Conf Women HIV. 1997 May 4-7;:115 (abstract no. 113.1). Unique Identifier : AIDSLINE MED/97927235; Cohen M; Wilson W; Chicken Soup Chinese Medicine, San Francisco, CA.; Chinese medicine and other alternative/natural therapies are being used regularly and increasingly by women with HIV as both primary care and as adjuncts to Western medicine. This session will focus on the current state-of-the-art in alternative therapies, with a particular focus on Chinese medicine. Chinese medicine
Latinas and sexual risk: acculturation, demographic factors and health beliefs.: Natl Conf Women HIV. 1997 May 4-7;:115 (abstract no. 114.1). Unique Identifier : AIDSLINE MED/97927236; Romero GJ; Wyatt GE; Newcomb MD; Tucker MB; Wayment HA; Vargas JH; Solis B; Mitchell-Kernan C; California State University, Department of Psychology, Los Angeles,; CA.; Latinas are among the fastest growing group at risk for HIV infection. This study investigated HIV related sexual risk taking and health promotion in a random, community sample of 227 sexually active single and married Latinas, ages 18 to 50. Structural equation models examined the relationship between antecedent vari
A comprehensive approach to African American women's sexual risk taking.: Natl Conf Women HIV. 1997 May 4-7;:115 (abstract no. 114.2). Unique Identifier : AIDSLINE MED/97927237; Wyatt GE; Tucker MB; Romero GJ; Vargas JH; Newcomb MD; Wayment HA; Solis BM; Loeb TB; Mitchell-Kernan C; University of California, Neuropsychiatric Institute, Los Angeles, CA.; African American women are disproportionately affected by the HIV/AIDS epidemic and are at greatest risk for unwanted sexual outcomes. This study examines factors predicting the context of HIV related sexual behaviors in a random, community sample of 227 African American single and married women, ages 18 to 50. Struct
Reexamining predictors of sexual risk taking among a community sample of White women.: Natl Conf Women HIV. 1997 May 4-7;:115 (abstract no. 114.3). Unique Identifier : AIDSLINE MED/97927238; Wyatt GE; Romero GJ; Tucker MB; Newcomb MD; Wayment HA; Vargas JH; Solis B; Loeb TB; Mitchell-Kernan C; University of California, Neuropsychiatric Institute, Los Angeles, CA.; This investigation examined factors predicting sexual risk taking in a random, community sample of 228 White single and married women, ages 18 to 50. The relationships between demographic variables, past sexual histories, victimization experiences, relationship factors, and risks for unintended pregnancies, sexually t
Neuropsychological performance and HIV serostatus in women.: Natl Conf Women HIV. 1997 May 4-7;:115 (abstract no. 114.4). Unique Identifier : AIDSLINE MED/97927239; Durvasula RS; Miller E; University of California, Los Angeles, CA.; While the deleterious effects of HIV-1 on neuropsychological performance has been widely documented, little of this work has been conducted with ethnic minority samples or women. The present study will report baseline neuropsychological data on a sample of women. The sample is comprised of Black, Latina, White, Asian
In search of support: social service utilization among women with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:116 (abstract no. 114.6). Unique Identifier : AIDSLINE MED/97927241; Axelrod J; Smith L; University of California, Los Angeles, CA.; As women comprise a greater percentage of the AIDS population, questions about their service needs and utilization of services emerge. The present study will describe the extent to which community organizations were used by HIV-positive women. The sample is comprised of 147 African-American, Latina, and White women wh
HIV negative partners of HIV positive women: factors associated with harmful behaviors in serodiscordant couples.: Natl Conf Women HIV. 1997 May 4-7;:116 (abstract no. 114.7). Unique Identifier : AIDSLINE MED/97927242; Hunt WK; Myers H; University of California, Los Angeles, CA.; Previous research on hemophiliacs infected with HIV has suggested that HIV negative partners of these individuals engage in risky behaviors with their partners. This is in spite of the risk of contracting HIV, or as is the case when both partners are HIV positive, the risk of reinfection. Thus far, there are very litt
Sexual decision making among HIV-infected women reporting recent sexual contact with a woman.: Natl Conf Women HIV. 1997 May 4-7;:116 (abstract no. 115.2). Unique Identifier : AIDSLINE MED/97927244; Kennedy M; Moore J; Schuman P; Schoenbaum E; Zierler S; Rompalo Anne; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: To characterize homosexual behavior, barrier use, female partners, and sexual decision making among HIV-infected women reporting recent (within the last 8 months) sexual contact with a woman. Methods: HIV-infected women (n=699) participating in a multi-center longitudinal study completed an interview that i
Where's the data? Challenges in creating responsive multi-disciplinary health services for lesbian, bisexual, and transgendered women.: Natl Conf Women HIV. 1997 May 4-7;:117 (abstract no. 115.3). Unique Identifier : AIDSLINE MED/97927245; Weiser BS; Cheek C; Morris S; Starling D; Flinn D; Los Angeles Gay and Lesbian Center, Los Angeles, CA.; Introduction: Current AIDS Surveillance Data indicates that women are the fastest growing population to be affected by HIV nationally, and one of the top three in Los Angeles County. Few AIDS Service organizations have successfully tackled the issues of risk and health care amongst lesbian, bisexual, and transgendered
Health, mental health, and social service needs of HIV+ lesbians and bisexual women.: Natl Conf Women HIV. 1997 May 4-7;:117 (abstract no. 115.4). Unique Identifier : AIDSLINE MED/97927246; Grooms K; Coons HL; Dykes and Dames, Philadelphia, PA.; Introduction: Lesbians or women who have sex with women (WSW) are a marginalized population. This presents difficulties in determining the number of HIV infected women in this population as well as determining what health, mental health, and social services are needed. Data are scant on HIV+ lesbians in racial and eth
Do lesbian and bisexual women worry about HIV and engage in risk prevention behaviors?: Natl Conf Women HIV. 1997 May 4-7;:117 (abstract no. 115.5). Unique Identifier : AIDSLINE MED/97927247; Diamant AL; Schuster MA; Lever J; McGuigan KA; Shapiro MF; University of Calfornia, Department of Internal Medicine, Los Angeles,; CA.; Objectives: To examine whether lesbians and bisexual women worry about contracting HIV and to explore sexual risk-taking and risk-prevention behaviors in this under-studied population. Design: Sample of 7,797 lesbian and bisexual women who responded to a 186-item questionnaire titled The 1995 Advocate Survey of Sexua
Women and substance abuse: setting the scene.: Natl Conf Women HIV. 1997 May 4-7;:117 (abstract no. 117.2). Unique Identifier : AIDSLINE MED/97927248; Hull B; National Association of People with AIDS, Washington, DC.; In my section of the symposium I will be discussing what it was like to be a woman using drugs intravenously (heroin and cocaine) in the 80 s and what it s like today. I will address problems of a drug using lifestyle as it pertains to women including barriers for women seeking help for their drug use and the conseque
Preventing drug injection-related HIV transmission among IDUs.: Natl Conf Women HIV. 1997 May 4-7;:117 (abstract no. 117.3). Unique Identifier : AIDSLINE MED/97927249; Jones TS; Centers for Disease Control and Prevention, Atlanta, GA.; Limitations of bleach for disinfection of syringes, indirect sharing, the importance of the use of sterile syringes and clean equipment in drug preparation and distribution, and the importance of substance abuse treatment as strategies to reduce transfer of blood among IDUs and, also, illegal drug injection.
Sex work is an occupation with occupational hazards: a proposal to use occupational safety and health regulations and labor codes to reduce the hazards, including the risk of HIV infection.: Natl Conf Women HIV. 1997 May 4-7;:118 (abstract no. 118.1). Unique Identifier : AIDSLINE MED/97927251; Alexander P; North American Task Force on Prostitution, New York, NY.; Introduction: Prostitution, like other occupations, has a number of safety and health hazards, among which are repetitive stress injuries, bladder and kidney problems, foot, knee, and back problems, sexually transmitted and respiratory infections, and stress related to bad working conditions, isolation, and stigma man
Ignorance is no excuse for a law, especially when the law increases the risk of HIV infection: decriminalize prostitution.: Natl Conf Women HIV. 1997 May 4-7;:118 (abstract no. 118.2). Unique Identifier : AIDSLINE MED/97927252; St. James M; COYOTE, San Francisco, CA.; Introduction: The prevalence of HIV infection among street-based, female prostitutes in the United States ranges from about 5% to more than 40%, depending on the city, and the level of repression against prostitutes and drug users. Although there is no evidence that female prostitutes
Training interviewers from the community for HIV research: the trials and the triumphs.: Natl Conf Women HIV. 1997 May 4-7;:118 (abstract no. 119.1). Unique Identifier : AIDSLINE MED/97927253; Simoni JM; Weinberg BA; Nero DK; Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY.; Introduction: In our research with seropositive inner-city women, we attempted to recruit interviewers of the same gender and ethnicity from the participants communities, in the hopes of obtaining interviewers with similar seropositive and socioeconomic statuses and life experiences. We were aiming to improve the qua
The role of the consumer as educator.: Natl Conf Women HIV. 1997 May 4-7;:119 (abstract no. 119.3). Unique Identifier : AIDSLINE MED/97927255; Brown M; Widmayer S; Children's Diagnostic and Treatment Center, Ft. Lauderdale, FL.; Throughout the nation, programs involved in HIV treatment and prevention services are increasingly utilizing consumers as HIV prevention educators. Consumer educators are individuals, infected and affected by HIV disease, who receive professional training to provide HIV/AIDS educational services in their communities,
A training for those who care: consumers, aware, responsible, and empowered.: Natl Conf Women HIV. 1997 May 4-7;:119 (abstract no. 119.4). Unique Identifier : AIDSLINE MED/97927256; Malveo K; Herwehe J; Children's Hospital, Pediatric AIDS Program, New Orleans, LA.; Introduction: In this four hour workshop, participants will receive basic information and training on the development of a peer program. The first two hour session will cover the implementation of a peer program and assist peers in the development of their perspective roles as peer educators. The second two hour sessi
The labor of our peers: is peer education exploitation?: Natl Conf Women HIV. 1997 May 4-7;:119 (abstract no. 119.5). Unique Identifier : AIDSLINE MED/97927257; Davids J; Maskovsky J; Philadelphia FIGHT, Philadelphia, PA.; Peer educators play an increasingly central role in the delivery of HIV-related prevention and care services across the US. For example, an entire branch of Ryan White funding has been designated for outreach efforts to pregnant women at risk for HIV infection that are primarily peer-based. Peer education can clearly
Take this job and... make it better; peer educators and outreach workers speaking for ourselves.: Natl Conf Women HIV. 1997 May 4-7;:119 (abstract no. 119.6). Unique Identifier : AIDSLINE MED/97927258; Acero D; Birch J; Capone A; Twynne Dasher B; Tucker Dorn N; Ott L; Scott J; Wideman M; Philadelphia FIGHT, Philadelphia, PA.; Introduction: Peer educators and outreach workers are the key to preventing HIV/AIDS in our neighborhoods, and getting life-saving information to our brothers and sisters who are living with the virus. We are the ones going out into the community, into the hit houses and shooting galleries, and holding the hands of wo
Project TEACH (Treatment Education Activists Combatting HIV) and Us Women: peerbased secondary prevention and community organizing.: Natl Conf Women HIV. 1997 May 4-7;:120 (abstract no. 119.7). Unique Identifier : AIDSLINE MED/97927259; Davids J; Tucker Dorn N; Maskovsky J; Pleasant K; Shull J; Philadelphia FIGHT, Philadelphia, PA.; Introduction: Peer education is a good way to bring HIV/AIDS education to communities with limited access to information on HIV/AIDS, treatment options, health care and services. Extensive training that encourages critical thinking and good communication skills helps peer educators in giving out accurate, current info
Evaluating two strategies for teaching safer sex to the wives and girlfriends of injection drug users: identification of an effective brief intervention.: Natl Conf Women HIV. 1997 May 4-7;:120 (abstract no. 120.3). Unique Identifier : AIDSLINE MED/97927262; Krauss BJ; Goldsamt LA; Bula E; National Development and Research Institutes, Inc., Institute for AIDS; Research, New York, NY.; Objectives: To evaluate the comparative efficacy of two 35 minute, scripted, manual-based interventions -- skills and demonstration -- designed to teach women who are current sexual partners of injected drug users (IDUs) about the safer sex hierarchy. Methods: Seventy-six eligible women (18 or over, sexually active in
Challenges to surviving HIV in prison and strategies for advocacy and service.: Natl Conf Women HIV. 1997 May 4-7;:121 (abstract no. 121.1). Unique Identifier : AIDSLINE MED/97927264; Greenspan J; Jones L; Knuckles Y; Lucey M; HIV/AIDS in Prison Project of Catholic Charities of the East Bay,; Oakland, CA.; Issues: Between 1980 and 1993 the rate of incarceration for women prisoners increased by 313%. Women entering the criminal justice system have a history of extreme poverty, sexual abuse, battery, prejudice, and substance abuse. Many enter prison with serious health problems including HIV, TB and hepatitis. Women priso
A model of an HIV prevention program for incarcerated women.: Natl Conf Women HIV. 1997 May 4-7;:121 (abstract no. 121.5). Unique Identifier : AIDSLINE MED/97927268; Sandeen P; AIDS Project of Central Iowa, Des Moines, IA.; Introduction: An HIV prevention program for incarcerated women was developed by the AIDS Project of Central Iowa and implemented at an Iowa Department of Corrections work-release facility which houses women from around the country. Obtaining support from the state of Iowa was crucial to the program s success and invol
Past abuse by a partner, drug abuse, and sexual HIV risk.: Natl Conf Women HIV. 1997 May 4-7;:122 (abstract no. 122.2). Unique Identifier : AIDSLINE MED/97927270; Morrill AC; Ickovics JK; New England Research Institutes, Inc., Watertown, MA.; Models of HIV risk tend to focus on individual characteristics, attitudes and beliefs. For women having sex with men, the context of those relationships may also be a crucial determinant of HIV risk. Past abuse by a partner may or may not have an overall direct effect on HIV risk; still, it may play an indirect, yet p
The relationship between sexual victimization and sexual HIV risk in a community sample of women.: Natl Conf Women HIV. 1997 May 4-7;:122 (abstract no. 122.5). Unique Identifier : AIDSLINE MED/97927273; Whitmire LE; Institute for Health, Health Policy, and Aging Research, Rutgers; University, New Brunswick, NJ.; Objective: Recent research studying the long-term effects of childhood sexual abuse (CSA) in women suggests that there is a relationship between CSA and risky sexual behaviors in adulthood. This study examined the relationship between CSA and sexual HIV risk in a community sample of women. Hypothesized mediators of th
Violence against women and HIV risk: implications for action.: Natl Conf Women HIV. 1997 May 4-7;:123 (abstract no. 122.6). Unique Identifier : AIDSLINE MED/97927274; Morrill AC; Robbin D; New England Research Institutes, Watertown, MA.; This workshop will consider the direct and indirect ways in which violence against women is related to HIV risk. Three main forms of violence against women will be considered: childhood sexual abuse, sexual assault, and partner violence. Conducted jointly by a research scientist and a community service activist, the w
Sexual abuse and HIV risk.: Natl Conf Women HIV. 1997 May 4-7;:123 (abstract no. 122.7). Unique Identifier : AIDSLINE MED/97927275; Paone D; Miller M; Shi Q; Des Jarlais DC; Beth Israel Medical Center, New York, NY.; Objective: To determine the impact of previous sexual abuse on current HIV sex and drug risk behaviors. Methods: One hour face-to-face interviews were conducted with 130 women opiate users. Subjects were recruited from methadone maintenance and syringe exchange programs in New York City. Sexual abuse and family histor
Clinical manifestations and predictors of survival among older women infected with HIV.: Natl Conf Women HIV. 1997 May 4-7;:126 (abstract no. 127.2). Unique Identifier : AIDSLINE MED/97927276; Clark R; Bessinger R; Louisiana State University Medical Center, HIV Outpatient Program, New; Orleans, LA.; Objective: To review the natural history of HIV infection and assess predictors of survival among older women. Methods: A retrospective review of women enrolled into the Charity Hospital HIV Outpatient Program was performed. Results: Women were identified as greater than or equal to 40 (n=84) and less than 40 years of
HIV/AIDS and the older woman.: Natl Conf Women HIV. 1997 May 4-7;:126 (abstract no. 127.1). Unique Identifier : AIDSLINE MED/97927277; Fowler JP; National Association on HIV Over Fifty (NAHOF), Kansas City, MO.; Between eight and nine percent of American women diagnosed with AIDS are more than 50 years of age, while many more mid-life and older women--an estimated 85,000 in 1993--are living with HIV. Because this group has largely been ignored by the AIDS community scientists, researchers, providers, educators), this workshop
Healing and HIV.: Natl Conf Women HIV. 1997 May 4-7;:124 (abstract no. 124.1). Unique Identifier : AIDSLINE MED/97927278; Huston R; Women's Wellness Fund, New Hope, PA.; Introduction: This workshop discusses ways to incorporate holistic living into life. Participants will be provided with a basic understanding of acupuncture, chiropractic, homeopathy, Chinese herbs and nutrition supplements. Discussions will follow on basic tenets of healthy living, such as diet, exercise, meditation,
Researchers and communities in partnership: the role of community women in HIV prevention.: Natl Conf Women HIV. 1997 May 4-7;:124 (abstract no. 125.1). Unique Identifier : AIDSLINE MED/97927279; Paikoff RL; Baptiste D; Sweet-Jemmott L; Wingood G; University of Illinois, Institute for Juvenile Research, Chicago, IL.; A two-hour workshop is proposed to engage participants around issues of involving community women in HIV prevention and intervention efforts. Initially, three projects currently underway within the NIMH families and AIDS Consortium will be described. All of these projects actively recruit and train community members t
Training women living with HIV as co-facilitators in conducting HIV secondary interventions for women.: Natl Conf Women HIV. 1997 May 4-7;:124 (abstract no. 125.2). Unique Identifier : AIDSLINE MED/97927280; Wingood GM; DiClemente RJ; University of Alabama, School of Public Health, Birmingham, AL.; Introduction: A two-hour workshop is proposed to discuss building partnerships of academic researchers with community residents in HIV prevention research with women. The workshop will discuss three projects currently funded by the NIMH family and HIV/AIDS consortium, all of which recruit and train community residents
Training community women as co-facilitators of HIV-prevention family group.: Natl Conf Women HIV. 1997 May 4-7;:124 (abstract no. 125.3). Unique Identifier : AIDSLINE MED/97927281; Paikoff RL; Baptiste D; University of Illinois, Institute for Juvenile Research, Chicago, IL.; The Chicago HIV and Adolescent Mental Health Project (CHAMP) is an NIMH-funded, HIV prevention research study based in a high risk, predominantly African American, inner city community. The intervention model calls for a parent/intern dyad to conduct multiple-family group sessions with about 550 families. CHAMP recrui
Working together to train women from public housing as facilitators in a HIV risk-reduction project.: Natl Conf Women HIV. 1997 May 4-7;:125 (abstract no. 125.4). Unique Identifier : AIDSLINE MED/97927282; Sweet Jemmott L; Outlaw F; University of Pennsylvania, School of Nursing, Philadelphia, PA.; Introduction: The incidence of AIDS is increasing at an alarming rate in African American families, especially among women and adolescents residing in public housing. Of particular concern are young African American adolescent males ages 11-15 living with their single mothers, where the key family member to teach them
Turning grassroots demand into legislative action for expanded research into woman controlled HIV prevention options.: Natl Conf Women HIV. 1997 May 4-7;:125 (abstract no. 126.1). Unique Identifier : AIDSLINE MED/97927283; Forbes A; Independent AIDS and Women's Health Policy Consultant, Ardmore, PA.; Introduction: Despite urgent need, the topic of woman-controlled HIV prevention received less than 10% of the available federal HIV/AIDS prevention research funding in FY 95. In 1996, Secretary Shalala announced the allocation of an additional $100 million over four years to microbicide research but federal sources re
Adolescent women with HIV: epidemiologic and clinical update.: Natl Conf Women HIV. 1997 May 4-7;:125 (abstract no. 200.1). Unique Identifier : AIDSLINE MED/97927284; Futterman D; Montefiore Medical Center, Bronx, NY.; It is estimated that one in four people with HIV were infected before the age of 21. Among adolescents with AIDS, young women account for over one-third of the cases. Trends in HIV infection and social and physical factors underlying the unique vulnerabilities of adolescent women will be addressed as will clinical con
Interventions to reduce perinatal transmission.: Natl Conf Women HIV. 1997 May 4-7;:125 (abstract no. 201.1). Unique Identifier : AIDSLINE MED/97927285; Mofenson LM; National Institute of Child Health and Human Development, NIH,; Bethesda, MD.; Description: In 1994, a regimen of AZT given during pregnancy and to the newborn was shown to reduce the risk of mother-to-child transmission by nearly 70%. However, many important issues remain regarding the mechanism(s) by which this reduction occur
Redefining the balance of power in relationships.: Natl Conf Women HIV. 1997 May 4-7;:126 (abstract no. 201.2). Unique Identifier : AIDSLINE MED/97927286; Wyatt GE; University of California, Neuropsychology Institute, Los Angeles, CA.; The relationship context is important for women regardless of their HIV serostatus, but a power imbalance between partners can increase women s HIV related risks. In the early 1980 s I was one of the first to document that sexual abuse before age 18 was reported for one in 2.5 African American and White women in Los A
Quantitative HPV DNA assay in screening for cervical intraepithelial neoplasia among HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:126 (abstract no. 203.1). Unique Identifier : AIDSLINE MED/97927290; Cohn J; Gagnon S; Spence M; Harrison D; Kluzak T; Langenberg P; Brinson C; Stein A; Hellinger J; Wayne State University, School of Medicine, Detroit, MI.; Objectives: We investigated the effect of combining a commercially available quantitative HPV DNA assay with routine Pap smears in screening for CIN among HIV-infected women with at least mild immunosuppression. Methods: 109 HIV-infected women with CD4+ lymphocyte counts less than or equal to 500 were enrolled in 6 US
Effects of HIV-tat and TNF\alpha on IL-6 signaling in cervical cancer cell lines, normal and human papillomavirus-immortalized keratinocytes.: Natl Conf Women HIV. 1997 May 4-7;:126 (abstract no. 203.2). Unique Identifier : AIDSLINE MED/97927291; Gage JR; Martinez-Maza O; Department of Obstetrics and Gynecology, University of California,; School of Medicine, Los Angeles, CA.; Background: The clinical manifestations of cervical cancer and other Human papillomavirus (HPV)-associated diseases are profoundly altered in women infected with HIV. Interleukin 6 IL-6) is a pleiotropic cytokine which has been implicated as an autocrine growth factor for another AIDS-associated cancer, Kaposi sarcoma
Cervicovaginal human papillomavirus infection in HIV-positive and high risk HIV-negative women.: Natl Conf Women HIV. 1997 May 4-7;:127 (abstract no. 203.3). Unique Identifier : AIDSLINE MED/97927292; Palefsky J; Minkoff H; Kalish LA; Levine A; Sacks H; Garcia P; Young M; Melnick S; Miotti P; Burk R; University of California, San Francisco, CA.; Background: Human papillomavirus (HPV) infection is strongly associated with cervical squamous intraepithelial lesions (CSIL) and cervical cancer. The prevalence of CSIL has been shown to be increased among HIV-positive women, and has a more aggressive course. Relatively little is known about the prevalence of HPV inf
Abnormal cervical cytology in HIV infected women.: Natl Conf Women HIV. 1997 May 4-7;:127 (abstract no. 203.4). Unique Identifier : AIDSLINE MED/97927293; Palefsky J; Fruchter RG; Riester KA; Anastos K; Burk RD; Burns D; Massad S; Miotti P; Jordan C; Muderspach L; University of California, San Francisco CA.; Background: Previous studies have demonstrated a higher prevalence of abnormal cytology in HIV-infected than in HIV-negative women and concomitant high rates of human papillomavirus (HPV) infection. However, limited numbers have precluded a detailed analysis of the determinants of the cytologic abnormalities. The Wome
High incidence of cervical abnormalities found on routine pap smears amongst HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:127 (abstract no. 203.5). Unique Identifier : AIDSLINE MED/97927294; Fischer C; Nealon MJ; Sutherland D; Atkins K; Community Family Planning Council, Brooklyn, NY.; Objective: To determine the clinical utility of routine Papanicolaou (Pap) testing amongst HIV positive women as well as colposcopic findings in those with Pap smear abnormalities. Methods: The Community Family Planning Council has a network of ten clinics in medically underserved areas in New York City that serve app
Anti-HIV therapy in pregnancy: where does the fetus stand?: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 204.2). Unique Identifier : AIDSLINE MED/97927296; Garland M; Columbia University, Department of Pediatrics, New York, NY.; Background: Therapy for the prevention of mother-to-infant transmission of HIV infection may have several aims: treatment of maternal HIV infection for maternal benefit; reduction of maternal viral load to reduce transmission to the fetus; postexposure prophylaxis in the fetus and newborn infant; treatment of an infec
The challenges of implementing recommendations for prevention of HIV perinatal transmission: how have we done so far?: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 204.3). Unique Identifier : AIDSLINE MED/97927297; Rogers MF; Centers for Disease Control and Prevention, Atlanta, GA.; In response to ACTG clinical trial 076 indicating that the use of zidovudine perinatally reduced transmission of HIV from mothers to their children by two-thirds, the USPHS issued recommendations for routine voluntary HIV counseling and testing for all pregnant women and the use of zidovudine for HIV-infected pregnant
Analgesia and pain management in HIV infected women.: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 205.1). Unique Identifier : AIDSLINE MED/97927298; Singer EJ; University of California, Department of Neurology, Los Angeles, CA.; I. Description of common pain problems in HIV+ Women II. Gender Differences in nociception and analgesia III. Innovative methods of managing pain in HIV IV. Potential drug interactions between analgesics and antivirals. Participants will learn: 1) to identify common pain problems at various stages of HIV infection; 2)
Staying a caring provider in the long haul.: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 205.2). Unique Identifier : AIDSLINE MED/97927299; Nalick M; Gay & Lesbian Center, Los Angeles, CA.; Discussion will include such topics as the importance of self care - nutrition, exercise, stress reduction and relaxation support (be it friends, colleagues, or a professional therapist). Finally we will talk about grief and bereavement.
Examining models of HIV/AIDS intervention for African American women.: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 206.1). Unique Identifier : AIDSLINE MED/97927300; Wyatt G; Ashing-Giwa K; University of California, School of Medicine, Division of Cancer; Prevention, Los Angeles, CA.; Objectives: In a effort to decrease the growing number of HIV/AIDS cases among African American women, six dimensions affecting African American women s sexuality were reviewed. These dimensions include: interrelatedness, sexual socialization, sexual practices, quality of relationship, economic status and access to me
Enhancing HIV prevention skills of separated/divorced women.: Natl Conf Women HIV. 1997 May 4-7;:129 (abstract no. 206.2). Unique Identifier : AIDSLINE MED/97927301; Hovell MF; Sipan CL; Blumberg EJ; Rodriguez GB; Kelley N; San Diego State University, School of Public Health, Center for; Behavioral Epidemiology, San Diego, CA.; Objectives: The primary aims of this 2-year study are: 1) to assess the level of condom negotiation and other assertive skills in divorced Latina and Anglo women; and 2) to test a behavioral rehearsal intervention by assessing differential change in trained women s skill levels relative to didactic training controls.
The role of women as opinion leaders in a community intervention to reduce HIV risk behavior.: Natl Conf Women HIV. 1997 May 4-7;:129 (abstract no. 206.3). Unique Identifier : AIDSLINE MED/97927302; Coley BI; Sikkema KJ; Perry MJ; Norman AD; Russ CR; Medical College of Wisconsin, Center for AIDS Intervention Research,; Milwaukee, WI.; Introduction: Community intervention models show promise as a vehicle for changing HIV risk behavior among low-income, inner-city women. This presentation describes the formation of Women s Health Councils (WHC) as a key component of a community based HIV prevention program for women living in housing developments acr
Determinants of relapse from safer sexual behavior.: Natl Conf Women HIV. 1997 May 4-7;:129 (abstract no. 206.4). Unique Identifier : AIDSLINE MED/97927303; Huszti HC; Parsons JT; Crudder SO; Schulz SL; Jarvis D; University of Oklahoma, Health Sciences Center, Oklahoma City, OK.; Objectives: Seronegative women in sexual relationships with men who are HIV positive are at high risk for becoming seropositive. Even for women who consistently practice safer sexual behaviors, relapse from this behavior can occur at any time. For these women even a single act of unprotected intercourse can have life
Effectiveness of a specialized vs. traditional AIDS education program attended by impoverished women alone or with significant others.: Natl Conf Women HIV. 1997 May 4-7;:130 (abstract no. 206.5). Unique Identifier : AIDSLINE MED/97927304; Nyamathi A; University of California, School of Nursing, Los Angeles, CA.; Impoverished minority women of color are disproportionately affected by Acquired Immune Deficiency Syndrome (AIDS), accounting for 75% of female AIDS cases diagnosed in the United States . Despite the fact that the literature on social support suggests that family relationships and frie
Pregnancy outcome expectancies among HIV-infected young women.: Natl Conf Women HIV. 1997 May 4-7;:130 (abstract no. 207.1). Unique Identifier : AIDSLINE MED/97927305; Murphy DA; Rotheram-Borus MJ; Mann T; O'Keefe Z; University of California, Neuropsychiatric Institute, Health Risk; Reduction Projects, Los Angeles, CA.; Research indicates that outcome expectancies affect behavior among teenagers. In this study, 67 HIV-infected young females (M [underline] age = 19.9 years, SD [underline] = 2.2, range = 13 - 24) were recruited through adolescent clinical and community-based sites in four AIDS epicenter cities and completed an assessme
Keepin' it R.E.A.L.: an HIV prevention program for mothers and their adolescents.: Natl Conf Women HIV. 1997 May 4-7;:130 (abstract no. 207.3). Unique Identifier : AIDSLINE MED/97927307; Dilorio C; Resnicow K; Manteuffel B; Childers K; Emory University, Rollins School of Public Health, Atlanta, GA.; Introduction: The purpose of the poster presentation is to share with conference participants the development and implementation of Keepin it R.E.A.L.!, an HIV prevention program for mothers and their adolescents. The major aim of Keepin it R.E.A.L.! is to develop and test two interventions designed to promote delay
HIV prevention program for pregnant and parenting teenagers.: Natl Conf Women HIV. 1997 May 4-7;:131 (abstract no. 207.4). Unique Identifier : AIDSLINE MED/97927308; Koniak-Griffin D; Lesser J; Torres A; University of California, School of Nursing, Los Angeles, CA.; AIDS is rapidly increasing among adolescents, with heterosexual contact being the primary transmission mode among young females. Pregnant adolescents and young mothers are a particularly vulnerable population as they often engage in unprotected sex and/or have multiple partners, and are largely ethnic minorities dispr
Power and partner objections to male condoms: implications for female controlled methods for HIV/STD prevention.: Natl Conf Women HIV. 1997 May 4-7;:131 (abstract no. 208.1). Unique Identifier : AIDSLINE MED/97927309; Cabral R; Pulley LV; Artz L; Brill I; Macaluso M; Centers for Disease Control and Prevention, Atlanta, GA.; Objectives: Promotion of latex condoms for the prevention of HIV among women has been controversial. It has been argued that male partner objections and women s powerlessness represent significant barriers and that female-controlled methods will be welcomed by partners of resistant men. This study evaluated patterns o
Patterns of condom use in HIV infected and HIV uninfected women.: Natl Conf Women HIV. 1997 May 4-7;:131 (abstract no. 208.2). Unique Identifier : AIDSLINE MED/97927310; Schoenbaum EE; Chang CJ; Moore J; Schuman P; Stein M; Warren D; AIDS Research Program, Montefiore Medical Center, Albert Einstein; College of Medicine, Bronx, NY.; Objective: To study patterns of condom use during vaginal sex in HIV infected and uninfected women with injection drug use (IDU) or sexual contact risk histories who enrolled in the HER Study. Methods: We interviewed heterosexually active women about sex, drug use and contraception practices during the past 6 months.
Psychosocial determinants of assertive communication about condom use by adolescent females.: Natl Conf Women HIV. 1997 May 4-7;:131 (abstract no. 208.3). Unique Identifier : AIDSLINE MED/97927311; Sturdevant MS; Elmore GR; Fish L; McCutchen T; Williams L; Brown P; DiClemente R; Kohler CL; University of Alabama, Department of Pediatrics, Birmingham, AL.; Objective: The objective of this study is to test an explanatory model of psychosocial determinants of communication about condom use between adolescent girls and their main sex partners. We hypothesized that adolescent females who had experienced prior positive responses from partners would expect more positive outco
Acceptability of over-the-counter barrier contraceptives.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 208.4). Unique Identifier : AIDSLINE MED/97927312; Padian N; Quan J; Glass S; Gould H; University of California, San Francisco, CA.; Objective: Identify factors associated with contraceptive choice among young men and women. Methods: Subjects were recruited from a University Health service, and planned parenthood, family planning and STD clinics. Data reported here reflect choices at baseline only among 163 women and 70 men. Participants were couns
From client to advocate: the struggles and victories of women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 209.1). Unique Identifier : AIDSLINE MED/97927313; Jiminez V; Pena J; Soto Romero M; Gonzales A; Pena K; Housing Works, Inc., New York, NY.; We are five women from Housing Works who would like to present a workshop on issues confronting women of color who are living with HIV. Two of us are currently Client Board reps at Housing Works, and one is a former Client Board rep. Two of us have graduated from the job training program and joined the staff of Housin
Pathogenesis of HIV disease: relationship to principles of therapy.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 210.1). Unique Identifier : AIDSLINE MED/97927314; Benson CA; Rush Presbyterian-St. Luke's Medical Center, Chicago, IL.; This lecture outlines the basic science and pathogenesis of HIV disease as these relate to the changing paradigm of antiretroviral therapy and the development of new principles of antiretroviral therapy. Data to be reviewed will include viral dynamics, viral decay, the impact of second receptors, the early development
Prevention of opportunistic infections.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 210.2). Unique Identifier : AIDSLINE MED/97927315; Kaplan J; Centers for Disease Control and Prevention, Atlanta, GA.; Data on the incidence and trends of OI s in HIV-infected persons will be presented, with emphasis on comparisons between women and men. Prevention of OI s will be discussed, with reference to the 1997 revised USPHS/IDSA guidelines for preventing OI s in HIV-infected persons. A few points will be made regarding problem
Practical aspects of antiretroviral therapy.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 210.3). Unique Identifier : AIDSLINE MED/97927316; Mayer KH; Memorial Hospital, Pawtucket, RI.; The talk will describe the rationale for combination antiretroviral therapy: Viral load is higher and more dynamic than previously understood; resistance to monotherapy develops rapidly; multiple effective choices that can inhibit either the viral reverse transcriptase or protease enzymes now exist. The most recent da
Pregnancy is not associated with an increase in progression of HIV disease in women attending an HIV outpatient program.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 211.1). Unique Identifier : AIDSLINE MED/97927317; Bessinger R; Clark R; Kissinger P; Rice J; Coughlin S; Louisiana State University Medical Center, HIV Outpatient Program, New; Orleans, LA.; Objectives: To assess the association of pregnancy and HIV disease progression in women who were pregnant while HIV infected. Methods: A retrospective review of women 15-35 years attending an HIV outpatient program in New Orleans from 1989 through 1995. Women with a term pregnancy (n = 192) after testing positive for
New York State's experience with consented HIV testing of newborns, 1996.: Natl Conf Women HIV. 1997 May 4-7;:132 (abstract no. 211.4). Unique Identifier : AIDSLINE MED/97927320; Birkhead G; Glebatis D; Glaros R; Walsh R; Pass K; Smith P; Schedlbauer L; DeBuono B; New York State Department of Health, AIDS Institute, Albany, NY.; Background: Since the late 1980s, many states have carried out blinded HIV antibody testing of newborn blood specimens submitted for screening for metabolic disorders; HIV test results have not been linked to patient identifiers nor returned to new mothers in these programs. On May 1, 1996, New York State (N.S.) insti
Surveillance of zidovudine prescription among HIV-infected pregnant women.: Natl Conf Women HIV. 1997 May 4-7;:133 (abstract no. 211.5). Unique Identifier : AIDSLINE MED/97927321; Lansky A; Jones JL; Wan PC; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: Zidovudine (ZDV) is recommended for pregnant HIV-infected women to reduce perinatal transmission risks. The purpose of this analysis is to describe patterns of ZDV prescription of HIV-infected women during pregnancy. Methods: We used data from the Adult/Adolescent Spectrum of Disease (ASD) Surveillance Proj
Maternal serum vitamin-A levels are not associated with mother-to-child transmission of HIV-1 in the United States.: Natl Conf Women HIV. 1997 May 4-7;:133 (abstract no. 211.6). Unique Identifier : AIDSLINE MED/97927322; Burger H; Kovacs A; Weiser B; Grimson R; Nachman S; Tropper P; van Bennekum A; Elie M; Blaner W; New York State Department of Health, Wadsworth Center, Albany, NY.; Objectives: HIV-1 transmission from mother to child has been associated with maternal vitamin A status in studies of women living in Africa. This finding has raised the question of whether vitamin A supplementation might help reduce transmission in the U.S. as well as world-wide. In industrialized nations, however, bo
Illinois response to the Coburn mandates.: Natl Conf Women HIV. 1997 May 4-7;:133 (abstract no. 211.7). Unique Identifier : AIDSLINE MED/97927323; Driscoll M; Taylor D; Cohen M; Cook County Hospital, MCH/HIV Integration Project, Chicago, IL.; HIV can be perinatally transmitted from an HIV positive woman to her fetus or newborn during pregnancy, labor and delivery, and the postpartum period through breastfeeding although it is not precisely known what proportions of infections are transmitted during each stage. Only a few years ago strategies to prevent per
When legislation is counter to program goals: a Brooklyn experience.: Natl Conf Women HIV. 1997 May 4-7;:134 (abstract no. 211.8). Unique Identifier : AIDSLINE MED/97927324; Rips J; State University of New York Health Science Center, Brooklyn, NY.; Introduction: Following the publication of ACTG 076 s results i.e., the efficacy of ZDV in reducing perinatal transmission of HIV), it became imperative to implement the findings widely while, ideally, still preserving voluntary prenatal HIV testing. Systems and programs had to be developed in order to provide expande
Using social networks to reduce risky sex and depression among women living with HIV.: Natl Conf Women HIV. 1997 May 4-7;:134 (abstract no. 214.1). Unique Identifier : AIDSLINE MED/97927325; Wingood GM; DiClemente RJ; University of Alabama, School of Public Health, Center for AIDS; Research, Birmingham, AL.; Introduction: If women living with HIV are to maintain their psychosocial equilibrium, they will need to adapt to the physical, psychological and emotional challenges of living with HIV. Moreover, promoting condom use among women living with HIV could reduce the risk of HIV infection among seronegative sex partners, r
Community collaboration and basic research: necessary ingredients for the development of a family-based HIV prevention project in Chicago public housing.: Natl Conf Women HIV. 1997 May 4-7;:134 (abstract no. 214.2). Unique Identifier : AIDSLINE MED/97927326; McKernan McKay M; Paikoff R; Department of Psychiatry, Institute for Juvenile Research, University; of Illinois, Chicago, IL.; Introduction: Over the last five years, the incidence of HIV and AIDS infection rates has risen dramatically in poor, primarily minority neighborhoods. For example, within Chicago, inner-city African Americans represent 50% of all new AIDS cases diagnosed. At the same time that HIV and AIDS are becoming more prominent
Impact on children of an HIV prevention training aimed at their parents: preliminary results.: Natl Conf Women HIV. 1997 May 4-7;:134 (abstract no. 214.3). Unique Identifier : AIDSLINE MED/97927327; Krauss BJ; Goldsamt LA; National Development and Research Institutes, Inc., Institute for AIDS; Research, New York, NY.; Objectives: To determine if an HIV prevention training aimed at parents and oriented toward making parents HIV prevention educators for their own 10-13 year old children had an impact on either parents or children. To see if a curriculum unit designed to increase comfort in interacting with persons with HIV (PwHIV) wa
Developing strategies to work with families in public housing: the mother-son HIV risk-reduction intervention model.: Natl Conf Women HIV. 1997 May 4-7;:135 (abstract no. 214.4). Unique Identifier : AIDSLINE MED/97927328; Sweet Jemmott L; Outlaw F; Jemmott JB; University of Pennsylvania, School of Nursing, Philadelphia, PA.; Introduction: The incidence of AIDS is increasing at an alarming rate in African American families, especially among women and adolescents residing in low income urban areas. Of particular concern are young African American adolescent males living with their single mothers, where the key family member to teach them HI
A randomized controlled trial of the effect of nonoxynol-9 film use on male-to-female transmission of HIV-1.: Natl Conf Women HIV. 1997 May 4-7;:135 (abstract no. 215.3). Unique Identifier : AIDSLINE MED/97927330; Roddy RE; Zekeng L; Ryan KA; Tamouofe U; Weir SS; Din E; Wong E; Dominik R; Taylor D; Wheeless A; Family Health International, Research Triangle Park, NC.; Primary Objective: To measure the effect of the use of vaginal film containing nonoxynol-9 on the rate of HIV infection in the context of condom promotion and treatment of sexually transmitted disease. Methods: This study is a randomized, triple-masked, multisite, placebo-controlled trial. Eligible for the study were
Clinical trials: an advocate's perspective.: Natl Conf Women HIV. 1997 May 4-7;:135 (abstract no. 215.4). Unique Identifier : AIDSLINE MED/97927331; Heise L; Health and Development Policy Project, Washington, DC.; This presentation will discuss the evolving dialogue between women s health advocates and the scientific establishment regarding the design and implementation of clinical trials for testing the safety and efficacy of topical microbicides. On April 27-30, 1997 60 advocates, scientists and researchers from 20 countries
Symptom management, symptom distress and emotional well-being in women with AIDS.: Natl Conf Women HIV. 1997 May 4-7;:136 (abstract no. 216.3). Unique Identifier : AIDSLINE MED/97927334; Van Servellen G; Sarna L; Nyamathi A; Padilla G; Brecht ML; Jablonski KJ; University of California, School of Nursing, Los Angeles, CA.; This descriptive survey explored the relationship of symptom distress and emotional well-being in a group of 44 HIV symptomatic women, recruited from Harbor-UCLA AIDS Clinic, UCLA s CARE Center, as well as from four free-standing women s HIV clinics in the greater Los Angeles area. This is a report of Time 1 data anal
Stress management and relaxation training with African-American, HIV-1 seropositive women.: Natl Conf Women HIV. 1997 May 4-7;:136 (abstract no. 216.4). Unique Identifier : AIDSLINE MED/97927335; Greenwood D; Antoni M; West C; Byrnes D; University of Miami, Miami, FL.; In this cognitive-behavioral intervention, 27 African American, HIV-1 seropositive women were randomly assigned to either a 10 week stress management intervention group, or a control condition. All participants were assessed pre- and post- the 10 week intervention for psychosocial adjustment, neuroendocrine and immune
Services to women in the federally funded HIV/AIDS mental health services demonstration.: Natl Conf Women HIV. 1997 May 4-7;:136 (abstract no. 216.5). Unique Identifier : AIDSLINE MED/97927336; Havens J; Draper K; Columbia Presbyterian Medical Center, Special Needs Clinic, New York,; NY.; Issues: Women represent an increasing percentage of HIV cases in the United States . Women of color are more specifically impacted as AIDS is the leading cause of death in African American women and the third leading cause of death in Latinas. For many women of color living with HIV, is
Kinship connection: mental health services, case management and permanency planning for infected women, children and caregivers.: Natl Conf Women HIV. 1997 May 4-7;:136 (abstract no. 216.6). Unique Identifier : AIDSLINE MED/97927337; Botwinick G; Mason-Reese C; Blatner Associates, Inc., Maplewood, NJ.; Issues: In N.J., AIDS is a family epidemic fueled by injecting drug use and heterosexual transmission. Thousands of children are being orphaned; numbers of infected women of childbearing age continue to grow; and orphaned adolescents are a particularly high risk group. In local Needs Assessments conducted in NJ, over
Incarceration as a unique opportunity for HIV diagnosis, initiation of comprehensive care, and linkage to the community.: Natl Conf Women HIV. 1997 May 4-7;:137 (abstract no. 217.1). Unique Identifier : AIDSLINE MED/97927339; Flanigan T; Rich J; Dickinson B; Vigilante K; Spaulding A; Brown University, Providence, RI.; Objective: To review the first five years of the HIV prison care program in Rhode Island, where all incoming men and women are tested for HIV. Methods: Review of the HIV test results reported to the RI State Dept. of Health (DOH) from 1990 to 1994 and description of the HIV care program in prison. Results: Between 199
Transitional case management for HIV+ prisoners in Connecticut.: Natl Conf Women HIV. 1997 May 4-7;:137 (abstract no. 217.2). Unique Identifier : AIDSLINE MED/97927340; Altice FL; Khoshnood K; Eicher A; Pinell V; Yale University, AIDS Program, New Haven, CT.; Background: Project Transitional Linkages to Communities (TLC) provides case management services to HIV+ prisoners with Ryan White Title I and Title II Planning Committee funds. Inmates are referred to Transitional Case Managers (TCM) by the DOC within 90 days before release. Client needs are assessed and case managem
Psychosocial issues of HIV negative high risk women.: Natl Conf Women HIV. 1997 May 4-7;:137 (abstract no. 217.3). Unique Identifier : AIDSLINE MED/97927341; Affleck P; Willis P; Brown University, Providence, RI.; Introduction: High Risk women have special issues that must be acknowledged and addressed before behavior change can occur. Project Description: The author is the clinical coordinator for a program that provides a biomedical intervention through a study focused on HIV negative high risk women. The complex issues that
Continuity of care when women with HIV are incarcerated.: Natl Conf Women HIV. 1997 May 4-7;:138 (abstract no. 217.4). Unique Identifier : AIDSLINE MED/97927342; Fiore T; Rich J; Vigilante K; Flanigan T; Delossantos C; Gormley J; Brown University, Providence, RI.; Introduction: At any one time, 8-12% of the women incarcerated in the Rhode Island state prison system are infected with the HIV virus. These women receive primary care in the community through The Miriam Hospital Immunology Center. Many women are also participants in a longitudinal study of the natural history of wom
Providing services within the prison setting.: Natl Conf Women HIV. 1997 May 4-7;:138 (abstract no. 217.5). Unique Identifier : AIDSLINE MED/97927343; Loewenthal H; Brown University, Providence, RI.; Introduction: The Miriam Hospital in conjunction with the Rhode Island Adult Correctional Institution s Women s Division provide a wide range of services to high risk incarcerated women. Project Description: A social worker provides interventions to high risk HIV negative women within the prison setting. The intervent
Discharge planning for incarcerated women.: Natl Conf Women HIV. 1997 May 4-7;:138 (abstract no. 217.6). Unique Identifier : AIDSLINE MED/97927344; Gallagher T; Page JA; The Fortune Society, New York, NY.; Introduction: The development of a discharge plan to enable clients to overcome the barriers in meeting both medical and other service needs upon release. Project Description: The Fortune Society serves incarcerated and recently released prisoners by offering them a support network and helping them to access the resou
Forging the linkages: a three step process.: Natl Conf Women HIV. 1997 May 4-7;:138 (abstract no. 217.7). Unique Identifier : AIDSLINE MED/97927345; Holmes L; Brown University, Providence, RI.; Introduction: Creating effective linkages is a three step process. The program needs to be connected to the community, to the clients, and to facilitate linking the clients to the service providers. Project Description: Project Bridge is a program that provides intensive case management to HIV positive women who are d
Mandatory HIV testing of childbearing women.: Natl Conf Women HIV. 1997 May 4-7;:138 (abstract no. 218.1). Unique Identifier : AIDSLINE MED/97927346; McGovern T; Diaz M; Rodriguez-Trias H; Marte C; Pacific Institute for Women's Health, Brookdale, CA.; Over the last year, a policy trend towards mandatory HIV testing of pregnant women and their newborns has emerged. The bases for these policy developments are the identification of a treatment regimen to reduce the likelihood of perinatal HIV transmission as well as the stated desire to identify HIV exposed infants. H
Pregnant women and newborns under attack - new mandatory HIV testing efforts.: Natl Conf Women HIV. 1997 May 4-7;:139 (abstract no. 218.2). Unique Identifier : AIDSLINE MED/97927347; Hansen E; Women's AIDS Network, San Francisco, CA.; This two-hour workshop will focus on recent, and continuing, efforts to mandate testing of pregnant women and newborns and the community-based responses to these efforts. Research overwhelmingly shows that voluntary HIV testing programs are working for pregnant women, maternal-fetal transmission rates are dropping, an
Barriers reduction among women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:139 (abstract no. 219.2). Unique Identifier : AIDSLINE MED/97927349; Hughes C; Melchior LA; Brown VB; Huba G; PROTOTYPES, Culver City, CA.; Introduction: Women living with HIV often encounter a number of barriers when seeking care for themselves and their families. Factors such as lack of transportation, not knowing what services exist, fearing that there would be a long wait for services, or that they cost too much may prevent women from obtaining needed
Relationships between needs of women with HIV and service utilization.: Natl Conf Women HIV. 1997 May 4-7;:139 (abstract no. 219.3). Unique Identifier : AIDSLINE MED/97927350; Melchior LA; Huba G; Brown VB; The Measurement Group, Culver City, CA.; Introduction: Women living with HIV have a myriad of health and social service needs, which are often unmet in the traditional health and social service system. Frequently, women s service concerns fall through the cracks, especially in a system that was not necessarily designed to match the women s needs. A settlemen
Symposium: HIV prevention: the challenge of linking bottom-up and top-down knowledge production (a blueprint for action and lessons learned by the Women's Committee of the NYS Prevention Planning Group).: Natl Conf Women HIV. 1997 May 4-7;:140 (abstract no. 219.4). Unique Identifier : AIDSLINE MED/97927351; Indyk DS; Coury-Doniger P; Klein SJ; Mount Sinai School of Medicine, New York, NY.; Introduction: Knowledge production and technology transfer in early intervention and prevention require the establishment of linkages among normally unconnected providers and sites. Prevention Planning Groups, mandated by CDC to be established by jurisdictions receiving CDC funding have been working since 1994 to iden
Secondary prevention of STD as an essential strategy for the primary prevention of HIV.: Natl Conf Women HIV. 1997 May 4-7;:140 (abstract no. 219.5). Unique Identifier : AIDSLINE MED/97927352; Coury-Doniger P; Indyk DS; Klein SJ; Stephens PC; Wilcox D; Monroe County Department of Health, Rochester, NY.; Introduction: In the past, policy makers, health care providers, and even public health departments have responded to HIV/AIDS as separate from STDs, in spite of similar modes of transmission and potential for prevention through reduction of the same risk behaviors. The determination that the presence of STDs facilita
How and why to mainstream HIV services.: Natl Conf Women HIV. 1997 May 4-7;:140 (abstract no. 219.6). Unique Identifier : AIDSLINE MED/97927353; Belville R; Indyk D; Grosz J; Johnson W; Yarmolinsky S; Pruden S; Kaudeyr K; Jordan S; Edwards T; Stevens PC; Dominican Sisters Family Health Service, Bronx, NY.; Introduction: The Women s Committee has consistently identified mainstreaming as a focus for much of its work by elaborating unmet prevention needs and developing action plans for addressing these needs. One approach to mainstreaming involves integrating HIV into the work of community workers who function as gatekeep
Integrating HIV prevention and care: implications and imperatives.: Natl Conf Women HIV. 1997 May 4-7;:140 (abstract no. 219.7). Unique Identifier : AIDSLINE MED/97927354; Indyk D; Golub S; Wainberg M; Mount Sinai School of Medicine, New York, NY.; Introduction: Recent advances in viral load testing and combination therapy with protease inhibitors are certain to have profound impact on the diagnosis and treatment of HIV infected individuals as well as on the pr
Door-to-door survey of HIV infection and risk behaviors among young women in five California counties.: Natl Conf Women HIV. 1997 May 4-7;:141 (abstract no. 220.1). Unique Identifier : AIDSLINE MED/97927355; Ruiz JD; Molitor F; Langrish P; Villa H; Smith C; Lynch M; Delgado V; Cahoon-Young B; California Department of Health Services, Office of AIDS, Sacramento,; CA.; Introduction: The Young Women Survey (YWS) is a randomized, population-based, door-to-door survey of young women aged 18 to 29 years who reside in defined low income census tracts. Field staff conduct structured one-hour face-to-face interviews with the use of a standardized questionnaire (English or Spanish versions)
Balance of power in heterosexual relationships among inner-city Latino couples.: Natl Conf Women HIV. 1997 May 4-7;:142 (abstract no. 222.1). Unique Identifier : AIDSLINE MED/97927360; Harvey SM; Beckman LJ; Pacific Institute for Women's Health, Los Angeles, CA.; This project is designed to address the major gaps in the research literature and in our knowledge and understanding of the male role in contraceptive decision-making and condom use for the prevention of HIV among inner city Latino heterosexual couples. The study design employs two innovative approaches: the use of bo
Heterosexual risk for HIV among female adolescents: sexual initiation with older male partners.: Natl Conf Women HIV. 1997 May 4-7;:142 (abstract no. 222.2). Unique Identifier : AIDSLINE MED/97927361; Miller KS; Clark LF; Moore JS; Centers for Disease Control and Prevention, Atlanta, GA.; Objectives: To describe differences in HIV risk behaviors of adolescent females who initiated sex with an older (3 or more years older than the female index) versus peer-age (same age, or one to less than 3 years older or younger than the female index) sex partner; and to discuss implications of these findings for the
Strengthening the ties para V.O.L.A.R. (Vision, Organize, Leadership, Accion, Revolution).: Natl Conf Women HIV. 1997 May 4-7;:142 (abstract no. 222.3). Unique Identifier : AIDSLINE MED/97927362; Sandoval-Guerra A; Torres I; Baez MI; Negroni M; National Latino/a Lesbian and Gay Organization, Washington, DC.; The goal of this workshop is to identify and address the issues that impact effective lesbiana specific programming in HIV/STD prevention services, as well as care for the patients. Latina lesbian and bisexual women are an unstudied population, underserved in the health care system and at risk of prejudicial treatment
Factors associated with unprotected vaginal intercourse among minority, heterosexual females 12-24 years of age attending a community-based health center in Los Angeles.: Natl Conf Women HIV. 1997 May 4-7;:142 (abstract no. 222.4). Unique Identifier : AIDSLINE MED/97927363; Stoyanoff SR; Weber MD; Gatson B; Ford WL; Kerndt PR; HIV Epidemiology Program, Los Angeles County Department of Health; Services, Los Angeles, CA.; Objective: To identify factors associated with unprotected vaginal intercourse among females 12-24 years of age who attend a community-based health center in South Central Los Angeles. Methods: HIV serologic and demographic/risk behavior data were collected using an unlinked methodology. Females 12-24 years of age wer
Social networks, access to community based services, and empowerment: implications for HIV infection in women.: Natl Conf Women HIV. 1997 May 4-7;:143 (abstract no. 223.1). Unique Identifier : AIDSLINE MED/97927364; Young B; Tabnak F; Sun R; Tager I; Center for Family and Community Health, University of California,; Berkeley, CA.; Introduction: Women in California who reside in low income, inner city communities are at greatest risk for HIV. Low income women are at risk for many other negative health outcomes, such as teen aged pregnancy, other sexually transmitted diseases (STDs), and infant mortality. Social networks, access to community serv
Developing HIV prevention services for women visiting incarcerated men.: Natl Conf Women HIV. 1997 May 4-7;:143 (abstract no. 223.2). Unique Identifier : AIDSLINE MED/97927365; Grinstead OA; Comfort M; Zack B; University of California, Center for AIDS Prevention Studies, San; Francisco, CA.; Introduction: The demographic profile of women at increased risk for HIV, young women, women of color, and low-income women, coincides with that of women who have incarcerated sexual or drug partners. Since prisoners have a higher prevalence of HIV infection than the general population, their partners face compounded
Women's reproductive decisions and the role of health care providers.: Natl Conf Women HIV. 1997 May 4-7;:143 (abstract no. 223.3). Unique Identifier : AIDSLINE MED/97927366; Fogarty LA; Gielen AC; Faden R; Eke A; Cohen A; Armstrong K; Johns Hopkins University, Baltimore, MD.; Objectives: This paper reports childbearing intentions of HIV-infected women along with factors potentially related to decision making such as attitudes about having children while HIV-infected, and information and advice received from health care providers (HCPs) about having children. Methods: 322 HIV positive women
Breaking perpetual cycles in care for women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:144 (abstract no. 223.4). Unique Identifier : AIDSLINE MED/97927367; Anderson K; Urada L; Worrell K; Prototypes, Los Angeles, CA.; Issue: Women living with HIV/AIDS face many barriers in receiving supportive services that address their specific needs. Many traditional social service and mental health programs have proven ineffective when issues of gender, sexuality, culture and language are not addressed. Project: Comprehensive program models hav
Changing from within: services for women at Gay Men's Health Crisis, Inc.: Natl Conf Women HIV. 1997 May 4-7;:144 (abstract no. 223.5). Unique Identifier : AIDSLINE MED/97927368; Oliveira A; Weinstein L; Cyrus I; Schaffzin T; Gery E; Gay Men's Health Crisis, Inc., New York, NY.; Introduction: Gay Men s Health Crisis s (GMHC s) Department of Evaluation Research has conducted preliminary research around the agency s female clients. The results of these initial efforts demonstrate the challenges of providing services for women in a gay-male-identified organization. Program Description: GMHC s de
Psychosocial care: an ethical dilemma in HIV/AIDS phenomenon.: Natl Conf Women HIV. 1997 May 4-7;:144 (abstract no. 223.6). Unique Identifier : AIDSLINE MED/97927369; Nansubuga A; National Community of Women Living with HIV/AIDS, Uganda.; Introduction: Psychosocial care is a delicate issue to handle in the HIV/AIDS situation given the varying cultural practices in Uganda . It has proved a dilemma yet it is one of the major components within the social and psychological care for PWAs and the entire family. The fact th
Demanding quality treatment for HIV: the Act Up Philadelphia women's standard of care.: Natl Conf Women HIV. 1997 May 4-7;:144 (abstract no. 223.7). Unique Identifier : AIDSLINE MED/97927370; Davids J; DePeiro J; Grooms K; Jones J; Krauss K; Larkin M; Rifkin L; Russell A; ACT UP, Philadelphia, PA.; Introduction: HIV+ women disproportionately represent people with little to no access to quality health care, and with complex psychosocial and economic issues that directly affect how they feel and how long they live. However, existing standards of care for HIV, which have been proven by activists as critical politic
Multicultural outreach project.: Natl Conf Women HIV. 1997 May 4-7;:144 (abstract no. 223.8). Unique Identifier : AIDSLINE MED/97927371; Bearden EM; Burgos A; Farmworkers Self-Help, Inc., Dade City, FL.; Issues: The little to no knowledge about HIV, its methods of transmission and prevention among the farmworker population and other area poor who lack relevant information. Lack of affordable means of obtaining condoms. Project Description: Utilizing a racially diverse outreach team consisting of bilingual Mexican form
Beliefs about anti-retrovirals and alternative treatment use in African-American women with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:145 (abstract no. 224.2). Unique Identifier : AIDSLINE MED/97927373; Coons HL; O'Connor BB; Tedaldi E; Harwell TS; Witek J; Health Federation of Philadelphia, Philadelphia, PA.; Objectives: While anti-retroviral therapy is now frequently encouraged early in the course of HIV, women may elect not to take or continue with treatment for a host of reasons. While some women use alternative therapies to fight their disease, few studies have used quantitative or qualitative approaches to assess comp
Reproductive choices among HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:145 (abstract no. 225.1). Unique Identifier : AIDSLINE MED/97927374; Bedimo AL; Bessinger R; Kissinger P; Louisiana State University Medical Center, HIV Outpatient Program, New; Orleans, LA.; Study Objectives: To describe the population of HIV-positive women who get pregnant, who choose to get sterilized, and who have an elective abortion after an HIV diagnosis. Methods: All HIV-infected women between the ages of 14 and 35 years (N=403) who were enrolled in the HIV Outpatient Program in New Orleans between
Prenatal HIV testing practices among obstetricians and gynecologists in New Orleans.: Natl Conf Women HIV. 1997 May 4-7;:146 (abstract no. 225.2). Unique Identifier : AIDSLINE MED/97927375; Kissinger P; Herwehe J; Brumley K; Ishaque U; Robinson W; Department of Medicine, Louisiana State University, New Orleans, LA.; Objectives: To assess the knowledge and practices of New Orleans based obstetricians and gynecologists with regards to HIV prenatal testing, protocols for the prevention of maternal-child HIV transmission, and the medical management of HIV-infected women. Methods: A self-administered mail survey was sent to all obstet
ZDV-use, HIV-testing and reproductive behavioral responses related to knowledge of ZDV to reduce infant HIV transmission.: Natl Conf Women HIV. 1997 May 4-7;:146 (abstract no. 225.3). Unique Identifier : AIDSLINE MED/97927376; Healton C; Taylor S; Molano F; Messeri P; Columbia University, School of Public Health, New York, NY.; Objective: The purpose of this randomized follow-up study was to determine the long-term behavioral effects of knowledge of the ZDV-during-pregnancy regimen to reduce infant HIV transmission on reproductive, HIV-testing and ZDV-use behaviors of a national cohort of HIV-positive and high-risk women. Methods: 265 HIV-po
HIV counseling and testing in high risk prenatal patients.: Natl Conf Women HIV. 1997 May 4-7;:146 (abstract no. 225.4). Unique Identifier : AIDSLINE MED/97927377; Hight EB; Bond A; Brown University, Department of Family Medicine, Providence, RI.; Introduction: In July 1995 the US Public Health Service recommended routine HIV counseling and testing for all pregnant women based on a clinical trial which showed that administration of AZT to HIV-infected pregnant women and their newborns reduced t
Coercive testing and the demonization of mothers: HIV policy and politics in New York State.: Natl Conf Women HIV. 1997 May 4-7;:146 (abstract no. 225.5). Unique Identifier : AIDSLINE MED/97927378; Bergman JL; Housing Works, Inc., New York, NY.; For several years, intensive legislative and regulatory efforts to impose mandatory HIV (and drug toxicology) tests on pregnant women and/or their newborn children have been waged in New York State. The justification given for forced testing is the health of infants, but these policies are widely opposed by physicians
Distress assessment and intervention for newly diagnosed HIV+ women.: Natl Conf Women HIV. 1997 May 4-7;:146 (abstract no. 226.1). Unique Identifier : AIDSLINE MED/97927379; Jenkins SR; University of North Texas, Department of Psychology, Denton, TX.; Objectives: This study designed and pilot-tested a single- session individual stressor assessment and intervention protocol to reduce acute distress among newly diagnosed HIV+ African-American and Anglo women, and evaluated intervention success. This presentation describes the resulting interview assessment and interv
Social support, community resources, mood, and sexual risk behavior among HIV-positive men and women.: Natl Conf Women HIV. 1997 May 4-7;:147 (abstract no. 226.2). Unique Identifier : AIDSLINE MED/97927380; Spiegel D; Koopman C; Israelski D; Gill M; Maldonado J; Gore-Felton C; Classen C; Porter J; Stanford University, School of Medicine, Department of Psychiatry,; Stanford, CA.; Objectives: This study examined the relationships between social support, access to community resources, mood, and sexual risk behavior among HIV-positive women and men. We also examined for sex differences in mood and sexual risk behavior. Methods: At present, we have recruited 18 female and 51 male HIV-positive adul
The management of HIV, sex, and risk among HIV sero-discordant heterosexual couples.: Natl Conf Women HIV. 1997 May 4-7;:147 (abstract no. 226.3). Unique Identifier : AIDSLINE MED/97927381; Knight KR; van der Straten A; Vernon KA; Gomez CA; Padian NS; Department of Obstetrics, Gynecology, and Reproductive Sciences,; University of California, San Francisco, CA.; Objectives: To assess the important issues related to HIV disease management, sexual safety, and social support among heterosexual HIV sero-discordant couples in The California Partner Study, a prospective 10-year study of HIV transmission. Methods: At the conclusion of The California Partner Study (1995), interviews
Psychological and psychosocial adjustment of HIV-infected women: race/ethnic comparisons.: Natl Conf Women HIV. 1997 May 4-7;:147 (abstract no. 226.4). Unique Identifier : AIDSLINE MED/97927382; Siegel K; Karus DG; Raveis VH; Memorial Sloan-Kettering Cancer Center, New York, NY.; Objectives: To determine whether reported levels of psychological and/or psychosocial adjustment varied with regard to race/ethnicity in a sample of HIV-infected women. Methods: Data from a purposive sample of 146 HIV-infected African American, Puerto Rican or White non-Hispanic women in NYC were analyzed. Prior to an
Predictors of satisfaction with life among women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:147 (abstract no. 226.5). Unique Identifier : AIDSLINE MED/97927383; DiFranceisco WM; Heckman TG; Somlai AM; Center for AIDS Intervention Research (CAIR), Medical College of; Wisconsin, Milwaukee, WI.; Objective: Most research on the experiences and problems of persons living with HIV/AIDS has focused on men in large urban epicenters. Comparatively little is known about the impact of the disease on the life circumstances and psychological well-being of infected women living in smaller cities and towns across the US.
Gender differences in quality of life among HIV+ men and women.: Natl Conf Women HIV. 1997 May 4-7;:148 (abstract no. 226.6). Unique Identifier : AIDSLINE MED/97927384; Avis NE; Smith KW; Mayer K; Swislow L; New England Research Institutes, Watertown, MA.; Objectives: This paper presents data on quality of life among HIV+ men and women. Methods: The sample consists of 121 HIV+ volunteers (36 women and 85 men) identified through announcements and recommendations by clinicians at a hospital and community health center. Study participants completed an hour long in person i
Emotional well-being among women engaged in AIDS caregiving.: Natl Conf Women HIV. 1997 May 4-7;:148 (abstract no. 226.7). Unique Identifier : AIDSLINE MED/97927385; LeBlanc AJ; London AS; Wight RG; University of Maryland, Department of Sociology, College Park, MD.; We examine emotional well-being among women engaged in AIDS caregiving. Our objective is to elaborate the ways in which women encounter stress emanating from the caregiving role, as well as how such stress can lead to the experience of depression, anxiety, and anger. Our analyses are guided by the widely recognized s
Protease inhibitor-related knowledge, attitudes and patterns of use by gender.: Natl Conf Women HIV. 1997 May 4-7;:148 (abstract no. 227.1). Unique Identifier : AIDSLINE MED/97927386; Stone VE; Clarke J; Lovell K; Mayer KH; Memorial Hospital, Providence, RI.; Introduction and Project Description: Currently, there is increased optimism among patients and providers regarding the treatment of HIV disease, due to the availability of protease inhibitors and potent three drug antiretroviral regimens containing these agents. To
Regarding research: HIV+ women consider clinical trials.: Natl Conf Women HIV. 1997 May 4-7;:148 (abstract no. 227.2). Unique Identifier : AIDSLINE MED/97927387; Parks VE; Donovan DA; ACT UP Golden Gate, San Francisco, CA.; Objectives: To present a snapshot of women s physical and emotional reasons for accepting or declining participation in research and make recommendations to better recruit women into clinical trials. Methods: Using a convenience sampling, 62 HIV+ women were recruited during the first half of 1996 to complete a 10-page
The meaning is in the women: gendered aspects of research participation.: Natl Conf Women HIV. 1997 May 4-7;:149 (abstract no. 227.3). Unique Identifier : AIDSLINE MED/97927388; McGuire JF; Massachusetts Department of Public Health, Cambridge, MA.; Objectives: To assess research decision-making practices in HIV primary care environments: specifically, the goal was to determine the meanings respondents attributed to research participation. Methods: Multi-level semi-structured interviews with over sixty-five individuals were conducted at eight geographically, stru
Dual roles in research and clinical care: successful research models for HIV infection in women.: Natl Conf Women HIV. 1997 May 4-7;:149 (abstract no. 227.4). Unique Identifier : AIDSLINE MED/97927389; Weber KM; Cohen M; Barkan S; Fitzpatrick J; Nicks G; Santiago M; Holman S; Cook County Hospital, Chicago, IL.; Objective: This symposium will present lessons of investigators, primary providers, and patients who both provide or receive medical services and design, implement, and participate in research related to women with HIV infection. To discuss the benefits and potential biases created by these dual roles. Methods: A mult
Combination therapy: to be or not to be for indigent HIV positive women?: Natl Conf Women HIV. 1997 May 4-7;:149 (abstract no. 227.5). Unique Identifier : AIDSLINE MED/97927390; Mahan-Rudolph P; Helfgott AW; University of Texas, Department of Obstetrics, Gynecology and; Reproductive Sciences, Houston, TX.; Introduction: 1996 was a year of renewed hope in the search for a cure for HIV disease. We have seen hope revived with the development of more effective treatment modalities and diagnostic tools to fight HIV disease progression. The advent of combination therapy , the a
The representation of women in AIDS clinical trials 1987-1996: is progress being made?: Natl Conf Women HIV. 1997 May 4-7;:150 (abstract no. 227.6). Unique Identifier : AIDSLINE MED/97927391; Khalsa AM; Johnson DL; University of Southern California, Pacific AIDS Education and Training; Center, Los Angeles, CA.; Objectives: To evaluate whether the proportion of women participating in ACTG studies is representative of the proportion of women with AIDS in the US. Methods: The annual and cumulative rates of AIDS in US women were taken from CDC statistics, with the 1996 figures actually being 6/95 through 6/96 (12/96 data pending
Protease inhibitor therapy in women: experience from clinical practice.: Natl Conf Women HIV. 1997 May 4-7;:150 (abstract no. 227.7). Unique Identifier : AIDSLINE MED/97927392; Johnson D; Currier JS; University of Southern California Medical Center, Los Angeles, CA.; Background: Protease inhibitors represent a major advance in the therapy of HIV infection. In the first year since FDA approval there have been no reports about the use of protease inhibitors in women. Objective: To describe the sid
Participation of HIV positive women in clinical research.: Natl Conf Women HIV. 1997 May 4-7;:150 (abstract no. 227.8). Unique Identifier : AIDSLINE MED/97927393; Singh MP; Dos Santos K; Winfrey J; Mezger JA; Williams A; Yale University School of Nursing, New Haven, CT.; Introduction: The HIV epidemic disproportionately affects women of lower socio-economic background, members of racial or ethnic minorities, and past or current drug users. Complex social, political and economic factors have led to exclusion or under representation of women in HIV clinical trials. Project Description:
HIV risk reduction in young women.: Natl Conf Women HIV. 1997 May 4-7;:150 (abstract no. 228.1). Unique Identifier : AIDSLINE MED/97927394; Kono C; Anderson J; Forman K; Los Angeles Free Clinic, Project ABLE, Los Angeles, CA.; Introduction: Multiple barriers exist in effectively providing HIV prevention for young women. These consist of difficulties in partner negotiation, women and youth disempowerment, domestic violence, and negative social stigmatization. These obstacles are further multiplied for young women who are at high-risk and are
Feminist model of HIV prevention for adolescent and young adult women.: Natl Conf Women HIV. 1997 May 4-7;:151 (abstract no. 228.2). Unique Identifier : AIDSLINE MED/97927395; Chu GS; McGaugh JA; Bay Area Young Positives, San Francisco, CA.; Introduction: The days of the stereotype of HIV being a gay, white male disease are over. The reality is that adolescent and young adult women are one of the fastest growing populations of new HIV infections. Prevention messages based on slogans and fear tactics cannot address the core issues of the mental health and
Mental health issues and interventions with families affected by HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:151 (abstract no. 229.1). Unique Identifier : AIDSLINE MED/97927396; Havens JF; Ryan S; Cicatelli B; Special Needs Clinic, Columbia-Presbyterian Medical Center, New York,; NY.; Issues: HIV-infected parents and their children commonly struggle with pre-existing mental health problems associated with substance abuse and complicated, stage-specific individual and family mental health issues throughout the course of HIV illness progression. After parental death, new caregivers and affected child
Partner notification: a public health imperative.: Natl Conf Women HIV. 1997 May 4-7;:151 (abstract no. 302.1). Unique Identifier : AIDSLINE MED/97927398; Lake S; Nexsen Pruet Jacobs and Pollard, LLP, Columbia, NC.; The implementation of basic public health measures, including disease reporting and partner notification, has been ignored, diminished or hindered by many HIV/AIDS policies. Reluctance to fully use these public health tools is particularly detrimental to women. We will explore legal and public health imperatives regar
Social and contextual issues in the promotion of harm reduction for women.: Natl Conf Women HIV. 1997 May 4-7;:151 (abstract no. 302.2). Unique Identifier : AIDSLINE MED/97927399; Wright-DeAguero L; Centers for Disease Control and Prevention, Atlanta, GA.; Methods to reduce women s risk for HIV Infection have been promoted through primary prevention interventions focusing on individual sexual and drug-use behaviors. Less attention has been given to social and contextual issues which shape these behaviors. This presentation examines the role of social, economic and polic
The safety and efficacy of Viracept (nelfinavir mesylate, NFV) in female patients who participated in pivotal phase II/III double-blind randomized controlled trials.: Natl Conf Women HIV. 1997 May 4-7;:152 (abstract no. 304.1). Unique Identifier : AIDSLINE MED/97927400; Gersten M; Chapman S; Farnsworth A; Chang Y; Yu G; Clendeninn N; Agouron Pharmaceuticals, Inc., La Jolla, CA.; Three pivotal double-blind controlled studies have recently been completed with Viracept (NFV), an inhibitor of the HIV protease. Efficacy was evaluated in terms of treatment effect on two surrogate markers, CD4 count and HIV RNA copy number. The latt
Antiretroviral use and other care markers in a cohort of women and men followed by the Seattle spectrum of HIV-related diseases study.: Natl Conf Women HIV. 1997 May 4-7;:152 (abstract no. 304.2). Unique Identifier : AIDSLINE MED/97927401; Buskin S; Sarkissian J; Chu S; Group Health Cooperative, Seattle, WA.; Objectives: Standards of HIV care have changed dramatically in the past 1-2 years. The recommendation to initiate antiretroviral therapy with zidovudine monotherapy based on a CD4+ lymphocyte count of less than 500 has been replaced with a myriad of mostly combination ther
Lack of tumors in infants with perinatal HIV exposure and fetal/neonatal exposure to zidovudine (AZT).: Natl Conf Women HIV. 1997 May 4-7;:152 (abstract no. 304.3). Unique Identifier : AIDSLINE MED/97927402; Hanson IC; Cooper E; Antonelli T; Mofenson L; Oleske J; Culnane M; Lee S; Sperling R; McSherry G; Shapiro D; Baylor College of Medicine, Houston, TX.; Background: Prophylaxis guidelines for perinatal HIV transmission risk reduction are modeled after ACTG 076 and include fetal antiretroviral exposure (maternal AZT after then 1st trimester and through labor) and neonatal antiretroviral exposure (infan
The prescription of protease inhibitors among women with AIDS in Los Angeles County.: Natl Conf Women HIV. 1997 May 4-7;:153 (abstract no. 304.5). Unique Identifier : AIDSLINE MED/97927404; Odem S; Sorvillo F; Kerndt P; Castillon M; Los Angeles County Department of Health Services, HIV Epidemiology; Program, Los Angeles, CA.; Objectives: To evaluate the factors associated with protease inhibitor (PI) use among women with AIDS in Los Angeles County. Methods: As part of a CDC sponsored AIDS surveillance study, adult women with AIDS are routinely interviewed. The population-based study samples 100% of all women reported with AIDS to the LA Co
Gender differences in adverse events on ritonavir: an analysis from the Abbott 247 study.: Natl Conf Women HIV. 1997 May 4-7;:154 (abstract no. 304.7). Unique Identifier : AIDSLINE MED/97927406; Currier JS; Yetzer E; Potthoff A; Glassman H; Heath-Chiozzi M; University of Southern California Medical Center, Los Angeles, CA.; Background: There is minimal data currently available on the safety and tolerability of protease inhibitors in women. The Abbott 247 study was a randomized, placebo controlled trial that compared the addition of
Contraceptive properties of a new topical microbicide for HIV prevention.: Natl Conf Women HIV. 1997 May 4-7;:154 (abstract no. 304.8). Unique Identifier : AIDSLINE MED/97927407; Sonderfan AJ; Stump DG; Chancellor T; McKinlay MS; Jenson JC; Profy AT; Procept Inc., Cambridge, MA.; Background: Worldwide, heterosexual contact accounts for greater than 70% of all HIV infections, and the proportion of women living with HIV is growing. While abstinence and the use of male condoms have been shown to reduce HIV transmission, inconsistent application of these methods has mean that many women remain at
HIV risk behaviors among urban and rural Native American women in California.: Natl Conf Women HIV. 1997 May 4-7;:154 (abstract no. 305.1). Unique Identifier : AIDSLINE MED/97927408; Elcock M; Araba-Owoyele L; Klein D; Zahnd E; California Department of Health Services, Office of AIDS, Sacramento,; CA.; Objectives: The Pregnant and Parenting American Indian Study PAIS) was conducted to provide information on HIV risk behaviors including drug use among Native American (NA) women residing in urban and rural areas of California. Methods: A convenience sample of 290 pregnant or parenting NA women between the ages of 15 a
Sexuality, close relationships, and HIV risk reduction behaviors among Latinas/os.: Natl Conf Women HIV. 1997 May 4-7;:154 (abstract no. 305.2). Unique Identifier : AIDSLINE MED/97927409; Castaneda D; San Diego State University, Psychology Department, San Diego, CA.; The purpose of this study was to determine, among a community sample of Latina/o women and men, which close relationship and sexuality-related variables predict HIV risk perception, extent of participant s use of condoms with a current partner, and degree of communication with a partner about HIV-relevant issues. The
Predictors of HIV risk among women, aged 40 and older, living in low-income housing developments.: Natl Conf Women HIV. 1997 May 4-7;:155 (abstract no. 305.3). Unique Identifier : AIDSLINE MED/97927410; Heckman TG; Sikkema KJ; Kelly JA; Wagstaff DA; Medical College of Wisconsin, Center for AIDS Intervention Research,; Milwaukee, WI.; Background: While many studies delineate patterns of HIV risk behavior among women, these studies tend to focus on younger women of reproductive age. Very few studies have examined HIV risk behavior and risk characteristics among older adult women. Consequently, the present study sought to obtain information that can
Factors predicting perceptions that conflict will result from safer sex negotiation: why women in disempowering relationships are at increased risk for HIV.: Natl Conf Women HIV. 1997 May 4-7;:155 (abstract no. 305.4). Unique Identifier : AIDSLINE MED/97927411; Raj A; Wingood GM; University of Alabama, School of Public Health, Birmingham, AL.; Objective: The objective of this study was to examine the relationship between factors related to gender-based power-differentials and perceptions that conflict will result from negotiating safer sex among African-American women. Method: A community-based sample of young adult African-American women N=165) were recrui
Towards a national women and HIV policy coalition: developing an agenda for action.: Natl Conf Women HIV. 1997 May 4-7;:155 (abstract no. 306.1). Unique Identifier : AIDSLINE MED/97927412; Hansen E; Booth K; Dawson C; Women's AIDS Network (WAN), San Francisco, CA.; The Women s AIDS Network (WAN) presents a two-hour workshop to introduce its work to develop a San Francisco Bay Area agenda for women and HIV policy, to facilitate discussion about the objectives, content and implementation of a nationwide women-centered HIV policy agenda, and to lay the foundation for a national pol
Positively well for women.: Natl Conf Women HIV. 1997 May 4-7;:155 (abstract no. 307.1). Unique Identifier : AIDSLINE MED/97927413; Lands L; Georgetown, CO.; Description: This discussion will focus on the nutritional and hormonal problems common to HIV+ women. Included will be recommendations on nutritional supplementation, hormonal replacement therapies, and other therapies needed to help prevent infections and cancers, stop a downhill slide into wasting, and eliminate sy
Training of trainers on the reduction of perinatal HIV transmission: the WIN experience.: Natl Conf Women HIV. 1997 May 4-7;:156 (abstract no. P1.1). Unique Identifier : AIDSLINE MED/97927414; Geney KL; Brown V; Hench K; Jeppson ES; Weissman G; National Pediatric and Family HIV Resource Center, Newark, NJ.; Introduction/Project Description: The Women s Initiative for HIV Care and Reduction of Perinatal HIV Transmission (WIN) under Title IV of the Ryan White Care Act, HRSA, funded WIN projects in 10 sites for three years in 6/95. The purpose of WIN is to expand and enhance outreach to women of childbearing age; offer HIV
Correlates of personal stigma and social stigma among mothers with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:156 (abstract no. P1.2). Unique Identifier : AIDSLINE MED/97927415; Bauman LJ; Camacho S; Westbrook L; Forbes-Jones E; Albert Einstein College of Medicine, Bronx, NY.; Objectives: To describe the social and psychological correlates of personal stigma and social stigma from HIV/AIDS among mothers with HIV/AIDS, and to identify characteristics of women more likely to hold stigmatizing beliefs about themselves. Methods: Pilot study of a convenience sample of 53 NYC mothers with late st
Progression of HIV disease in women.: Natl Conf Women HIV. 1997 May 4-7;:156 (abstract no. P1.3). Unique Identifier : AIDSLINE MED/97927416; Kovacs A; Stek A; Rother C; Thurston L; Chan LS; University of Southern California Medical Center, Los Angeles, CA.; HIV infection manifests itself differently in women than in men. Studies to identify female-specific CD4 decline risk factors are needed. At LAC+USC Medical Center, from April 1987 through October 1994, a total of 392 HIV+ women were seen, 183 at the Maternal-Child AIDS clinic (MCC) and 209 at the adult AIDS clinic. T
Women loving women to death.: Natl Conf Women HIV. 1997 May 4-7;:156 (abstract no. P1.4). Unique Identifier : AIDSLINE MED/97927417; Hotchko BA; Oak Lawn Community Services, Dallas, TX.; Introduction: Women Loving Women to Death is a 2 hour workshop designed by a lesbian for lesbians who: were, are, or could be at risk for HIV infection. In Dallas, TX we often find lesbians with a decreased knowledge of how HIV is transmitted in female-to-female sex. It is our goal to dispel their myths and reinforc
AIDS risk behaviors and correlates in young women attending STD clinics.: Natl Conf Women HIV. 1997 May 4-7;:157 (abstract no. P1.5). Unique Identifier : AIDSLINE MED/97927418; Maxwell AE; Bastani R; Warda US; University of California, School of Public Health, Los Angeles, CA.; Objectives: Women attending Sexually Transmitted Diseases clinics are at increased risk for HIV/AIDS and are easily accessible for interventions. We assessed AIDS risk behaviors and correlates and developed two clinic-based interventions to increase condom use. Methods: We conducted face to face interviews with 210 fe
Coping with HIV/AIDS - an experience of positive women's network in Taso Mulago.: Natl Conf Women HIV. 1997 May 4-7;:157 (abstract no. P1.6). Unique Identifier : AIDSLINE MED/97927420; Namyalo Ganafa M; Agali E; The AIDS Support Organisation (TASO), Kampala-Uganda, East Africa.; Introduction: A group of positive women at TASO Mulago centre felt and realized the need to form a support group. They meet on a monthly basis to share their personal experiences, get new ideas/information about HIV/AIDS and also to offer support to one another. Description: As part of the group s programme we offer e
AIDS among women in California: 1986-1995.: Natl Conf Women HIV. 1997 May 4-7;:157 (abstract no. P1.7). Unique Identifier : AIDSLINE MED/97927421; Tabnak F; Sun RK; California Department of Health Services, Office of AIDS, Sacramento,; CA. E-mail: ftabnak@hwl.cahwnet.gov.; Objective: To examine the status of the AIDS epidemic among women aged 20 and over in California. Method: We analyzed female adult 20 years or older) AIDS cases diagnosed in 1986-1995. We calculated county-, age-, and race-adjusted incidence rates using 1986-1995 projected population data. The number of cases were adj
Pneumocystis carinii pneumonia as an initial diagnosis among adult female AIDS patients reported in California, 1983-1993.: Natl Conf Women HIV. 1997 May 4-7;:157 (abstract no. P1.8). Unique Identifier : AIDSLINE MED/97927423; Tabnak F; Trevejo RT; Sun RK; Colford JM; California Department of Health Services, Office of AIDS, Sacramento,; CA. E-mail: ftabnak@hwl.cahwnet.gov.; Objective: To analyze the risk of having Pneumocystis carinii pneumonia (PCP) as an initial AIDS-defining condition among female AIDS patients in California. Method: We analyzed the effect of mode of exposure, demographics and regional variations on the risk of having PCP as an initial AIDS-defining condition among ad
HIV risk among women arrestees in California: opportunities for intervention.: Natl Conf Women HIV. 1997 May 4-7;:158 (abstract no. P1.9). Unique Identifier : AIDSLINE MED/97927424; Grella CE; Anglin MD; University of California, Drug Abuse Research Center, Los Angeles, CA.; Objective: This presentation will discuss data on HIV risk behaviors of women arrestees who have been interviewed as part of the Drug Use Forecasting Project, sponsored by the California Department of Alcohol and Drug Programs and the National Institute of Justice. The goal of the project is to assess drug use and oth
Epidemiology and survival of women with AIDS in San Francisco.: Natl Conf Women HIV. 1997 May 4-7;:158 (abstract no. P1.10). Unique Identifier : AIDSLINE MED/97927425; Hsu L; Schwarcz S; Katz M; San Francisco Department of Public Health, AIDS Office, San Francisco,; CA.; Objectives: To describe the epidemiology of AIDS and to evaluate survival following AIDS diagnosis for women diagnosed with AIDS in San Francisco (SF). Methods: Women aged 13 years or older who were diagnosed with AIDS in SF between 1980 and 1995 were analyzed and compared to men who were diagnosed with AIDS in SF. We
The cytokine interleukin-6 enhances neurotoxicity involving receptors in developing central nervous system neurons.: Natl Conf Women HIV. 1997 May 4-7;:158 (abstract no. P1.11). Unique Identifier : AIDSLINE MED/97927426; Conroy SM; Gruol DL; Scripps Research Institute, La Jolla, CA.; Children infected with HIV exhibit a variety of neurologic disorders thought to be caused by HIV infection in the central nervous system (CNS). The biological bases for these abnormalities are unknown, but presumably involve changes in CNS neuronal function, structure and development. Our studies focus on the role of
Increasing providers' knowledge about reduction of perinatal HIV transmission: a statewide approach.: Natl Conf Women HIV. 1997 May 4-7;:158 (abstract no. P1.12). Unique Identifier : AIDSLINE MED/97927427; Burr CK; Bartelli D; Averick D; Gross E; Bardeguez A; National Pediatric and Family HIV Resource Center, Newark, NJ.; Introduction: When the results of ACTG 076 in 2/94 showed a dramatic reduction of HIV transmission from mother to infant with the use of AZT , educators of providers in New Jersey felt an urgency to disseminate that information to women s health provid
Acceptability of microbicides among women attending a sexually transmitted disease clinic in Alabama.: Natl Conf Women HIV. 1997 May 4-7;:158 (abstract no. P1.13). Unique Identifier : AIDSLINE MED/97927428; Scarlett M; Macaluso M; Duerr A; Centers for Disease Control and Prevention, Atlanta, GA.; Background: While studies of condoms demonstrate that consistent and correct use of condoms is highly effective in preventing the transmission of HIV, these methods may not always be feasible for women at risk for STD and HIV. While the effectiveness of microbicides is not known, the acceptability of microbicides in U
Acceptability research during a Phase I trial of a new vaginal microbicide: BufferGel.: Natl Conf Women HIV. 1997 May 4-7;:159 (abstract no. P1.15). Unique Identifier : AIDSLINE MED/97927430; Bentley ME; Morrow KM; Chesney M; Bettencourt F; Mayer K; Johns Hopkins University, School of Hygiene and Public Health,; Baltimore, MD.; Introduction: Vaginal microbicides for prevention of STDs and HIV are in various stages of research and development. Several products that have previously been marketed as spermicides have been tested for safety and many are in various stages of efficacy research. Project Description: BufferGel, a new product that is
Insistence works; condom use increases with partner insistence for both males and females in a community sample.: Natl Conf Women HIV. 1997 May 4-7;:159 (abstract no. P1.16). Unique Identifier : AIDSLINE MED/97927431; Collins C; Raj A; DiClemente R; Kohler C; Wingood G; Wang MQ; University of Alabama, School of Public Health, Birmingham, AL.; Objective: There were two objectives to the community survey (1) To determine condom use patterns and drug/alcohol histories with regard to gender differences and (2) To determine if insistence on condom use increases the probability that condoms will be used. Method: A community sample (n=522) taken from four neighbo
Correlates of depression in women with AIDS.: Natl Conf Women HIV. 1997 May 4-7;:160 (abstract no. P1.17). Unique Identifier : AIDSLINE MED/97927432; Breitbart W; McDonald M; Rosenfeld B; Passik S; Kaim M; Stein K; Memorial Sloan-Kettering Cancer Center, New York, NY.; Objectives: To examine the relationships between depressive symptoms and pain, physical symptoms medical and psychosocial variables in women with AIDS. Method: 154 ambulatory women with AIDS were surveyed as part of a study on quality of life in AIDS. Assessment measures included: 1) Beck Depression Inventory (BDI) it
Income, race/ethnicity and AIDS rates among women in Los Angeles County.: Natl Conf Women HIV. 1997 May 4-7;:160 (abstract no. P1.18). Unique Identifier : AIDSLINE MED/97927433; Simon PA; Lu SW; Wohl AR; Bunch JG; Los Angeles County Department of Health Services, HIV Epidemiology; Program, Los Angeles, CA.; Objective: To examine trends in the AIDS epidemic by income level and race/ethnicity among women in Los Angeles County (LAC). Methods: 1990 U.S. census data were used to classify the 1,652 LAC census tracts (CTs) by median household income into equally partitioned low ($4,999 $29,040), middle ($29,056 - $41,303), and
Neuropsychological test performance among HIV-infected women seeking primary medical care.: Natl Conf Women HIV. 1997 May 4-7;:160 (abstract no. P1.19). Unique Identifier : AIDSLINE MED/97927434; Becker JT; Dew MA; Lopez OL; University of Pittsburgh Medical Center, Neuropsychology Research; Program, Pittsburgh, PA.; Objective: To characterize neuropsychological test performance by HIV-infected women seeking primary medical care, and to examine factors that may influence such performance. Methods: The performance of 42 HIV-infected women recruited through a sentinel physician survey network was compared with that of 35 HIV seroneg
Early identification and intervention program for accessing care and reducing perinatal transmission.: Natl Conf Women HIV. 1997 May 4-7;:160 (abstract no. P1.20). Unique Identifier : AIDSLINE MED/97927435; Stewart R; Candelas A; Maki G; Glaros R; Strano AM; Warren B; New York State Department of Health, AIDS Institute, Albany, NY.; In response to the increase in HIV infection among women and their children, the New York State Department of Health (NYS DOH), in 1994, developed a comprehensive approach to reduce the impact of HIV in this population. Fundamental to this approach was the development of a new standard of care in which providers in al
How many women with an HIV infection cause of death are confirmed AIDS cases? Counts and characteristics of women from upstate New York who died in 1995.: Natl Conf Women HIV. 1997 May 4-7;:161 (abstract no. P1.21). Unique Identifier : AIDSLINE MED/97927436; Gallagher B; Bourgeois E; Maslak J; New York State Department of Health, Bureau of HIV/AIDS Epidemiology,; Albany, NY.; Objectives: To determine the proportion and characteristics of women identified from death certificates with an HIV infection cause of death (ICD9 code 042 - 044) in the primary or any secondary cause of death field who are dying prior to becoming confirmed AIDS cases. Methods: Confirmed and suspect AIDS cases in New
Prevalence of psychiatric disorders and factors affecting mental health services utilization in a primary care population of HIV+ women.: Natl Conf Women HIV. 1997 May 4-7;:161 (abstract no. P1.22). Unique Identifier : AIDSLINE MED/97927437; Dew MA; Blechman IJ; Sanchez J; Wess J; Lopez OL; Becker JT; University of Pittsburgh School of Medicine, Department of Psychiatry; and Epidemiology, Pittsburgh, PA.; Objectives: We examined (a) rates of DSM-III-R depressive, anxiety, and substance use disorders among HIV+ women and (b) service utilization for these disorders, and psychosocial correlates of utilization of such services. Methods: To date, 36 HIV+ women (aged 21-50; 43% non-Caucasian) attending primary care practices
Cell-associated and free HIV detection by cervicovaginal lavage CVL) PCR.: Natl Conf Women HIV. 1997 May 4-7;:161 (abstract no. P1.23). Unique Identifier : AIDSLINE MED/97927438; Mayer KH; Cu-Uvin S; Rodriguez I; Tucker L; XU C; Zierler S; Flanigan T; Warren D; Anderson D; Memorial Hospital, Infectious Disease Division, Pawtucket, RI.; Objectives: To evaluate the relationship of systemic viral load, CD4 count and genital tract infections to the PCR detection of HIV DNA and RNA in cervicovaginal secretions obtained by lavage. Methods: The current data are derived from an ongoing substudy of the HIV epidemiology Research Study (HERS) conducted solely
Cervicovaginal lavage (CVL) leukocytes (WBC) and genital tract infections in asymptomatic (ASX) HIV+ and high risk HIV- women.: Natl Conf Women HIV. 1997 May 4-7;:161 (abstract no. P1.24). Unique Identifier : AIDSLINE MED/97927439; Mayer KH; Warren D; Cu-Uvin S; Klein R; Sobel J; Peipert J; Brown W; Holmberg S; Memorial Hospital, Infectious Disease Division, Pawtucket, RI.; Objectives: To evaluate the prevalence and types of leukocytes WBC) found in the cervicovaginal secretions of HIV-infected women and matched high-risk HIV (-) controls, and to assess whether HIV serostatus, HIV progression or other variables were associated with alterations in the number and type of cervicovaginal WBC
HIV-1 RNA load distinguishes progressive from nonprogressive HIV-1 infection in men and women.: Natl Conf Women HIV. 1997 May 4-7;:162 (abstract no. P1.25). Unique Identifier : AIDSLINE MED/97927440; Fang G; Siegal FP; Weiser B; Grimson R; Anastos K; Back S; Burger H; New York State Department of Health, Wadsworth Center, Albany, NY.; Objectives: To investigate distinctive patterns of HIV-1-related clinical disease progression and their relationship to HIV-1 load in men and women. Methods: HIV-1 RNA was measured in serum or plasma from 4 groups of patients using reverse transcription quantitative competitive PCR. 22 women and 23 men were stratified
HIV-1 plasma RNA in relationship to p24 antigenemia and anti-p24 immune response in HIV-1-infected women and men.: Natl Conf Women HIV. 1997 May 4-7;:162 (abstract no. P1.26). Unique Identifier : AIDSLINE MED/97927441; Povolotsky J; Baron P; Carrow M; Liu KN; Polsky B; Memorial Sloan-Kettering Cancer Center, New York, NY.; 172 plasma samples from HIV-1-infected women (n=30) and men n=87) were evaluated for plasma RNA, ICD-p24 antigen, and p24 antibody levels. In this study, detection of p24 antibody levels were proportionate between women and men: high, low and very low p24 antibody levels were found in 42.5%, 37.5%, and 20% of women an
High incidence of sexually transmitted diseases amongst HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:162 (abstract no. P1.27). Unique Identifier : AIDSLINE MED/97927442; Fischer C; Nealon MJ; Dumois A; Lane R; Atkins A; Community Family Planning Council, New York, NY.; Objective: To determine the incidence and distribution of sexually transmitted diseases amongst HIV positive women at the initial primary care visit. Methods: The Community Family Planning Council has a network of ten clinics in medically underserved areas in New York City that serve approximately 600 active HIV posit
Reaction time performance of HIV-seropositive women.: Natl Conf Women HIV. 1997 May 4-7;:162 (abstract no. P1.28). Unique Identifier : AIDSLINE MED/97927443; Martin EM; Pitrak DL; Mullane KM; Pursell KJ; Novak RM; Carson VL; Arruda J; Somerville J; Stern RA; University of Illinois, Department of Psychiatry, Chicago, IL.; Objective: Computerized measures of reaction time have been used successfully to detect subclinical HIV-related motor and mental slowing in gay men and male injection drug users, but have not been studied in HIV-seropositive women. The purpose of this preliminary study was to evaluate reaction time performance in HIV-
Risk profiles for HIV disease among women in rural Alabama.: Natl Conf Women HIV. 1997 May 4-7;:163 (abstract no. P1.29). Unique Identifier : AIDSLINE MED/97927444; Vermund SH; Moon TD; Beltrami J; Fawal HJ; Howard AC; DiClemente R; Holmes R; Holmberg S; University of Alabama, School of Public Health, Department of; Epidemiology, Birmingham, AL.; The HIV epidemic in Alabama (AL) is of moderate magnitude (1995 AIDS incidence 26/100,000). A rising female-to-male ratio (0.23 in 1995), a disproportionate ratio of rates (7:1) for African-American females compared to white females, expansion of the geographic scope of the epidemic within the state, and substantial m
Differences between urban men and rural women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:163 (abstract no. P1.30). Unique Identifier : AIDSLINE MED/97927445; Heckman TG; Somlai AM; Franzoi S; Bissett R; Medical College of Wisconsin, Center for AIDS Intervention Research,; Milwaukee, WI.; Objective: Most research examining the life circumstances of persons living with HIV disease has focused on men living in large urban AIDS epicenters. Consequently, health science researchers and practitioners know little about the psychosocial impact of AIDS on women, particularly those living in small towns and rura
A study of the association of economic strategies of women and the persistence of HIV risk behavior in three rural communities.: Natl Conf Women HIV. 1997 May 4-7;:163 (abstract no. P1.31). Unique Identifier : AIDSLINE MED/97927446; Stratford BD; Ellerbrock TV; University of Florida, Department of Anthropology, Gainesville, FL.; Introduction: The purpose of this study was to determine why high rates of HIV transmission persist in an area where community-wide HIV prevention strategies have been implemented since the mid-1980 s. This area includes three small rural communities with a combined population of about 36,000, which have reported more
The effect of social networks upon the HIV risk behavior of adolescent African-American females.: Natl Conf Women HIV. 1997 May 4-7;:163 (abstract no. P1.32). Unique Identifier : AIDSLINE MED/97927447; Lombardi EL; Cargill V; Stephens R; Gigliotti R; University of Akron, Department of Sociology, Akron, OH.; Currently, HIV/AIDS is a primary concern for many women within society. Many are at one time or another at risk of exposure to HIV; however, some are at a greater risk than others. At this point in time, inner city black adolescents are at a high risk for HIV infection (Jemmott, Jemmott, and Fong 1992). There is, ther
Risk misperception among high risk incarcerated women despite HIV education.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.34). Unique Identifier : AIDSLINE MED/97927451; Affleck PC; Rich JD; Dickinson BP; Flynn MM; Loewenthal HG; Vigilante KC; Brown University, Providence, RI.; Objective: To describe discrepancies in HIV risk behavior and self-perceived HIV risk of women enrolled in the Discharge Planning Program (DPP) at the Adult Correctional Institution of Rhode Island (ACI). Methods: In 1992 the DPP was implemented at the Rhode Island State Prison (ACI) to help high risk HIV negative wom
Women need to know: utilizing a comprehensive media campaign to reach women of color.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.35). Unique Identifier : AIDSLINE MED/97927452; Brown VB; PROTOTYPES, Culver City, CA.; In order to reach women of color who may not be contacted through other means, a comprehensive HIV/AIDS media campaign was designed and implemented by PROTOTYPES, A Center for Innovation in Health, Mental Health and Social Services, a non profit agency doing wide-scale outreach to women, and Healthier Solutions, a med
A model care system to meet the needs of pregnant and parenting adolescents.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.36). Unique Identifier : AIDSLINE MED/97927453; Nevels A; T-Net, Pediatric AIDS Network, Dallas, TX.; Introduction: Dealing with the multifaceted care issues of adolescents with HIV presents special challenges for both the adolescent and her care providers. Provision of comprehensive, long term care including strategies to ensure risk reduction and promote self-care can be further challenged when the adolescent is pre
Pregnancy and the HIV positive woman: a time to establish a continuum of care.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.37). Unique Identifier : AIDSLINE MED/97927454; Noone S; University of Massachusetts Medical School, Department of Obstetrics; and Gynecology, Worcester, MA.; Introduction: Women diagnosed HIV positive during pregnancy are often the index case for diagnosis of other family members. Due to socioeconomic and other factors, some women with HIV drop out of the care system shortly after pregnancy. Consequently, pregnancy offers the unique opportunity to engage the woman with HIV
Maintaining HIV-positive women in care.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.38). Unique Identifier : AIDSLINE MED/97927455; DiDonato D; Kupiec BA; New Jersey Department of Health and Senior Services, Trenton, NJ.; Introduction: New Jersey s HIV/AIDS problem continues to escalate with 31,579 cases of AIDS reported as of September 30, 1996. Over 25 percent of all reports of AIDS in New Jersey are women, ranking the State highest in the nation by percentage of AIDS cases in adult/adolescent women. HRSA s Maternal and Child Health
The prenatal care assistance program (PCAP) and HIV-infected women's birth outcomes.: Natl Conf Women HIV. 1997 May 4-7;:165 (abstract no. P1.39). Unique Identifier : AIDSLINE MED/97927456; Turner BJ; Newschaffer C; Cocroft J; Hauck W; Fanning T; Thomas Jefferson University, Philadelphia, PA.; Objective: PCAP is a state-federal Medicaid prenatal program in NYS dating from 1990 that mandates: coordinated medical care, promotion of early care, nutrition/health counseling, psychological services, and HIV counseling/testing. The effect of PCAP participation on low birth weight (LBW) less than 2500 gms. preterm
Viral load in cervical, vaginal, and menstrual fluids as compared to peripheral blood levels in a group of women with HIV and AIDS.: Natl Conf Women HIV. 1997 May 4-7;:165 (abstract no. P1.41). Unique Identifier : AIDSLINE MED/97927458; Stephens PC; Heimer R; New York State Department of Health, Albany, NY.; Objectives: In a small (N=11), diverse group of women with HIV infection and AIDS, (1) to discern the level of viable HIV-1 in cervical, vaginal, and menstrual fluids, as compared to peripheral blood levels, (2) to explore the effect of typical conditions such as vaginitis and cervicitis on viral load in the genital t
Neurobehavioral and medical differences between HIV-infected men and women.: Natl Conf Women HIV. 1997 May 4-7;:166 (abstract no. P1.42). Unique Identifier : AIDSLINE MED/97927459; Lopez OL; Wess J; Sanchez J; Dew MA; Becker JT; University of Pittsburgh, Pittsburgh, PA.; Objectives: To examine the neurobehavioral and medical differences between human immunodeficiency virus (HIV)-infected men and women. Methods: We reviewed the baseline medical, psychosocial, and neurological characteristics of 187 men and 32 women infected with the HIV participating of longitudinal study of neuropsych
Support for HIV-positive women: an assessment of needs and barriers to services.: Natl Conf Women HIV. 1997 May 4-7;:166 (abstract no. P1.43). Unique Identifier : AIDSLINE MED/97927460; Morrow KM; Boland R; Fiore T; Gromley J; Aromin I; Flanigan T; Abrams D; Brown University, Center for Alcohol and Addiction Studies,; Providence, RI.; Introduction: Women make up the fastest growing population of new cases of HIV infection worldwide. As such, there is a crucial need for efficacious and cost-effective psychosocial treatment technologies which are sensitive to the diverse needs of HIV+ women. The present study attempts to assess barriers to adherence
Women who have sex with women: consumer satisfaction with an HIV/STD prevention program.: Natl Conf Women HIV. 1997 May 4-7;:166 (abstract no. P1.44). Unique Identifier : AIDSLINE MED/97927461; Morrow KM; Fuqua RW; Brown University, Center for Alcohol and Addiction Studies,; Providence, RI.; Introduction: Throughout the course of the HIV epidemic, little attention or resources have been dedicated to the prevention of HIV transmission in women who have sex with women. Presently, however, more providers are aware of the need for education and prevention programs tailored to the unique characteristics and ne
Fellatio is not a safe sex activity: results of seven years of monitoring the incidence of HIV among female street-based sex workers in New York City.: Natl Conf Women HIV. 1997 May 4-7;:166 (abstract no. P1.45). Unique Identifier : AIDSLINE MED/97927462; Wallace JI; Alexander P; Weiner A; Horn S; Foundation for Research on Sexually Transmitted Diseases, Inc.; FROST'D), New York, NY.; Objectives: To examine the association between fellatio and HIV infection among women who engage in street-based sex work in New York City. Methods: Since 1989, FROST D has counseled and testing more than 3,451 female sex workers who contact their clients on the street in New York City, for HIV, syphilis, and Hepatiti
Health status and depression in women infected with HIV: comparisons between men and among risk groups.: Natl Conf Women HIV. 1997 May 4-7;:167 (abstract no. P1.46). Unique Identifier : AIDSLINE MED/97927463; Page-Shafer K; Turner J; Osmond D; Chesney M; Hopewell P; University of California, Center for AIDS Prevention, San Francisco,; CA.; Objectives: To examine differences in dimensions of health status and symptoms of depression in men and women participating in a clinical study of HIV infection. Additionally, to examine whether health status and depression are different between female injection drug users (IDU) and non-IDU s. Methods: A cross-section
Evaluation of the Alameda County prenatal HIV testing demonstration project.: Natl Conf Women HIV. 1997 May 4-7;:167 (abstract no. P1.47). Unique Identifier : AIDSLINE MED/97927464; Kennedy G; Young B; Taheripour M; Liang A; University of California, Institute for Health Policy Studies, San; Francisco, CA.; Introduction: National attention has been directed to prenatal HIV testing and maternal transmission of HIV since the release of the results of the Pediatric AIDS Clinical Trials Group Protocol 076. Findings demonstrated that AZT treatment decreased m
Use of federal HIV/AIDS treatment information resources by HIV-infected and -affected women.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.50). Unique Identifier : AIDSLINE MED/97927467; Brown C; Cadden C; HIV/AIDS Treatment Information Service and AIDS Clinical Trials; Information Service, Rockville, MD.; Introduction: Analysis of gender and requester types recorded by the staff of the HIV/AIDS Treatment Information Service (ATIS) and the AIDS Clinical Trials Information Service (ACTIS) indicate that women utilize these federal information resources more as caregivers than as patients. Although the proportion of HIV+ f
Latina women and HIV: coping and resilience.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.51). Unique Identifier : AIDSLINE MED/97927468; Moreno CL; Simoni JM; Columbia University, School of Social Work, New York, NY.; The number of Latina women infected with HIV is growing disproportionaly. Yet, we know little about cultural factors that influence Latina women s coping. Latina women s socio-historical context and experiences with oppression affect how they perceive and live with HIV/AIDS (Vasquez, 1994). This paper describes the us
HIV infection among homeless women in San Francisco.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.52). Unique Identifier : AIDSLINE MED/97927469; Robertson MJ; Tulsky J; Hahn JA; McKenzie M; Moss A; University of California, San Francisco, CA.; Objective: This paper presents preliminary findings on the prevalence of and correlates of HIV infection among homeless women in San Francisco. Methods: Over a four-year period, a representative sample of 2806 adults, including 649 women, was selected from shelters, free-meal programs, and SRO hotels. Respondents were
HIV risk factors in women accessing HIV testing sites in California, 1994-1996.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.53). Unique Identifier : AIDSLINE MED/97927470; Forquera JM; Truax SR; Libet M; Norman A; Webb D; California Department of Health Services, Sacramento, CA.; Background: Recently attention has been focused on women and HIV infection. Various reports describe an increase in HIV seropositivity in women and a dramatic increase in the proportion of female AIDS cases. Other studies have shown a stable or declining prevalence in California. However, few studies have systematical
Analysis of potential gender difference in lamivudine (3TC) disposition using population pharmacokinetics from two Phase III clinical trials in HIV-infected patients.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.54). Unique Identifier : AIDSLINE MED/97927471; Moore KH; Yuen GJ; Hussey EK; Glaxo Wellcome, Research Triangle Park, NC.; Objectives: To determine the influence of patient covariates gender, ethnic origin, age, surrogate markers of HIV disease, renal function, and zidovudine (ZDV) coadministration) on 3TC population pharmacokinetics. Methods: 3TC serum concentration data
Dialogue: expanding the response to HIV/AIDS in women and men.: Natl Conf Women HIV. 1997 May 4-7;:169 (abstract no. P1.55). Unique Identifier : AIDSLINE MED/97927472; McGeown MK; Family Health International, AIDS Control and Prevention Project,; Arlington, VA.; Introduction: Dialogue aims to provide men and women with an added skill and gender awareness needed for open and honest communication on issues that are critical to protective sexual behavior and health. While dialogue does operate in a variety of AIDS prevention projects/programs, it is not often considered a centra
Consequences facing lesbians with AIDS undergoing home care in Nairobi, Kenya.: Natl Conf Women HIV. 1997 May 4-7;:169 (abstract no. P1.56). Unique Identifier : AIDSLINE MED/97927473; Hwayire N; Yoshi L; Atinbou M; Positive Women Group (PWG), Nairobi, Kenya.; Introduction: To assess the needs and problems facing lesbians undergoing home care in Nairobi, Kenya . Project Description: Twenty four (24) lesbians living with AIDS were interviewed from their homes where they are undergoing home care by relatives and supported by PWG group member
Women, poverty, and HIV: implications for prevention programs.: Natl Conf Women HIV. 1997 May 4-7;:169 (abstract no. P1.57). Unique Identifier : AIDSLINE MED/97927474; Furin JJ; Harvard Medical School, Department of Social Medicine, Cambridge, MA.; Although HIV has affected women since the beginning of the pandemic--in some places disproportionately--investigations of women s risk have largely been limited to biological factors and individual-level behaviors and risks. In fact, a majority of women infected with HIV are poor; they live in conditions which are rif
Psychological growth in women living with HIV: an exploratory study.: Natl Conf Women HIV. 1997 May 4-7;:169 (abstract no. P1.58). Unique Identifier : AIDSLINE MED/97927475; Mueller CW; Medina C; Dunbar H; Wolf T; University of Hawaii, School of Social Work, Honolulu, HI.; Objectives: To identify and describe the extent and nature of psychological growth in women living with HIV using in-depth interviews. Methods: Thirty four (34) women living in various stages of HIV were interviewed using open-ended semi-structured individual face-to-face interview procedures. Participants were betwee
TAPP for Latinas (Teatro AIDS Prevention Project for Latinas).: Natl Conf Women HIV. 1997 May 4-7;:170 (abstract no. P1.59). Unique Identifier : AIDSLINE MED/97927476; Alvarado EM; Hispanic Designers, Inc., Washington, DC.; Overview: The teatro AIDS Prevention Program for Latinas (TAPP for Latinas) which is funded by the Centers for Disease Control and Prevention (CDC) and Prudential Foundation is a health communications and social marketing program which operates at the national and local levels simultaneously and addresses the need for
Incidence of pregnancy in a European cohort of HIV infected women.: Natl Conf Women HIV. 1997 May 4-7;:170 (abstract no. P1.60). Unique Identifier : AIDSLINE MED/97927477; De Vincenzi I; European Centre for the Epidemiological Monitoring of AIDS,; Saint-Maurice, France. Fax: 33 1 43 96 50 81. E-mail:; idvceses@b3e.jussieu.fr.; Objective: To analyse the impact of HIV testing on the incidence and termination of pregnancy among HIV-infected women. Methods: The analysis is based on data collected through a multicentre European cohort study of HIV(+) women with a known date of infection. The incidences of pregnancies conceived in the 2 years pre
Creative challenges and occasional opportunities: treating and responding to women with HIV/AIDS and breast cancer.: Natl Conf Women HIV. 1997 May 4-7;:124 (abstract no. 123.2). Unique Identifier : AIDSLINE MED/97927478; Tanur MV; Boston Medical Center, Upham's Corner Health Center, Boston, MA.; Issues: Since the onset of the 1990s, women represent the greatest increase of AIDS cases in the U.S. Simultaneously women confront -and largely manage - the steady epidemic of breast cancer in their own lives and families. Little work to date has explored the joint etiologies of HIV infection and breast cancer. More
Stressful events, repressive coping, pessimism and natural killer cell cytotoxicity in women with human immunodeficiency virus and human papillomavirus.: Natl Conf Women HIV. 1997 May 4-7;:170 (abstract no. P1.61). Unique Identifier : AIDSLINE MED/97927479; Byrnes D; Antoni M; Goodkin K; Ironson G; Asthana D; Efantis-Potter J; Simon T; Munajj J; Fletcher MA; University of Miami, Department of Psychology, Coral Gables, FL.; Objectives: To examine whether stressful negative life events, emotional non-expressiveness, and pessimism were associated with lower natural killer cell cytotoxicity (NKCC) in women co-infected with Human Immunodeficiency Virus - Type 1 (HIV-1) and Human Papillomavirus (HPV), a viral initiator of cervical cancer. Met
Changes in body weight and composition in HIV-infected women and men from 1984 to 1996.: Natl Conf Women HIV. 1997 May 4-7;:170 (abstract no. P1.62). Unique Identifier : AIDSLINE MED/97927480; Engelson ES; Wang J; Pierson RN Jr; Kotler DP; St. Luke's-Roosevelt Hospital Center, New York, NY.; Objectives: Significant advances in the treatment of HIV disease--including effective treatment of opportunistic infections, employment of nutritional interventions, and, most recently, the application of highly active antiretroviral therapies--have impacted the course of HIV disease within the
A prospective observational database of 15,611 HIV-positive individuals: a subset analysis of 1,925 women.: Natl Conf Women HIV. 1997 May 4-7;:170 (abstract no. P1.63). Unique Identifier : AIDSLINE MED/97927481; Cohen CJ; Iwane MK; Mayer KH; Skowron G; Palensky J; Frost KR; American Foundation for AIDS Research (AmFAR), New York, NY.; The AmFAR-sponsored Community-Based Clinical Trial Network Observational Database (ODB) contains data prospectively collected on 1,925 HIV-positive females and 13,686 HIV-positive males at least 13 years of age followed by 252 community-based clinical sites coordinated by 21 units throughout the
HIV serostatus and factors relating to physical and emotional wellbeing among Latina family AIDS caregivers.: Natl Conf Women HIV. 1997 May 4-7;:171 (abstract no. P1.64). Unique Identifier : AIDSLINE MED/97927482; Hudson SM; Land H; University of Southern California, School of Social Work, Los Angeles,; CA.; Objectives: Virtually no information is available in the published literature on Latina women who provide care for a loved one with AIDS. The overall objective of this project was to address this subject, examining general wellbeing in Latinas caring for a family member with AIDS. The analyses presented here explore w
Protease inhibitors: experiences of women with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:171 (abstract no. P1.65). Unique Identifier : AIDSLINE MED/97927483; MacNeil N; Butcher K; Lucey M; Barnum P; Senterfitt W; Johnson D; Women Alive, Los Angeles CA.; Introduction: The protease inhibitor class of antiretroviral drugs were approved for marketing on the basis of clinical trials including few women -- too few to permit statistically precise analysis of potential gender differences in efficacy or safety and tolerance profiles. Yet, women were prescribed these drugs imm
HIV infection in families of HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:171 (abstract no. P1.66). Unique Identifier : AIDSLINE MED/97927484; Flore T; Flanigan T; Hogan J; Cram R; Schuman P; Schoenbaum E; Solomon L; Moore J; Brown University AIDS Program, Providence, RI.; Objectives: To investigate HIV infection in family members of HIV seropositive and HIV seronegative women and to consider the impact of multiple HIV infections within the family. Design: Prospective observational cohort of 871 seropositive and 439 seronegative at-risk women who are participants in a natural history st
Acceptability study of the JANESWAY female condom.: Natl Conf Women HIV. 1997 May 4-7;:172 (abstract no. P1.67). Unique Identifier : AIDSLINE MED/97927485; Hunnicutt J; HHH Development Co., Inc., Sebastopol, CA.; Introduction: Since the early 70s, the World Health Organization WHO) estimates that worldwide there have been about 6 million cases of AIDS reported among men, women and children. Currently, an estimated 18 to 22 million persons are also infected with HIV; of these, 3 million are wome
The protective effect of condoms and nonoxynol-9 against HIV infection.: Natl Conf Women HIV. 1997 May 4-7;:172 (abstract no. P1.68). Unique Identifier : AIDSLINE MED/97927486; Wittkowski KM; Dietz K; Center for Urban Epidemiological Studies, New York, NY.; Objective: Even with the new results from the comparison of N9 vs. placebo available (Weir, this conference), the former Cameroon study [5] still is the only source where the efficacy of both condoms and spermicides against HIV transmission can be assessed in a comparable setting
Does condom promotion influence contraceptive practices?: Natl Conf Women HIV. 1997 May 4-7;:172 (abstract no. P1.69). Unique Identifier : AIDSLINE MED/97927487; Lawrence JM; Kamb ML; Douglas JM; Rogers J; Zenilman J; Rhodes F; Bolan GA; Peterman TA; Centers for Disease Control and Prevention, Atlanta, GA.; Background: Most women at risk for HIV infection are in their reproductive years. Therefore, effective strategies to prevent HIV infection and unintended pregnancies are essential. We studied how a condom promotion intervention influenced women s contraceptive practices. Methods: Contraceptive practices and condom use
HIV antibody home testing: the new craze.: Natl Conf Women HIV. 1997 May 4-7;:172 (abstract no. P1.70). Unique Identifier : AIDSLINE MED/97927488; Jones-Redmond S; Cohen M; Williamson M; Moore B; Cook County Hospital, HIV Primary Care Center, Chicago, IL.; Introduction: HIV infection is the leading cause of death in the United States among people 25 to 44 years of age. An estimated 34 million HIV antibody tests are performed in the United States each year. Until recently, these HIV antibody tests were performed exclusively in doctor s of
Retrospective analysis of lamivudine (3TC) plus stavudine (d4T) combination therapy: HIV viral load and CD4 changes in women.: Natl Conf Women HIV. 1997 May 4-7;:173 (abstract no. P1.71). Unique Identifier : AIDSLINE MED/97927489; Cohen CJ; Anderson ME; Wong T; Campbell K; Smith JJ; Frost KR; American Foundation for AIDS Research (AmFAR), New York, NY.; Objectives: We performed a retrospective analysis based on chart reviews of 330 patients who had received combination therapy with 3TC plus
HIV infected streetwalking prostitutes: implications for social work practice.: Natl Conf Women HIV. 1997 May 4-7;:173 (abstract no. P1.72). Unique Identifier : AIDSLINE MED/97927490; Weiner AP; Wallace JI; Yeshiva University, Wurzweiler School of Social Work, New York, NY.; Introduction: HIV infected streetwalkers represent a highly vulnerable population with few resources to meet their basic needs. Due to the illicit nature of their activities, they are extremely difficult to reach through traditional social services. Project Description: Since April 1989 a mobile outreach van has been e
Detection of HIV-1 RNA in cervical lavage fluid and blood.: Natl Conf Women HIV. 1997 May 4-7;:173 (abstract no. P1.73). Unique Identifier : AIDSLINE MED/97927491; Kovacs A; Chen ZC; Meyer B; Chan L; Anastos K; Young M; Levine A; University of Southern California, School of Medicine, Los Angeles,; CA.; Objectives: To evaluate the effect of time to processing and the best sample to use to quantitate HIV-1 RNA in Cervical Lavage CVL) fluid and to correlate cervical lavage RNA levels with plasma RNA levels and clinical and immunologic parameters. Methods: Unfractionated CVL and plasma from 57 human immunodeficiency vire
Depression and level of burden among outreach clients.: Natl Conf Women HIV. 1997 May 4-7;:173 (abstract no. P1.74). Unique Identifier : AIDSLINE MED/97927492; Slaughter R; Melchior LA; Brown VB; Huba G; Prototypes, Culver City, CA.; Introduction: Women living with HIV or at risk for HIV often have multiple issues they must deal with in addition to HIV/AIDS. Based on a model proposed by Brown, Huba, & Melchior (1995), this presentation will examine multiple issues confronting women with HIV or at high risk for HIV. The presentation will examine
Papanicolaou (PAP) smears and follow-up in women with HIV infection receiving primary care in an inner-city community health center (CHC): a role for continuous quality improvement CQI) and quality care.: Natl Conf Women HIV. 1997 May 4-7;:174 (abstract no. P2.1). Unique Identifier : AIDSLINE MED/97927493; Hirschhorn LR; Miller L; Chireau MV; Dimock Community Health Center, Roxbury, MA.; Introduction: As the epidemiology of the HIV epidemic and health care patterns continue to evolve, increasing numbers of women and minorities with HIV are entering care in CHC s. Dimock CHC DCHC), an inner-city CHC serving a predominantly minority population, has seen a rapid increase in the number of women receiving
Health service needs for HIV positive and at-risk young women.: Natl Conf Women HIV. 1997 May 4-7;:174 (abstract no. P2.2). Unique Identifier : AIDSLINE MED/97927494; Woods ER; Samples CL; Melchiono M; Keenan PM; Fox DJ; Chase L; Burns M; Paradise J; Price V; Kula L; Goodman E; Children's Hospital, Division of Adolescent/Young Adult Medicine,; Boston, MA.; Objective: The HAPPENS (HIV Adolescent Provider and Peer Education Network for Services) Program is an innovative SPNS model of HIV care for adolescents. This network integrates 8 agencies (2 youth outreach multi-service agencies, 3 health centers and 3 teaching hospitals) to plan and coordinate care for HIV infected,
Does HPV typing influence the clinical management of HIV infected women with abnormal PAP smears?: Natl Conf Women HIV. 1997 May 4-7;:174 (abstract no. P2.3). Unique Identifier : AIDSLINE MED/97927495; Clark R; Watts DH; Lousiana State University Medical Center, HIV Outpatient Program, New; Orleans, LA.; Objective: To determine the influence of HPV typing results on the clinical management of HIV infected women. Methods: A brief survey was administered to all Pediatric and Adult AIDS Clinical Trials Unit sites (n = 55). Results: Of the 29 surveys returned, only 6 investigators currently used HPV typing in clinical pra
Preventing perinatal transmission of HIV through the Ryan White CARE Amendments of 1996: therapeutic policy?: Natl Conf Women HIV. 1997 May 4-7;:174 (abstract no. P2.4). Unique Identifier : AIDSLINE MED/97927496; Flood MF; University of Nebraska, Lincoln, NE.; Introduction: The Ryan White CARE Amendments of 1996 establish procedures for the implementation of Centers for Disease Control and Prevention Recommendations for Counseling and Testing for Pregnant Women in all states receiving CARE Act funds. Although the provisions stop short of mandatory testing of either pregnant
Spousal notification provisions in the Ryan White CARE Amendments of 1996: development of therapeutic policy.: Natl Conf Women HIV. 1997 May 4-7;:175 (abstract no. P2.5). Unique Identifier : AIDSLINE MED/97927497; Flood MF; University of Nebraska, Lincoln, NE.; Introduction: The Ryan White CARE Amendments of 1996 require states to implement spousal notification procedures to be eligible for CARE Act funds. Although the provision lacks specific mandatory procedures, the requirement itself may result in the development of policies and procedures with varied and wide-ranging ef
Responses of hospitalized women with HIV/AIDS to nurses.: Natl Conf Women HIV. 1997 May 4-7;:175 (abstract no. P2.6). Unique Identifier : AIDSLINE MED/97927498; Kemppainen JK; University of California, School of Nursing, Fremont, CA.; Objectives: As the AIDS epidemic progressed to include the heterosexual and bisexual population, especially among IV drug users and their sex partners, the number of women with AIDS has steadily increased. As a result, greater numbers of women with HIV/AIDS seek specialized treatment from health care professionals in
Outcome evaluation of an innovative peer counseling intervention for women at risk for and living with HIV.: Natl Conf Women HIV. 1997 May 4-7;:175 (abstract no. P2.7). Unique Identifier : AIDSLINE MED/97927499; Cabral R; Armstrong K; Cohen A; Fogarty L; Galavotti C; Gielen AC; Green B; Milstein B; Centers for Disease Control and Prevention, Atlanta, GA.; Objectives: Project CARES is theory-based intervention to prevent HIV and unplanned pregnancies in women at risk for and living with HIV. In addition to offering reproductive health services RHS) in nontraditional settings, women were provided counseling by peer paraprofessionals, based on the Stages of Change Model S
A psychosocial support-linkage model for women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:175 (abstract no. P2.8). Unique Identifier : AIDSLINE MED/97927501; Cambridge BS; Nevels A; Squires H; Squires R; Squires K; Squires C; Squires J; Squires J; University of Texas, Southwestern Medical Center, Dallas, TX.; Introduction: This presentation describes a support model for the early identification and enrollment of HIV/AIDS impacted pregnant and parenting women into a support-linkage system designed to increase timely access and sustained utilization of health care, psychosocial support services, and community based social
Program theory for service delivery systems for HIV+ women.: Natl Conf Women HIV. 1997 May 4-7;:175 (abstract no. P2.9). Unique Identifier : AIDSLINE MED/97927502; Dodds S; Nuehring E; Blakley T; University of Miami, Department of Psychiatry, Miami, FL.; For more than a decade, organizational response to HIV in the form of health service delivery systems has evolved out of the epidemic as experienced by gay men. Although many of the problems of HIV-infected women are similar to those of men, women must also contend with complex gender-specific medical, psychosocial, a
The female condom: attitudes and perceived barriers to use among young HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:176 (abstract no. P2.10). Unique Identifier : AIDSLINE MED/97927503; Murphy DA; O'Keefe Z; Rotheram-Borus MJ; Division of Social and Community Psychiatry, Department of Psychiatry,; University of California, Los Angeles, CA.; Few acceptability studies of the female condom have been conducted, and none have been conducted with HIV-infected young women. This study was developed to determine barriers to use of the female condom among HIV-infected females, and to identify their attitudes and feelings about the method. Fifty-seven females infec
Women Alive: a grassroots organization developed to inform women.: Natl Conf Women HIV. 1997 May 4-7;:176 (abstract no. P2.11). Unique Identifier : AIDSLINE MED/97927504; Davis L; MacNeil N; Lucey M; Women Alive, Los Angeles, CA.; Introduction: Women Alive has a goal of bringing women affected and infected with HIV/AIDS out of isolation through information, encouragement and emotional support. Project Description: In July of 1993 Being Alive (People with HIV/AIDS Action Coalition), branched off into women specific issues by starting a newslette
Mothers' Voices united to end AIDS.: Natl Conf Women HIV. 1997 May 4-7;:176 (abstract no. P2.12). Unique Identifier : AIDSLINE MED/97927505; Mayo JR; Mother's Voices, Hollywood, CA.; Mothers Voices is a national grassroots parent education organization for all mothers. Noting that sexuality education has been demonstrated to be the most effective HIV/AIDS prevention approach for adolescents (CAPS Fact Sheet, 1995), Mothers Voices was formed primarily for the purpose of disseminating knowledge an
Evaluation of treatment access fund for women living with HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:189 (abstract no. P2.74). Unique Identifier : AIDSLINE MED/97927506; Serenity M; Lambert B; Keels V; Voices of Positive Women, Toronto, Canada.; Introduction: Voices of Positive Women is the only organization in the province of Ontario, and one of only two agencies in Canada that provide services exclusively to women living with HIV/AIDS. We have a membership of approximately 230 women with an average growth of three new me
Limited use of contraception amongst sexually active HIV positive women in medically underserved communities in New York City.: Natl Conf Women HIV. 1997 May 4-7;:176 (abstract no. P2.13). Unique Identifier : AIDSLINE MED/97927507; Fischer C; Nealon MJ; Lane R; Atkins K; Community Family Planning Council, New York, NY.; Objective: To determine the level of use of contraception amongst sexually active HIV positive women in an effort to assess the ultimate risk of pregnancy and continued sources of perinatal transmission. Methods: The Community Family Planning Council has a network of ten clinics in medically underserved areas in New Y
Mothers' disclosure of HIV status to her children.: Natl Conf Women HIV. 1997 May 4-7;:177 (abstract no. P2.15). Unique Identifier : AIDSLINE MED/97927509; Witte SS; Lewis M; Columbia University, School of Social Work, Social Intervention Group,; New York, NY.; Introduction: A mother s disclosure of HIV status to her children and the attendant issues of anticipatory grief and bereavement associated with such disclosure are among the quality of life issues for HIV+ women requiring further exploration. The research literature is scant on issues of parental disease disclosure t
Recognizing susceptibility to HIV and being tested: the experiences of HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:177 (abstract no. P2.18). Unique Identifier : AIDSLINE MED/97927512; Siegel K; Raveis VH; Gorey E; Memorial Sloan-Kettering Cancer Center, New York, NY.; Introduction: The barriers that impeded infected women from recognizing their at-risk status and from seeking testing once their vulnerability was acknowledged were investigated. Also examined were the pathways that led women into testing. Project Description: Indepth focused interviews with 84 HIV-infected white, Afr
Stressors and coping styles of women whose families are affected by HIV/AIDS.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.19). Unique Identifier : AIDSLINE MED/97927513; Goldman SL; Bressler J; Vera MD; Family Planning Council, Philadelphia, PA.; Objectives: To understand the sources of greatest stress for women whose families are affected by HIV/AIDS, the coping styles used by women in dealing with HIV disease, and the physical and mental consequences of these coping styles. Method: 75 HIV-infected women with resident children participated in a semi-structure
Reducing vertical HIV transmission: practical application of ACTG 076.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.20). Unique Identifier : AIDSLINE MED/97927514; Bathon R; DeMarco D; Sims B; Burgess A; Rogers C; Horgan M; Williamson C; Meredith K; Fraser V; Washington University, School of Medicine, Helena Hatch Special Care; Center, St. Louis, MO.; Introduction: The rate of HIV vertical transmission has drastically decreased with the implementation of ACTG 076 using ZDV during pregnancy, delivery and newborn administration. The issue facing health care providers is the practical application of this protocol within clinical and community settings. Project Descrip
National study of HIV in adolescents.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.21). Unique Identifier : AIDSLINE MED/97927515; Belzer M; Abdalian SE; Futterman D; Moscicki AB; Murphy D; Rogers A; Wilson C; Children's Hospital, Los Angeles, CA.; Objective: This national study has been funded to characterize HIV disease progression/spectrum of disease, the effect of co-morbidity with STDs/viral infection, and assess the influence of risk behavior, pubertal hormonal variation and cervical maturation in HIV-infected adolescents. This presentation describes the i
The prevalence, perpetrators, social and sexual correlates of African-American women.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.23). Unique Identifier : AIDSLINE MED/97927517; Wingood GM; DiClemente RJ; University of Alabama, School of Public Health, Birmingham, AL.; Objectives: The objective of this study was to examine the prevalence, social and sexual correlates of rape among young adult African-American women. Methods: Using street outreach 165 African-American women, 18-29 years of age, were recruited from a lower socioeconomic community in San Francisco, CA. A face-to-face i
A profile of adolescent women with or at high risk for HIV: personal and service needs.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.24). Unique Identifier : AIDSLINE MED/97927518; Huba G; Hodgins A; Woods E; Kipke M; Feudo R; Lothrop J; Wallace M; Remafedi G; Greenberg B; Sturdevant M; Tenner A; Marconi K; Brady R; Singer B; Melchior L; The Measurement Group, Culver City, CA.; Introduction: Adolescent women living with HIV or who are at high risk for HIV have a unique set of personal and service needs which often slip through the cracks in traditional service delivery systems. To address the needs of young people with HIV, the Special Projects of National Significance (SPNS) Program of the
Outreach to adolescent women with or at high risk for HIV: a report from ten innovative service models.: Natl Conf Women HIV. 1997 May 4-7;:179 (abstract no. P2.25). Unique Identifier : AIDSLINE MED/97927519; Melchior L; Feudo R; Greenberg B; Hodgins A; Kipke M; Lothrop J; Remafedi G; Sturdevant M; Tenner A; Wallace M; Woods E; Marconi K; Singer B; Brady R; Huba G; The Measurement Group, Culver City, CA.; Introduction: Adolescent women living with HIV or who are at high risk for HIV have a unique set of personal and service needs which often slip through the cracks in traditional service delivery systems. To address the needs of young people with HIV, the Special Projects of National Significance (SPNS) Program of the
Peer advocate participation in the Boston Massachusetts Win Program.: Natl Conf Women HIV. 1997 May 4-7;:179 (abstract no. P2.26). Unique Identifier : AIDSLINE MED/97927520; Hagerty CA; Garcia M; Winslow S; Merriam G; Dimock Community Health Center, Boston, MA.; The inclusion of Peer Advocates in all phases of the work of the Win project is an effective approach for our outreach and education work. Outreach to women of childbearing age and to pregnant women has been done in multiple locations using varied materials. This project was developed on the invitation of a pharmacist
Issues in implementing evaluations of HIV programs for adolescent women.: Natl Conf Women HIV. 1997 May 4-7;:179 (abstract no. P2.27). Unique Identifier : AIDSLINE MED/97927521; Kipke MD; Melchior LA; Huba GJ; Children's Hospital, Division of Adolescent Medicine, Los Angeles, CA.; Introduction: Evaluations of programs for young women who are living with or at-high-risk for HIV must address a number of issues. Many standardized assessments may be unsuitable for use with young women because they are written for adult populations, oriented towards male-specific issues, or may be linguistically or
Empowerment model for HIV prevention among Asian Pacific Islander women in the commercial sex industry.: Natl Conf Women HIV. 1997 May 4-7;:180 (abstract no. P2.28). Unique Identifier : AIDSLINE MED/97927522; Kang E; Oh-Kim M; Soriano I; Asian Pacific Health Care Venture, Inc., Los Angeles, CA.; Prevailing HIV/AIDS prevention models have continued to focus on individualized risk reduction strategies, while ignoring the context of HIV risk behavior. Such approaches assume that the problem lies within the individual, and that changing the individual will eradicate the problem. In contrast, the empowerment appro
Women, children and families affected by HIV: families in crisis.: Natl Conf Women HIV. 1997 May 4-7;:180 (abstract no. P2.29). Unique Identifier : AIDSLINE MED/97927523; Jones-Robinson W; Tallon T; New York State Department of Health, AIDS Institute, Albany, NY.; By the end of the year 2001, it is estimated there will be 58,000 children in New York State (NYS) orphaned by the HIV-related deaths of their mothers. Between 1985 and 1994, there has been a tenfold increase in the annual number of maternal deaths related to AIDS; HIV/AIDS now surpasses any other single cause of deat
HIV infection among undocumented immigrant Hispanic women: two case studies.: Natl Conf Women HIV. 1997 May 4-7;:180 (abstract no. P2.30). Unique Identifier : AIDSLINE MED/97927524; Delossantos C; Fiore T; Ortiz C; Rich J; Flanigan TP; Miriam Hospital, Immunogy Center, Providence, RI.; Introduction: HIV infection is rapidly increasing among Hispanic women. Many women seen in clinics in major cities are undocumented immigrants and have few or no resources for lab tests, medications, and specialized care. This abstract will illustrate the importance of intensive case management by a culturally sensiti
Women living with HIV: violence, social support and disclosure.: Natl Conf Women HIV. 1997 May 4-7;:180 (abstract no. P2.31). Unique Identifier : AIDSLINE MED/97927525; Gielen A; Fogarty L; Anderson J; Keller J; O'Campo P; Faden R; Johns Hopkins University, School of Hygiene and Public Health,; Baltimore, MD.; Objectives: The purposes of this paper are to: 1) describe the frequency of women s disclosure of their HIV status and 2) examine the extent to which women living with HIV experience negative social consequences. Methods: Women living with HIV were recruited from medical care settings in a large urban area; 257 women
Psychosocial predictors of women's self-reported condom use.: Natl Conf Women HIV. 1997 May 4-7;:181 (abstract no. P2.33). Unique Identifier : AIDSLINE MED/97927526; Soet J; Dilorio C; Dudley W; Emory University, Rollins School of Public Health, Atlanta, GA.; Objectives: The purpose of this study was first, to explore the salience of both inter- and intra-personal factors in explaining women s self-reported use of (male) condoms. Secondly, we wanted to examine the possibility of ethnic differences in inter- and intra-personal factors that may differentially affect African
Unusual cases of breast cancer in HIV infected women: data from Women's Interagency HIV Study (WIHS).: Natl Conf Women HIV. 1997 May 4-7;:123 (abstract no. 123.1). Unique Identifier : AIDSLINE MED/97927527; Levine AM; Preston-Martin S; Fruchter R; Silver S; Hessol N; Melnick S; Burns D; Miotti P; University of Southern California, Norris Cancer Center, Dorchester,; MA.; Background: HIV infected persons are at risk for various malignancies, including lymphoma, KS and cervical cancer, which are AIDS-defining. The incidence of additional cancers has significantly increased in HIV seropositive gay men in recent years, when compared to seronegative controls (Lyter, Proc ASCO, 1996). Altho
The Bold and Beautiful: a support group success story.: Natl Conf Women HIV. 1997 May 4-7;:181 (abstract no. P2.35). Unique Identifier : AIDSLINE MED/97927528; Mahan-Rudolph PM; Boyd A; Skinner J; Rankins Madkin D; Kirkland BS; Kirkland K; University of Texas, Department of Obstetrics, Gynecology and; Reproductive Sciences, Houston, TX.; Introduction: In 1995 the Bold and Beautiful support group was formed, in response to the unique needs of indigent HIV (+) women of color. The group was designed to meet the emotional and educational needs of the women, within a safe and supportive atmosphere. The group s success hinged on the elimination of two key b
The Women's Immunology Center: a continuum of care.: Natl Conf Women HIV. 1997 May 4-7;:181 (abstract no. P2.36). Unique Identifier : AIDSLINE MED/97927529; Mahan-Rudolph P; Helfgott AW; Eriksen N; Pearson D; Kirkland K; Boyd A; Bishop J; University of Texas, Department of Obstetrics, Gynecology and; Reproductive Sciences, Houston, TX.; Introduction: In the City of Houston, TX there are approximately 2620 women living with HIV/AIDS; 1660 African-American, 275 white and 160 Hispanic. The mode of transmission is primarily heterosexual 47%, IVDA 34%, other 18% and transfusion 1%. The Women s Immunology Center (WIC) is the only comprehensive primary care
Vaginal yeast infections in HIV positive women.: Natl Conf Women HIV. 1997 May 4-7;:182 (abstract no. P2.38). Unique Identifier : AIDSLINE MED/97927531; Williams AB; Andrews S; Frankel R; Tashima K; Mezger JA; Yale University, School of Nursing, New Haven, CT.; Objective: To describe factors associated with vulvo-vaginal candidiasis (VVC) and candida vaginitis (CV) among women with HIV infection. Methods: Baseline analysis of history, physical findings and laboratory studies of data provided by 184 HIV + women enrolled in a prospective clinical trial. VVC was defined as a va
Comprehensive HIV care for women in a small Northeast urban center.: Natl Conf Women HIV. 1997 May 4-7;:182 (abstract no. P2.39). Unique Identifier : AIDSLINE MED/97927532; Tashima KT; Nejman W; Silversmith H; Marzilli DA; Weil BJ; Sousa HB; Flanigan TP; Brown University, Providence, RI.; Introduction: The third wave of the HIV epidemic describes the changing face of AIDS in small urban and rural communities. Fall River is a poor industrial city of 90,000 people. In 1992 the Family Healthcare Center at SSTAR began providing a comprehensive HIV primary care program with a focus on women. This includes
Compliance: can we assess it?: Natl Conf Women HIV. 1997 May 4-7;:182 (abstract no. P2.40). Unique Identifier : AIDSLINE MED/97927533; Rother C; Khoury M; Assraf A; Fukushima L; Chan L; Kovacs A; University of Southern California, School of Medicine, Los Angeles,; CA.; Objective: In view of the availability of antiretroviral agents such as the protease inhibitors for which compliance is critical, we undertook a retrospective study to review patient records to evaluate past compliance of HIV+ women and their children. Methods: Char
Disclosure practices of caregivers to children of a human immunodeficiency virus diagnosis.: Natl Conf Women HIV. 1997 May 4-7;:182 (abstract no. P2.41). Unique Identifier : AIDSLINE MED/97927534; Hilliard CL; Rosen N; Colegrove RW; Hudson B; Moriarta ML; Kovacs A; University of Southern California, School of Medicine, Los Angeles,; CA.; The diagnosis of a family member with human immunodeficiency virus (HIV) has significant emotional and social implications for the entire family. Parents are confronted with many complex issues, including the complicated task of determining who should know what and with what kind of detail regarding HIV. One model for
Chronic urban stress, HIV/AIDS salience, and level of risk of sexual behavior in African American women.: Natl Conf Women HIV. 1997 May 4-7;:183 (abstract no. P2.42). Unique Identifier : AIDSLINE MED/97927535; Sherman C; Pacific Institute for Women's Health, Los Angeles, CA.; Objective: To examine the relationship between chronic urban environmental stress, the salience of HIV/AIDS, and level of risk of sexual behavior in a sample of African American women. Methods: 83 African American women aged 18-45 attending vocational programs in south central Los Angeles were recruited via convenienc
The relationship between condom use and fear of conflict resulting from safer sex negotiation among low-income African-American women.: Natl Conf Women HIV. 1997 May 4-7;:183 (abstract no. P2.43). Unique Identifier : AIDSLINE MED/97927536; Raj A; Wingood GM; University of Alabama, School of Public Health, Birmingham, AL.; Objective: The objective of this study was to examine the relationship between condom use and perceptions of conflict resulting from negotiation of safer sex among African-American women. Method: A community-based sample of young adult African-American women (N=165) were recruited from the Bayview community of San Fra
Understanding processes of change.: Natl Conf Women HIV. 1997 May 4-7;:183 (abstract no. P2.44). Unique Identifier : AIDSLINE MED/97927537; Parsons JT; Jersey City State College, Jersey City, NJ.; The Transtheoretical Model (TM) of Stages of Change suggests that there are certain types of interventions that can be made to encourage change in individuals. These interventions are called processes of change. Processes of change are based on well known psychotherapeutic methods of change and are similar to techniqu
Translating processes of change into HIV risk reduction interventions.: Natl Conf Women HIV. 1997 May 4-7;:183 (abstract no. P2.45). Unique Identifier : AIDSLINE MED/97927538; Crudder SO; Centers for Disease Control and Prevention, Atlanta, GA.; The processes of change can easily be adapted for use with HIV risk reduction activities. Each processes of change can also be used for a variety of risk reduction target behaviors. For example, in a recently concluded five year study of a behavioral risk reduction intervention for serodiscordant heterosexual couples,
Problem-solving and adapting the Transtheoretical Model (TM).: Natl Conf Women HIV. 1997 May 4-7;:183 (abstract no. P2.46). Unique Identifier : AIDSLINE MED/97927539; Gage BE; University of Oklahoma Health Sciences Center, Oklahoma City, OK.; One of the advantages of the Transtheoretical Model (TM) is its flexibility. Every processes of change can be operationalized utilizing activities that match to each counselor s unique client population. For instance, one five year multi-site study utilized this approach with serodiscordant heterosexual couples. The p
The Transtheoretical Model (TM) and assessment of the stages of change.: Natl Conf Women HIV. 1997 May 4-7;:184 (abstract no. P2.47). Unique Identifier : AIDSLINE MED/97927540; Huszti HC; University of Oklahoma Health Sciences Center, Oklahoma City, OK.; This didactic presentation will provide a brief overview of the Transtheoretical Model (TM) developed by Drs. James Prochaska and Carlo DiClemente. The TM conceptualizes that behavior change occurs in a series of five stages rather than through a sudden change. Individuals are hypothesized to progress from Precontempl
Identifying and treating mental health problems in women with HIV: lessons from a woman-centered program.: Natl Conf Women HIV. 1997 May 4-7;:184 (abstract no. P2.48). Unique Identifier : AIDSLINE MED/97927541; Cohen M; Furumoto-Dawson A; Koshy R; Moore B; Demain L; Wright G; Cook County Hospital, Chicago, IL.; Objective: To determine the prevalence and treatment of documented mental illness and chemical dependency in women with HIV enrolled in an urban public hospital s primary HIV care setting. Methods: The Women and Children with HIV Program at Cook County Hospital has cared for 1200 medically indigent women since 1988. C
Empowering approach to HIV/AIDS among Latino women.: Natl Conf Women HIV. 1997 May 4-7;:184 (abstract no. P2.49). Unique Identifier : AIDSLINE MED/97927542; Vallejo ML; Martinez P; Family Service Inc., Providence, RI.; Twenty six Latino women, recent arrivals to the USA and in the process of learning the second language is the target population of this innovative project. The curriculum guide contains six major topics: Developing Self-Esteem, Responsibilities at Home, Who Decides?, The Role of Men and of Women, Latino Women and HIV/
The effect of HIV testing and counseling on health care planning and serostatus disclosure among HIV+ adolescent females.: Natl Conf Women HIV. 1997 May 4-7;:184 (abstract no. P2.50). Unique Identifier : AIDSLINE MED/97927543; Lee MB; Murphy D; Rotheram-Borus MJ; Langabeer K; University of California, Department of Psychiatry, Los Angeles, CA.; Objectives: Testing and early detection of HIV-infection are important elements in reducing risk behavior and the transmission of HIV. This research investigated the association of HIV testing, pretest and post-test counseling, and disclosure of serostatus among female HIV+ adolescents. Methods: HIV testing informatio
Access to HIV care for indigent women in the District of Columbia: dilemmas and solutions.: Natl Conf Women HIV. 1997 May 4-7;:184 (abstract no. P2.51). Unique Identifier : AIDSLINE MED/97927544; Macher A; Goosby E; Office of HIV/AIDS Policy, US Public Health Service, Washington, DC.; Introduction/Project Description: In a collaborative effort with the Commissioner of Health, in February 1996 we created and implemented the City-Wide Continuity of HIV/TB Care Clinical Conference Series for the District of Columbia. Clinical cases of HIV-infected women in homeless shelters, correctional facilities, c
Family-centered care provides women with a one-stop shopping approach.: Natl Conf Women HIV. 1997 May 4-7;:185 (abstract no. P2.52). Unique Identifier : AIDSLINE MED/97927545; Callaway CC; Brady MT; Crim LB; Hunkler JA; Columbus Children's Hospital, Family AIDS Clinic and Educational; Services (FACES), Columbus, OH.; The medical care of women with HIV disease is often complicated by obstetrical, gynecological, and family issues that are separate from those seen in their male counterparts. Many of these women are mothers. This has an added significance in that women who see their role as caregiver often choose to attend to their ch
Play in the HIV playroom.: Natl Conf Women HIV. 1997 May 4-7;:185 (abstract no. P2.53). Unique Identifier : AIDSLINE MED/97927546; Younoszai MM; Columbus Children's Hospital, Family AIDS Clinic and Educational; Services, Columbus, OH.; A playful environment is a major asset for the Immune Deficiency Clinic (IDC) at Columbus Children s Hospital. The clinic playroom creates an atmosphere where health care encounters can be fun and family-focused. Clinic staff understand that health care experiences are often dreaded events. A playful setting has great
An exploration of factors influencing drug use among homeless women.: Natl Conf Women HIV. 1997 May 4-7;:185 (abstract no. P2.55). Unique Identifier : AIDSLINE MED/97927548; Nyamathi A; Keenan C; University of California, School of Nursing, Los Angeles, CA.; Homeless women now represent a rapidly growing population at risk for poor health outcome. Several studies indicate that homeless women in Los Angeles are vulnerable to drug dependency, as injection drug use (IDU) has been reported in 10-20% of homeless women, and more than 50% of women studied reported past and/or pr
Accessing HIV/AIDS prevention, education, treatment and service delivery information via phone, fax, clearinghouses, electronic bulletin boards, and the Internet.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.56). Unique Identifier : AIDSLINE MED/97927549; Wescott BM; Centers for Disease Control and Prevention, National AIDS; Clearinghouse, Rockville, MD.; This workshop will review HIV prevention and education information gathering, information transfer and information-user networking. Staff will familiarize participants with an array of information products and services related to women and HIV/AIDS, spanning low tech pencil and paper or telephone to high tech use
Organized peer support: an effective tool for community prevention and for increasing primary care utilization among women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.57). Unique Identifier : AIDSLINE MED/97927550; Forbes A; Torres-Sanchez A; Caldaron M; St. Cyr M; Trapp S; Cintron M; Hoffmann La Roche, Inc., Public Affairs Department, Ardmore, PA.; Introduction: The rising incidence of HIV infection among women in the US calls for the development of creative approaches to working with underserved female populations at risk of, and living with, HIV/AIDS. Programs that help women with HIV get clinical care on an ongoing basis are particularly needed since the wome
Developing a clinic for HIV+ women: the Northeast valley experience.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.58). Unique Identifier : AIDSLINE MED/97927551; Murata J; Matta G; Parker K; HIV Division, Northeast Valley Health Corporation, San Fernando, CA.; AIDS is increasing in women in the San Fernando Valley, an area of Los Angeles County that has seen complex demographic changes over the past decade, including rising poverty levels, an influx of immigrants from every corner of the world, and an increasing number of its 1.3 million inhabitants at risk for HIV. The per
Physical abuse and continued at-risk sex among HIV+ women in an inner city AIDS clinic.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.59). Unique Identifier : AIDSLINE MED/97927552; Jordan WC; Martin Luther King-Drew Medical Center, OASIS Clinic, Los Angeles, CA.; Women in an Inner City AIDS Clinic were interviewed as part of their initial intake. Baseline histories of physical and mental abuse were obtained as well as follow-up to those who participated in Partner Notification; baseline histories of at-risk sexual activities were obtained and also 6 months after enrollment in
Family factors related to HIV risk in Chicana girls.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.60). Unique Identifier : AIDSLINE MED/97927553; Murata JM; HIV Division, Northeast Valley Health Corporation, Chatsworth, CA.; About 20% of AIDS results from exposure in adolescence. Among Mexican Americans (Chicanos), where the disease is on the increase, the risk of contracting HIV infection in youth stems mainly from unprotected sexual activity and injectable drug use. For Chicano adolescents, the family may serve either a protective or a
To prevent the spread of HIV with at risk women and their families including determinants of and relapse to high risk HIV related behaviors.: Natl Conf Women HIV. 1997 May 4-7;:186 (abstract no. P2.61). Unique Identifier : AIDSLINE MED/97927554; Walker D; Community Family Planning Council, New York, NY.; Objective: To maximize the extent to which women protect themselves and their partners from HIV. To expand drug treatment and rehabilitation services for women and expand the support available to their family members and significant others. Methods: Increase their awareness of the potential negative consequences high-
The relationship between domestic violence and high risk to HIV/AIDS in a sample of young Puerto Rican women.: Natl Conf Women HIV. 1997 May 4-7;:187 (abstract no. P2.62). Unique Identifier : AIDSLINE MED/97927555; Galarza M; Cruz D; Serrano-Garcia I; University of Puerto Rico, Bayamon, PR.; Introduction: At present there are 18,676 HIV/AIDS cases on the Island of which 21.3% are women; 57% of these inform being infected by high risk behaviors during heterosexual contact PASET, 1996). One of the many factors that hinders women s use of safer sex behaviors is domestic violence. As is HIV/AIDS, domestic vio
Child sexual abuse as a risk factor for HIV/AIDS in adolescents: implications for prevention.: Natl Conf Women HIV. 1997 May 4-7;:187 (abstract no. P2.63). Unique Identifier : AIDSLINE MED/97927556; Jackson S; Weisz V; University of Nebraska, Center on Children, Families, and the Law,; Lincoln, NE.; This paper presentation will conceptually link child sexual abuse, subsequent risky behavior, and HIV/AIDS infection. Next, we will turn to the practical and policy implications for prevention among adolescents who have been victims of child sexual abuse. Adolescents are the fastest growing group of HIV infected indiv
Designing and testing HIV risk reduction strategies for African American adolescent women in community settings.: Natl Conf Women HIV. 1997 May 4-7;:187 (abstract no. P2.64). Unique Identifier : AIDSLINE MED/97927557; Sweet Jemmott L; University of Pennsylvania, School of Nursing, Philadelphia, PA.; Introduction: AIDS is emerging as a major health crisis for adolescents in the United States , particularly African-American adolescent women. The most promising method of curtailing the spread of AIDS is to reduce HIV risk-associated behavior in this population. This paper reports resu
Lesbian and bisexual adolescents: identity formation, coming out and HIV risk behaviors.: Natl Conf Women HIV. 1997 May 4-7;:187 (abstract no. P2.65). Unique Identifier : AIDSLINE MED/97927558; Hunter J; HIV Center for Clinical and Behavioral Studies, New York, NY.; Introduction: During adolescence, personal identity achievement is a central task for all youth, including lesbian and bisexual adolescent girls, and is also a period of risk taking. Many are also coming out with regard to their homosexuality, where they begin to explore sexually. To understand this most vulnerable pe
The development of an HIV prevention program for pregnant teens and teen mothers.: Natl Conf Women HIV. 1997 May 4-7;:187 (abstract no. P2.66). Unique Identifier : AIDSLINE MED/97927559; Adivi CJ; Pittman A; Division of Adolescent Medicine, Childrens Hospital, Los Angeles, CA.; Pregnant teens and teen mothers are at particularly high risk of becoming infected with HIV as a result of engaging in unprotected sexual intercourse. Many of these young women lack the skills and confidence necessary to refuse unwanted sex and to negotiate protective behaviors within sexual relationships. Women With
The female condom: counseling women in successful use of the newest method of barrier protection from STD/HIV that puts control into the hands of the woman.: Natl Conf Women HIV. 1997 May 4-7;:188 (abstract no. P2.67). Unique Identifier : AIDSLINE MED/97927560; Rogers C; French P; Gollub E; Latka M; Philadelphia Department of Public Health, Philadelphia, PA.; The City of Philadelphia has actively promoted research and education on the female condom, the newest barrier method of protection against STD, HIV and unintended pregnancy. We will focus on the counseling message developed at the Philadelphia Department of Public Health, based on our experiences in undertaking a cit
Get real: a humane approach to serving drug-using women living with HIV.: Natl Conf Women HIV. 1997 May 4-7;:188 (abstract no. P2.68). Unique Identifier : AIDSLINE MED/97927561; Acero D; Prevention Point Philadelphia, Project TEACH, Philadelphia, PA.; Introduction: Many women who are living with HIV in Philadelphia were infected by injection drug use. They may or may not still use drugs. Drug users face discrimination in services, including housing, mental health and medical care, if they are thought to be using or high. If you used to use drugs, you have to prove
"Health Choices" is neither: women fighting forced managed care in Philadelphia.: Natl Conf Women HIV. 1997 May 4-7;:188 (abstract no. P2.69). Unique Identifier : AIDSLINE MED/97927562; Capone A; Davids J; Living Positive, Philadelphia, PA.; Introduction: Health Choices is a plan for Southeast Pennsylvania that forces all Medical Assistance and Social Security recipients into managed care plans (HMOs). The state s plan does not take into account the needs of people living with HIV. For the first time in local history, a broad coalition of AIDS service and
The kids get their vitamins, I get my meds: women living with HIV strategizing "compliance" for themselves and their peers.: Natl Conf Women HIV. 1997 May 4-7;:188 (abstract no. P2.70). Unique Identifier : AIDSLINE MED/97927563; Acero D; Birch J; Capone A; Twynne Dasher B; Tucker Dorn N; Ott L; Scott J; Wideman M; Project TEACH, Philadelphia, PA.; Introduction: More HIV+ women, many of whom are African American, Latino/a, and/or low income, are taking antiviral drugs, as well as prevention or treatment for opportunistic infections. There are few treatment education materials or programs for people of color and/or women that can really help us figure out how to
Issues in education and prevention for African American women: experience of the CDC National AIDS Hotline.: Natl Conf Women HIV. 1997 May 4-7;:188 (abstract no. P2.71). Unique Identifier : AIDSLINE MED/97927564; Adams TA; Scott SA; American Social Health Association; CDC National AIDS Hotline,; Research Triangle Park, NC.; Introduction: Over 10 years into the HIV epidemic, health surveys continue to show that African Americans are not being reached with basic information about sexual health and HIV/AIDS. The National Health Interview Survey of 1990 found that almost one quarter of Black adults felt that they knew little or nothing abo
Listening to women: lessons on HIV/AIDS prevention from the National AIDS Hotline.: Natl Conf Women HIV. 1997 May 4-7;:189 (abstract no. P2.72). Unique Identifier : AIDSLINE MED/97927566; Scott SA; Mathews AP; American Social Health Association; CDC National AIDS Hotline,; Research Triangle Park, NC.; Introduction: Health information seeking is an important component of self-help and personal empowerment for women. The CDC National AIDS Hotline (NAH) provides an accessible source of AIDS health information to all women in the United States . Project Description: Each year, the NAH
The female condom as a woman-controlled protective method.: Natl Conf Women HIV. 1997 May 4-7;:189 (abstract no. P2.73). Unique Identifier : AIDSLINE MED/97927568; McGeown MK; Family Health International, AIDS Control and Prevention Project,; Arlington, VA.; Objectives: A female condom study (FCS) designed by the AIDSCAP Women s Initiative has been carried out in Brazil and Kenya . The objectives of the study are to: 1) determine use and non-use of the female condom (FC); 2) determine ways in which in
Strategies to prevent the consequences of HIV/AIDS (e.g, psychosocial, neuropsychiatric, physical disability, and stress and coping) with women and their families.: Natl Conf Women HIV. 1997 May 4-7;:181 (abstract no. 2.34). Unique Identifier : AIDSLINE MED/97927569; Rose NJ; Collins S; AIDS Widow Orphan Family Support (AWOFS), Kampala, Uganda.; A presentation on individual clinical experience strategies: 1. Education and Counselling: To educate the infected and affected that one can live positively for many years. 2. Imparting skills: Skill Training for infected women/orphans and foster parents. 3. Projects: Projects e.g Piggery, Tailoring, Poultry etc., hav
When "just say no" isn't enough: parents educating parents about AIDS.: Natl Conf Women HIV. 1997 May 4-7;:182 (abstract no. P2.37). Unique Identifier : AIDSLINE MED/97927570; Rankin DL; Carr MR; Richmond, VA.; Issue: Parents have the potential to be excellent HIV/AIDS educators, but many have limited access to that training. Project: An HIV/AIDS education program for parents was initiated with the assistance of the Virginia State PTA. Workshops entitled How to talk to your child about HIV/AIDS were held at State PTA Leaders
Delavirdine gains approval as second NNRTI for anti-HIV combination regimens. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):29-30. Unique Identifier : AIDSLINE MED/97702729; The Food and Drug Administration ( FDA ) has granted accelerated approval for delavirdine ( Rescriptor ) for use in combination with other anti-HIV drugs
PML update. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Crit Path AIDS Proj. 1997 Summer;(No 32):31. Unique Identifier : AIDSLINE MED/97702731; Progressive multifocal leukoencephalopathy (PML) is caused by a virus that attacks the brain s white matter at various sites. PML affects two to four percent of AIDS patients and generally carries a poor prognosis. The disease, difficult to detect and treat, causes a progressive decline in speech, vision and motor fun
Two bucks a baby.: Posit Aware. 1997 Mar/Apr;8(2):15. Unique Identifier : AIDSLINE MED/97702740; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; ACTG 250 showed that nevirapine was safe for women and their newborn infants, and further research may show that it is effective in cutting HIV transmission rates from mothers to children for a cost of only two dollars. Women in labor were given the d
Hope for the best, plan for the worst.: Posit Aware. 1997 Mar/Apr;8(2):25-7, 43-4. Unique Identifier : AIDSLINE MED/97702744; Larson P; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; People taking anti-HIV drugs face financial hardships due to the cost of the medications, and they need to make informed choices about health care, insurance, and financial benefits that fit their own situation. Social Security payments may be impacted if the patient returns to work, even for a limited time, and that
Health insurance more available: Federal legislation effective July 1.: AIDS Treat News. 1997 Jul 18;(No 275):1-3. Unique Identifier : AIDSLINE MED/97702754; James JS; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; A new Federal law makes it easier for persons with preexisting conditions to change jobs without losing their health insurance. The Health Insurance Portability and Accountability Act, effective July 1, prohibits employers from denying coverage to individuals covered under a group plan for more than twelve months, if
Delavirdine levels in women.: Posit Aware. 1997 Jul/Aug;8(4):14. Unique Identifier : AIDSLINE MED/97702770; Vazquez E; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Results from a clinical trial of 718 participants, 139 of them women, indicate that women experience 1.8 times higher concentrations of delavirdine ( Rescriptor ) than do men. Women s s
New discoveries in the treatment of AIDS-related cancers.: Posit Aware. 1997 Jul/Aug;8(4):24. Unique Identifier : AIDSLINE MED/97702773; Prescott LM; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS-related cancer research may also lead to advances in cancer treatment in HIV-negative people. Significant findings in the treatment of AIDS-related cancers were presented at the American Society of Clinical Oncology meeting. Researchers at the Center for AIDS Research at the University of California, San Diego, f
Staying afloat.: Posit Aware. 1997 Jul/Aug;8(4):53-7. Unique Identifier : AIDSLINE MED/97702777; McCormack TP; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Maryland Disability Entitlement Advocacy Program, Baltimore,; MD. 97702777; HIV/AIDS patients who are living longer may want to return to the workforce, but do not want to jeopardize their eligibility for coverage under government heath insurance programs (Medicare and Medicaid). Suggestions for returning to work and maintaining eligibility are outlined, and include: subsidized employment, te
[New combination medications]: Sidahora. 1997 Jun/Jul;:43-6. Unique Identifier : AIDSLINE MED/97702791; Agosto M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; National Minority AIDS Council, Washington, DC.; Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are the latest drugs used to treat HIV infection. Three NNRTIs are introduced: Viramune ( nevirapine ),
Court lets plaintiffs pursue job bias claims while on disability. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):1, 10-1. Unique Identifier : AIDSLINE MED/97702793; The U.S. Court of Appeals for the District of Columbia held that a person who files for disability benefits does not automatically forfeit the right to pursue an employment discrimination claim. This ruling allows a person who loses his or her job to seek disability suits and file suit under the Americans with Disabil
Worker's refusal to conceal HIV tattoo amounts to misconduct. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):3. Unique Identifier : AIDSLINE MED/97702797; John Baldetta was fired in 1994 from his job as a nurse s aide at the Seattle, WA Harborview Medical Center after refusing to cover a tattoo on his left inside forearm that reads HIV POSITIVE. The 9th U.S. Circuit Court of Appeals rejected Baldetta s arguments that he was terminated because of his HIV status and not t
State prisons are covered by ADA, 7th Circuit rules. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):7. Unique Identifier : AIDSLINE MED/97702800; Prison inmate Ricky Crawford sued the Indiana Department of Corrections, claiming it violated the Americans with Disabilities Act (ADA) by denying him access to education programs, the library, and the dining hall because he is blind. The 7th U.S. Circuit Court of Appeals rejected the district court s decision to dism
State court rejects estoppel in job accommodation case. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Jul 25;12(13):10. Unique Identifier : AIDSLINE MED/97702803; The Supreme Judicial Court of Massachusetts ruled that a person who applies for disability benefits does not forfeit his right to pursue an employment discrimination claim if the employer refuses to accommodate his disability. The court ruled in favor of Alan J. Labonte, who sued the law firm of Hutchins and Wheeler i
Open clinical trials for HIV/AIDS treatments.: BETA. 1997 Jun;:54-7. Unique Identifier : AIDSLINE MED/97702830; Hanna L; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Information on new or changed clinical trials is presented, and users are directed to the AIDS Clinical Trials Information Service for further information on specific trials. The trials that are reviewed are studying antiretroviral treatments, treatments for opportunistic infections, treatments for malignancies and ca
Regaining lost abilities: the prospect of returning to work.: Focus. 1997 Jul;12(8):1-4. Unique Identifier : AIDSLINE MED/97702834; Bettinger M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; The success of combination therapy and protease inhibitors has allowed many AIDS patients to return to work. This change in status has financial, psychological, and practical implications for people who expected to b
Clearinghouse: returning to work. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Focus. 1997 Jul;12(8):4-5. Unique Identifier : AIDSLINE MED/97702835; A bibliography of articles related to HIV-positive patients reentering the workplace is provided. Topics include mental health issues, the psychological impact of unemployment, and how working positively effects quality of life.
It's back to work we go: HIV and re-entering the job market.: Focus. 1997 Jul;12(8):5-7. Unique Identifier : AIDSLINE MED/97702836; Kohlenberg B; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; Kohlenberg and Associates, San Francisco, CA.; People with HIV frequently adjust to the idea of dying, and need to adapt to the prospect of being healthy and stable enough to live a normal life and return to work. Patients need to investigate the coordination of benefits to insure that they have insurance coverage, and may need vocational counseling or retraining
Study underscores need for increased ADAP funding. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 8;12(14):6-9. Unique Identifier : AIDSLINE MED/97702844; A study conducted by the National Alliance of State and Territorial AIDS Directors and the AIDS Treatment Data Network for the Kaiser Family Foundation determined that state-run AIDS drug assistance programs (ADAPs) are in the midst of financial crisis. The number of new ADAP clients was growing at the rate of 1,000 p
`96-`97 new drugs and the nominees for 1997 are.... Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: Notes Undergr. 1997 Jun/Jul;(No 35):suppl 1-2. Unique Identifier : AIDSLINE MED/97702855; The 1997 HIV/AIDS drugs are outlined and information is provided on their dosage, storage, efficacy, anti-viral effect, effect on T-cells, drug interactions, cross-resistance, cost, and availability. The drugs include Viramune (
New developments in women and AIDS research. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: PI Perspect. 1997 Jul;(No 22):16-8. Unique Identifier : AIDSLINE MED/97702866; An overview is provided of recent advances made in understanding HIV disease as it affects women, including recent information on HIV-associated gynecologic conditions. Drug blood levels in women, the effects of nelfinavir and oral contraceptives, and the problem of wasting and opportunistic infection control are expl
Scientific basis for PEP rests in animal trials. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Alert. 1997 Sep;12(9):100-1. Unique Identifier : AIDSLINE MED/97702871; The efficacy of post-exposure prophylaxis (PEP) in treating non-occupational HIV exposure is not yet known, primarily due to the inability to conduct a double-blind, randomized study. Clinical monkey trials have shown that treatment given within 24 hours after exposure can protect the animals from SIV. However, the on
ADA lawsuit does not survive plaintiff's death. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):1-2. Unique Identifier : AIDSLINE MED/97702879; U.S. District Judge David Sam of Utah ruled that Kim Allred s estate could not proceed with an Americans with Disabilities Act ADA) lawsuit brought against Solaray, Inc. Prior to his death, Allred sued his employer, Solaray, for back pay, damages for intentional infliction of emotional distress, and a court order enjo
6th Circuit: insurance policies are not covered by the ADA. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):1, 8-9. Unique Identifier : AIDSLINE MED/97702880; The 6th U.S. Circuit Court of Appeals ruled that Title III of the Americans with Disabilities Act (ADA) does not cover the products that an insurer offers. The ADA only covers the physical premises of an insurance company. The court also ruled that the ADA does not mandate equality in employer-provider insurance cover
Suits say child with HIV denied admission to day care. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):7. Unique Identifier : AIDSLINE MED/97702886; Suits were filed by the U.S. Justice Department in the U.S. District Court for the Western District of Wisconsin against three day-care centers that refused to admit a four-year-old boy with HIV. These actions mark the first time the Justice Department filed suit regarding child care access under Title III of the Amer
Texas addresses HIV job bias and end-of-life issues. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.: AIDS Policy Law. 1997 Aug 22;12(15):10. Unique Identifier : AIDSLINE MED/97702888; Governor George W. Bush of Texas signed four HIV-related bills at the closing of the 1997-98 legislative session. The State employment discrimination law was amended to include people with HIV and AIDS. House Bill 1865 enhances options that group or individual life insurance policy holders have in obtaining accelerate
Helping drug users stay well.: Focus. 1997 Aug;12(9):5-6. Unique Identifier : AIDSLINE MED/97702917; Brock LC; Edell M; Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD; 20849-6003. 800-458-5231 ext. 5714. A fee will apply.; AIDS Community Research Consortium, Redwood City, CA.; A significant number of HIV-infected people living in East Palo Alto, CA are also drug addicts and alcoholics, many of whom are seeking rehabilitation. To aid in their treatment and rehabilitation, a community care partnership of care providers, social workers, case managers, and drug recovery counselors has been deve
The biology of HIV-1 infection in women and men.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 100.3). Unique Identifier : AIDSLINE MED/97927193; Weiser B; New York State Department of Health, Wadsworth Center for Lab and; Research, Albany, NY.; The 1990 s were marked by tremendous progress in understanding HIV-1 infection and disease progression in infected individuals. The new discoveries had direct applications for predicting clinical outcomes and monitoring antiviral therapies. With the identification of secondary receptors for HIV-1 cell entry, the CCR-5
An update on HIV vaccine development.: Natl Conf Women HIV. 1997 May 4-7;:106 (abstract no. 101.3). Unique Identifier : AIDSLINE MED/97927195; Stanley SK; National Institute of Allergy and Infectious Diseases, NIH, Bethesda,; MD.; While promising new drug therapies for HIV have recently improved the health of many HIV-infected individuals in the United States and elsewhere, control of the epidemic worldwide will require the development of an effective anti-HIV vaccine. Development of such a vaccine for HIV requi
Biological factors affecting HIV transmission.: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 105.1). Unique Identifier : AIDSLINE MED/97927205; Anderson D; Harvard Medical School, Boston, MA.; Whereas HIV can be detected in a majority of semen and cervicovaginal samples from seropositive individuals, high titers are often associated with genital tract infections or inflammation. Sexual transmission of HIV is thought to occur through CD4+ CCR5+ host cells (dendritic cells, T cells or macrophages) in the male
HIV infection and other sexually transmitted diseases among female adolescents.: Natl Conf Women HIV. 1997 May 4-7;:108 (abstract no. 106.1). Unique Identifier : AIDSLINE MED/97927207; Inungu J; Morse A; Gordon C; Louisiana Office of Public Health, New Orleans, LA.; Purpose: Many reports show that over half of adolescents in the United States (US) have engaged in sexual intercourse by the age 19 and female adolescents represent the fastest growing subset of AIDS patients in the US. The lack of formal education dealing with sexually transmitted dis
Challenges to recruitment and retention of women in biomedical HIV prevention research.: Natl Conf Women HIV. 1997 May 4-7;:109 (abstract no. 106.3). Unique Identifier : AIDSLINE MED/97927209; La Salvia TA; Smith C; Affleck P; Doherty-Iddings P; Brown-Peterside P; Fenway Community Health Center, Boston, MA.; Introduction: The development of biomedical HIV prevention methods, such as microbicides and vaccines, could have a significant impact on reducing the rate of infections in female populations. However, recruitment and retention of women at risk of HIV infection for such prevention studies in the US are complicated by
Kaposi's sarcoma in women with AIDS.: Natl Conf Women HIV. 1997 May 4-7;:109 (abstract no. 106.4). Unique Identifier : AIDSLINE MED/97927210; Blair JM; Kovacs A; Beall G; Beer V; Sorvillo F; Kerndt P; Los Angeles County Department of Health Services, HIV Epidemiology; Program, Los Angeles, CA.; Objectives: To describe the incidence and characteristics of women with acquired immunodeficiency syndrome (AIDS)-related Kaposi s sarcoma (KS) in the Los Angeles site of the Adult Spectrum of Disease study (ASD), a database of the Centers for Disease Control and Prevention (CDC). ASD is a medical records cohort study
Barriers and motivating factors impacting delaying seeking medical care among HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:111 (abstract no. 108.1). Unique Identifier : AIDSLINE MED/97927218; Siegel K; Raveis VH; Gorey E; Memorial Sloan-Kettering Cancer Center, New York, NY.; Introduction: Women appear to be at a disadvantage in managing their HIV-infection. They tend to access the health care system later, presenting with more advanced disease, more symptoms and a greater duration of symptoms than men. This presentation will describe the reasons or circumstances reported by women who dela
Four faces of HIV: risk and adjustment among Asian/Pacific Islander and Native American women.: Natl Conf Women HIV. 1997 May 4-7;:116 (abstract no. 114.5). Unique Identifier : AIDSLINE MED/97927240; Chin D; Durvasula RS; Wyatt GE; University of California, Los Angeles, CA.; Asian/Pacific Islander (API) and Native American (NA) women have received virtually no attention to date in the realm of HIV/AIDS research and intervention. While it is generally assumed that these women are at low risk for HIV, there are little empirical data supporting this and other claims about these groups. Indee
Breaking through invisibility; silences, substance use, sexuality and provider misinformation concerning "marginalized" communities of lesbians, WSW and other women at risk for HIV and AIDS.: Natl Conf Women HIV. 1997 May 4-7;:116 (abstract no. 115.1). Unique Identifier : AIDSLINE MED/97927243; Hollibaugh AL; Gay Men's Health Crisis, Lesbian AIDS Project, New York, NY.; Many marginalized communities and subsets of women exist who are at risk for HIV but remain elusive to both primary and secondary prevention, education campaigns and interventions. Often lumped together in the broadest category, woman , the particular and unique characteristics and vulnerabilities of different clustea
The Women and Infants Demonstration Project: a community intervention trial for the prevention of HIV in women.: Natl Conf Women HIV. 1997 May 4-7;:118 (abstract no. 117.4). Unique Identifier : AIDSLINE MED/97927250; Person B; Centers for Disease Control and Prevention, Atlanta, GA; The Women and Infants Demonstration Project (WIDP) was a CDC-sponsored study to test the efficacy of a community-level behavioral intervention for preventing HIV infection among women. The objective of the intervention was to change women s attitudes, beliefs, and behaviors related to protecting themselves from HIV ina
HIV risk behavior involvement among low-frequency and high-frequency crack-using women.: Natl Conf Women HIV. 1997 May 4-7;:120 (abstract no. 120.1). Unique Identifier : AIDSLINE MED/97927260; Klein H; Rodriguez-Crane SM; Hoffman JA; Clark DC; Neighborhoods In Action, Friends Research Institute, Washington, DC.; Objectives: Preliminary analyses conducted by the authors indicated that female noninjecting crack users, injectors who didn t use crack, and drug-injecting crack users had comparable HIV seropositivity rates. This paper strives to understand how this is possible for the crack users, since they lack the HIV risk from a
Association of methamphetamine use with risky sexual behaviors and STDS among heterosexual women at California HIV testing sites.: Natl Conf Women HIV. 1997 May 4-7;:120 (abstract no. 120.2). Unique Identifier : AIDSLINE MED/97927261; Molitor F; Truax S; Ruiz JD; Sun RK; California Department of Health Services, Office of AIDS, Sacramento,; CA.; Objectives: Morbidity, mortality, drug treatment, and law enforcement data indicate that methamphetamine use is on the rise. We chose to examine the relationship between methamphetamine use and risky sexual behaviors and self-reported sexually transmitted diseases (STDs) among women tested for HIV antibodies at publica
HIV sex and drug risk behaviors and behavior change in a national sample of injection drug and crack cocaine using women.: Natl Conf Women HIV. 1997 May 4-7;:121 (abstract no. 120.4). Unique Identifier : AIDSLINE MED/97927263; Stevens SJ; Wechsberg WM; University of Arizonia, Southwest Institute for Research on Women,; Tucson, AZ.; This presentation describes HIV sex and drug risk behaviors and behavior change of 1,368 injection drug and/or crack cocaine using women enrolled in a national multi-site Cooperative Agreement program. All women enrolled in the study participated in a standardized two-session HIV prevention intervention which includeda
Partner abuse and sexual risk behavior among women in an emergency department.: Natl Conf Women HIV. 1997 May 4-7;:122 (abstract no. 122.1). Unique Identifier : AIDSLINE MED/97927269; El-Bassel N; Gilbert L; Krishnan S; Schilling RF; Purpura S; Columbia University, School of Social Work, New York, NY.; Objective: To examine the relationship between partner abuse and sexual risk behaviors among a sample of predominantly African-American and Latina women low triage patients attending an inner-city hospital emergency department. Methods: Face-to-face structured interviews covering demographics, drug use, family violenca
The role of domestic violence in heterosexual women's sexual safety.: Natl Conf Women HIV. 1997 May 4-7;:122 (abstract no. 122.3). Unique Identifier : AIDSLINE MED/97927271; Baker SA; Beadnell B; University of Washington, School of Social Work, Seattle, WA.; The risk of infection with sexually transmitted diseases (STDs), including HIV, may be particularly great among women who are physically abused by their intimate partners. Women with violent partners are likely to have difficulty engaging in the assertive behavior necessary for risk reduction due to realistic fear of a
The Women's Interagency HIV Study (WIHS): correlates of childhood sexual violence and HIV risk.: Natl Conf Women HIV. 1997 May 4-7;:122 (abstract no. 122.4). Unique Identifier : AIDSLINE MED/97927272; Cook JA; Department of Psychiatry, University of Illinois, Chicago, IL.; Objective: To explore the relationship between childhood sexual abuse and risk behaviors for HIV among women. Preliminary findings will be used in order to develop and test a multivariate model defining the association between physical and sexual violence and participation in HIV risk activities. Methods: The WIHS is a
Global overview of perinatal transmission trials.: Natl Conf Women HIV. 1997 May 4-7;:128 (abstract no. 204.1). Unique Identifier : AIDSLINE MED/97927295; Mofenson LM; National Institutes of Health, National Institute of Child Health and; Human Development, Bethesda, MD.; Background: AIDS Clinical Trials Group (ACTG) Protocol 076 demonstrated that a regimen of zidovudine (ZDV) administered to HIV-infected pregnant women during pregnancy, labor and to their newborns for 6 weeks can significantly reduce perinatal HIV transmission. ACTG 076 was first devised in 1989-1990, when there was ra
HIV prevention education for adolescent women with disabilities.: Natl Conf Women HIV. 1997 May 4-7;:130 (abstract no. 207.2). Unique Identifier : AIDSLINE MED/97927306; Hardy S; Pearson L; University of California, Family Planning Clinic, Los Angeles, CA.; Introduction: Adolescent women with disabilities are at risk for HIV infection. Current research indicates that they may be at increased risk due to cognitive or emotional difficulties that can effect both their ability to acquire information about HIV and their risk-taking behavior. The mainstream education programs a
Phase I study of a new vaginal microbicide, BufferGel: rationale and clinical data.: Natl Conf Women HIV. 1997 May 4-7;:135 (abstract no. 215.2). Unique Identifier : AIDSLINE MED/97927329; Mayer KH; Memorial Hospital of Rhode Island, Division of Infectious Diseases,; Pawtucket, RI.; Introduction: HIV and other STD pathogens (e.g. HSV-2, syphilis and gonorrhea) are rapidly inactivated by exposure to acidic pH. The human vagina usually has a pH of 3.5 to 4.5, but this is neutralized by semen or genital tract infections that diminish lactobacilli. As part of the NIAID-funded HIV Network for Preventia
Stress, relationships, and stress management in HIV+ women.: Natl Conf Women HIV. 1997 May 4-7;:135 (abstract no. 216.1). Unique Identifier : AIDSLINE MED/97927332; Jenkins SR; University of North Texas, Department of Psychiatry, Denton, TX.; This symposium brings together three examinations of stress in the lives of HIV+ women, highlighting social and medical sources of stress, including violence from partners, substance abuse and its social cofactors, medical symptoms of HIV disease, and hospitalization for HIV symptoms. Socially supportive relationshipsa
Partner violence in the joint HIV/substance abuse epidemic.: Natl Conf Women HIV. 1997 May 4-7;:136 (abstract no. 216.2). Unique Identifier : AIDSLINE MED/97927333; Krauss BJ; Goldsant LA; Bula E; National Development and Research Institutes, Inc., New York, NY.; Objectives: The lower East Side of New York City (LES) is a high HIV seroprevalence (11%) and high drug trafficking neighborhood. We wished to complement anecdotal reports of the co-occurrence of partner violence, regular substance use, and HIV seropositivity in the LES with more systematic investigation. Methods: In-a
Family-based HIV mental health services.: Natl Conf Women HIV. 1997 May 4-7;:137 (abstract no. 216.7). Unique Identifier : AIDSLINE MED/97927338; Havens J; Mellins CA; Ryan S; Columbia Presbyterian Medical Center, Special Needs Clinic, New York,; NY.; Issues: As rates of HIV infection and AIDS increase in women of child bearing age, HIV/AIDS has evolved into a disease of families with children. Each stage of familial HIV disease, including diagnosis of HIV infection, illness progression, late-stage illness, death and family reconfiguration presents particular mentaa
Level of burden among women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:139 (abstract no. 219.1). Unique Identifier : AIDSLINE MED/97927348; Brown VB; Melchior LA; Huba G; PROTOTYPES, Culver City, CA.; Introduction: Women living with HIV often have multiple issues they must deal with in addition to HIV/AIDS. Based on a model proposed by Brown, Huba, & Melchior (1995), this presentation will examine multiple issues confronting women with HIV disease. The presentation will examine level of burden among clients of a
Cocaine and cocaethylene accelerate HIV/AIDS progression in African American women.: Natl Conf Women HIV. 1997 May 4-7;:141 (abstract no. 221.1). Unique Identifier : AIDSLINE MED/97927356; Shapshak P; Metsch L; McCoy V; Shah S; McCoy C; Weatherby N; Chiapelli F; Page B; Banstra E; Bonney C; Fletcher M; Gardner B; Hearn W; Mash D; University of Miami, School of Medicine, HIV Laboratory, Miami, FL.; Hypothesis: Cocaine and cocaethylene accelerate HIV/AIDS progression in African American women, in vivo, and HIV replication in their PBLs, in vitro. (Cocaethylene is a by-product of co-ingestion of cocaine and ethanol). Background: In the USA, 25% of HIV infection is due to drug abuse; in African Americans this avera
Continuing risk behaviors among HIV seropositive crack using women.: Natl Conf Women HIV. 1997 May 4-7;:141 (abstract no. 221.2). Unique Identifier : AIDSLINE MED/97927357; Metsch LR; McCoy CB; Lai S; McAnany H; University of Miami, School of Medicine, Miami, FL.; Objective: Relatively little is known about the continuing risk behaviors among HIV seropositive crack using women. Street recruited samples in Miami, Florida from 1992 - 1994 provide an opportunity to investigate whether crack-using women after learning their HIV status (N=144) continue to engage in high risk behavio
Utility of GC/MS hair analysis for cocaine, benzoylecgonine, and cocaethylene in HIV-positive cocaine-using African-American women.: Natl Conf Women HIV. 1997 May 4-7;:141 (abstract no. 221.3). Unique Identifier : AIDSLINE MED/97927358; Bandstra E; Shapshak P; Weatherby N; Shah S; Steele B; Wu NC; Page B; Mash D; Hearn L; Hime G; McCoy C; University of Miami, School of Medicine, Miami, FL.; Background: Biologic markers for cocaine and its metabolites are important to determine the severity of cocaine use for correlation with laboratory and physical signs of HIV/AIDS. Self-reported drug use is often unreliable, especially in minority women of child-bearing age who perceive themselves at risk for prosecuti
The association between STDs and HIV/AIDS progression in African-American drug-using women.: Natl Conf Women HIV. 1997 May 4-7;:142 (abstract no. 221.4). Unique Identifier : AIDSLINE MED/97927359; McCoy HV; Weatherby N; Shapshak P; Metsch LR; McCoy CB; Bonney C; University of Miami, School of Medicine, Miami, FL.; Objective: Cocaine users, particularly crack cocaine smokers, have high rates of HIV infection as a result of having multiple sex partners in exchanging sex for drugs. They have also self-reported high rates of sexually transmitted diseases (STDs). This analysis proposes to determine whether cocaine injectors, who hav
HIV-infected women recovering from alcohol and/or substance abuse may be at increased risk for malnutrition.: Natl Conf Women HIV. 1997 May 4-7;:145 (abstract no. 224.1). Unique Identifier : AIDSLINE MED/97927372; Druyan ME; Trigalo E; Leopoldo L; Department of Human Nutrition and Dietetics, University of Illinois,; Chicago, IL.; Introduction: Residents of an all-women s substance abuse recovery home were interviewed to assess their nutritional intake and identify ways to improve their diets. These women represent a cohort of mainly inner-city, minority, alcohol and/or substance abusers, most of whom are confirmed HIV positive. They have multi
AIDS-related cancers in HIV-infected women.: Natl Conf Women HIV. 1997 May 4-7;:151 (abstract no. 300.1). Unique Identifier : AIDSLINE MED/97927397; Levine A; University of Southern California, Kenneth Norris Cancer Hospital, Los; Angeles, CA.; Three cancers are currently considered AIDS defining. These include Kaposi s sarcoma, non-Hodgkin s lymphoma , and cervical cancer. Each of these cancers has been associated with a viral infection, including HHV-8 in Kaposi s sarcoma; Epstein Barr virus in lymphoma; and human papill
Combination therapy with delavirdine (DLV) plus zidovudine (ZDV) versus ZDV alone: demographics, HIV viral load, and CD4 changes in female patients.: Natl Conf Women HIV. 1997 May 4-7;:152 (abstract no. 304.4). Unique Identifier : AIDSLINE MED/97927403; Wathen L; Freimuth W; Cox S; Chuang-Stein C; Daenzer C; Wang Y; Pharmacia and Upjohn, Kalamazoo, MI.; Objectives: We performed a phase III blinded, dose-ranging study comparing DLV plus ZDV versus ZDV alone. Analyses of the entire study population (n=718) showed that the activity of DLV plus ZDV in decreasing HIV viral load and increasing CD4 cell counts was dose-dependent. The objective of the substudy reported here
Epidemiology of CCR5 allele variants in a multiracial, multirisk cohort of U.S. women with or at risk for HIV infection.: Natl Conf Women HIV. 1997 May 4-7;:153 (abstract no. 304.6). Unique Identifier : AIDSLINE MED/97927405; Hodge T; Smith DK; Qari S; Centers for Disease Control and Prevention, Atlanta, GA.; Objective: To investigate the frequency and correlates of genetic variation in the CCR5 chemokine receptor within racial subgroups of women enrolled in the HIV Epidemiology Research (HER) Study. Methods: PCR amplification with primers flanking the coding region for the known CCR5 32 bp deletion (\delta32) mutation is
Introducing female condom use to African American and Latina women exchanging sex for money or drugs in New York City.: Natl Conf Women HIV. 1997 May 4-7;:159 (abstract no. P1.14). Unique Identifier : AIDSLINE MED/97927429; Witte SS; El-Bassel N; Schilling RF; Wallace J; Bidassie B; Scaief J; Columbia University, School of Social Work, Social Intervention Group,; New York, NY.; Objectives: To introduce female condom use among low-income African American and Latina women exchanging sex for money or drugs in New York City. Methods: Face to face, structured interviews covering demographic characteristics, drug use, sexual risk behavior, contraceptive history, and attitudes towards the female co
Incarceration and violence/drug use/support among HIV+ and HIV- high risk women.: Natl Conf Women HIV. 1997 May 4-7;:164 (abstract no. P1.33). Unique Identifier : AIDSLINE MED/97927448; Flanigan TP; Sheu M; Hogan J; Stein M; Vlahov D; Schoenbaum E; Schuman P; Moore J; Brown University, Providence, RI.; Introduction: HIV seroprevalence among incarcerated women ranges from less than 1% to 25% and in general is 3 times higher than in incarcerated men. OBJECTIVE: To compare risk behaviors and psychosocial factors in women who have been recently incarcerated. METHODS: Cross sectional interview of HIV risk behaviors, psyc
Gender differences in HIV-related risk behaviors among a community-based sample of African American drug users and non-drug users.: Natl Conf Women HIV. 1997 May 4-7;:165 (abstract no. P1.40). Unique Identifier : AIDSLINE MED/97927457; Raj A; Deluca N; Marsh S; Wingood G; Collins C; Wang MQ; Kohler C; DiClemente R; University of Alabama, School of Public Health, Birmingham, AL.; Objectives: The objectives of this CSAT-funded study were twofold: (1) to identify HIV-related risk behaviors among African-American women and men residing in a high risk social environment; and (2) to determine if polysubstance using women, as compared to polysubstance using men, are at increased risk for HIV and oth
Social and health functioning in substance abusing women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:167 (abstract no. P1.48). Unique Identifier : AIDSLINE MED/97927465; Smereck G; Melchior LA; Huba G; Andersen M; Well-Being Institute, Ann Arbor, MI.; Introduction: Substance abusing women are one of the highest risk groups for HIV for three reasons: a) contact with HIV through the exchange of needles with other substance users with HIV; b) contact through participation in sex work; or c) contact with a male sex partner who has HIV. In treating substance abusing wom
Health promotion among homeless women at risk for AIDS.: Natl Conf Women HIV. 1997 May 4-7;:168 (abstract no. P1.49). Unique Identifier : AIDSLINE MED/97927466; Mosley Y; Heard K; University of California, School of Nursing, Los Angeles, CA.; Homeless women are considered to be at increased risk for HIV/AIDS due to a higher incidence of HIV-risk behaviors, such as unprotected sex with multiple sexual partners, and addiction to drugs and/or alcohol. The purpose of this presentation is to describe our current NIMH funded study which is a longitudinal quasi-e
Following a cohort of high risk women: risk behaviors and readiness to change.: Natl Conf Women HIV. 1997 May 4-7;:176 (abstract no. P2.14). Unique Identifier : AIDSLINE MED/97927508; Brown-Peterside P; Koblin BA; Ren L; Chiasson MA; Taylor PE; Stevens CE; Medical and Health Research Association, New York, NY.; Objectives: To identify the HIV risk profile and risk behaviors of non-injecting women in the South Bronx, NY, and assess how these behaviors change over time. Methods: Women (N=89) were recruited for an HIV vaccine feasibility study. Eligibility criteria included: a current high risk sexual partner, an STD in the pas
Community care in a residential hotel.: Natl Conf Women HIV. 1997 May 4-7;:177 (abstract no. P2.16). Unique Identifier : AIDSLINE MED/97927510; Dawson CS; University of California, San Francisco, CA.; Introduction: As cases of AIDS in women continue to increase one of the most affected groups remains the least understood--women drug users. The lives of women drug users living with HIV/AIDS are often complicated by other cofactors that have proved significant to people living with HIV/AIDS--stigma and poverty. The p
Satisfaction with care, ethnicity and depression among women with HIV.: Natl Conf Women HIV. 1997 May 4-7;:177 (abstract no. P2.17). Unique Identifier : AIDSLINE MED/97927511; Eversley RB; Israelski D; Galzegorry G; Smith S; University of California, Department of Social and Behavioral; Sciences, San Francisco, CA.; Objective: Satisfaction with health care is increasingly being used to study health care utilization as well as medical outcomes for people with HIV. Little is known, though, about satisfaction with health care among women with HIV. Method: We developed and pilot tested a new 12 item measure to assess satisfaction wit
The association of alcohol and drug use, STD history and depression as correlates of condom use and multiple sex partners among African-American women.: Natl Conf Women HIV. 1997 May 4-7;:178 (abstract no. P2.22). Unique Identifier : AIDSLINE MED/97927516; Wingood GM; DiClemente RJ; University of Alabama, School of Public Health, Birmingham, AL.; Objectives: This study examined the association of alcohol and drug use, STD history, interpersonal skills and depression as correlates of noncondom use and multiple sex partners among African-American women residing in a high risk social environment. Methods: Using street outreach 180 African-American women, 15-40 ye
HIV-risk behaviors and mental health characteristics among homeless or drug-recovering women and their supportive person.: Natl Conf Women HIV. 1997 May 4-7;:185 (abstract no. P2.54). Unique Identifier : AIDSLINE MED/97927547; Gilchrist A; University of California, School of Nursing, Los Angeles, CA.; Currently, there is limited information about HIV-related behaviors and mental health characteristics of the closest sources of social support of inner city women of color. However, there is reason to believe that the risk behavior of a supportive person, defined in this study as the most important person with whom th
Variations in adolescents' sexual risk based on sexual orientation and gender.: Natl Conf Women HIV. 1997 May 4-7;:180 (abstract no. P2.32). Unique Identifier : AIDSLINE MED/97927571; Langabeer KA; Rotheram-Borus MJ; Gwadz M; University of California, Department of Psychiatry, Los Angeles, CA.; While the risk for HIV has been demonstrated among young gay men, there has been little data on young lesbian women, particularly among minority ethnic groups. The goal of this study was to examine differences in the frequency of sexual risk acts and the social-cognitive factors that were likely to mediate this risk f
Prevention of transmission of AIDS to health care workers.: Rinsho Kyobu Geka. 1988 Apr;8(2):211-3. Unique Identifier : AIDSLINE MED/97447384
[Consideration of blood transfusion in cardiac surgery]: Rinsho Kyobu Geka. 1988 Feb;8(1):7-11. Unique Identifier : AIDSLINE MED/97447357; Ninomiya K
3,6-Disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles: synthesis and evaluation for antimicrobial and antiviral activity. III.: Farmaco. 1997 Apr;52(4):259-61. Unique Identifier : AIDSLINE MED/97385819; Invidiata FP; Furno G; Simoni D; Lampronti I; Musiu C; Milia C; Scintu F; La Colla P; Istituto Farmacochimico dell'Universita di Palermo, Italy.; A series of novel 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives was prepared and tested to evaluate their antimycotic, antibacterial and anti-HIV-1 activities. The reaction of thiocarbohydrazide with carboxylic acids at the melting temperature allows an improved preparation of the 5-substituted
Th1-Th2: reliable paradigm or dangerous dogma?: Immunol Today. 1997 Aug;18(8):387-92. Unique Identifier : AIDSLINE MED/97412340; Allen JE; Maizels RM; Institute of Cell, Animal and Population Biology, University of; Edinburgh, UK. j.allen@ed.ac.uk
Targeted and general population interventions for HIV prevention: towards a comprehensive approach [editorial]: AIDS. 1997 Aug;11(10):1201-9. Unique Identifier : AIDSLINE MED/97401098; Sumartojo E; Carey JW; Doll LS; Gayle H
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.: AIDS. 1997 Aug;11(10):1211-7. Unique Identifier : AIDSLINE MED/97401099; Ercoli L; Sarmati L; Nicastri E; Giannini G; Galluzzo C; Vella S; Andreoni M; Department of Public Health and Cellular Biology, University of Rome; Tor Vergata, Italy.; OBJECTIVES: The aim of the study was to investigate changes in virological characteristics of HIV strains isolated from 38 HIV-seropositive subjects during antiretroviral therapy. DESIGN AND METHODS: Patients with a CD4+ cell count
Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells.: AIDS. 1997 Aug;11(10):1219-25. Unique Identifier : AIDSLINE MED/97401100; Zhang YJ; Fadeel B; Hodara V; Fenyo EM; Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm,; Sweden.; OBJECTIVE: To study the apoptosis-inducing capacity of HIV-1 primary isolates in human peripheral blood mononuclear cells PBMC) in relation to the viral biological phenotype. DESIGN AND METHODS: Four HIV-1 primary isolates capable of replicating and inducing syncytia in the MT-2 cell line and two primary isolates lack
The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells.: AIDS. 1997 Aug;11(10):1227-35. Unique Identifier : AIDSLINE MED/97401101; Zocchi MR; Poggi A; Rubartelli A; Laboratory of Clinical Pathology, National Institute for Cancer; Research, Genoa, Italy.; OBJECTIVE: HIV-1 Tat can be released by infected cells and exert various extracellular functions on bystander cells, possibly contributing to immunodeficiency. In order to investigate whether exogenous Tat can affect antigen presentation, the effects of synthetic Tat on the function of dendritic cells displaying antig
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis.: AIDS. 1997 Aug;11(10):1237-42. Unique Identifier : AIDSLINE MED/97401102; Samper S; Martin C; Pinedo A; Rivero A; Blazquez J; Baquero F; van Soolingen D; van Embden J; Department of Microbiology and Public Health, Saragossa University,; Spain.; OBJECTIVE: To investigate outbreaks of multidrug-resistant tuberculosis (TB) by using DNA fingerprint databases. DESIGN: Investigation of two outbreaks of multidrug-resistant TB in separate hospitals in Spain by restriction fragment length polymorphism (RFLP) and spoligotyping. Outb
Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients.: AIDS. 1997 Aug;11(10):1243-8. Unique Identifier : AIDSLINE MED/97401103; Styrt BA; Chaisson RE; Moore RD; Office of Epidemiology and Biostatistics, Center for Drug Evaluation; and Research, Food and Drug Administration, Rockville, Maryland 20857,; USA.; OBJECTIVE: Many drugs used for prophylaxis against opportunistic infections in AIDS also have activity against common bacteria. This study was performed to delineate relationships between prior use of antimicrobials and Staphylococcus aureus bacteremia. DESIGN: To compare prior exposure to selected antimicrobial drugs
Effect of antiviral treatment on the shedding of HIV-1 in semen.: AIDS. 1997 Aug;11(10):1249-54. Unique Identifier : AIDSLINE MED/97401104; Vernazza PL; Gilliam BL; Flepp M; Dyer JR; Frank AC; Fiscus SA; Cohen MS; Eron JJ; Institute for Clinical Microbiology and Immunology, Kantonsspital, St; Gallen, Switzerland.; OBJECTIVE: The potential role of antiretroviral treatment on the infectiousness of HIV-1-infected men was examined by studying the effect of antiviral treatment on the shedding of HIV-1 in semen. METHODS: Forty-four patients enrolled in various treatment protocols were asked to donate a semen sample before they began
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.: AIDS. 1997 Aug;11(10):1255-62. Unique Identifier : AIDSLINE MED/97401105; Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D; Department of Epidemiology, Johns Hopkins School of Hygiene and Public; Health, Baltimore, Maryland, USA.; OBJECTIVES: To assess the relationship between various injecting drug use patterns and the rate of CD4+ lymphocyte decline in HIV-1-infected injecting drug users in Baltimore, Maryland, USA. METHODS: A cohort of 605 HIV-1-infected injecting drug users was recruited between 1988 and early 1989 in East Baltimore using e
Recent upturn in mortality in rural Zimbabwe: evidence for an early demographic impact of HIV-1 infection?: AIDS. 1997 Aug;11(10):1269-80. Unique Identifier : AIDSLINE MED/97401107; Gregson S; Anderson RM; Ndlovu J; Zhuwau T; Chandiwana SK; Wellcome Trust Centre for the Epidemiology of Infectious Disease,; Zoology Department, Oxford University, UK.; OBJECTIVES: To describe recent mortality trends in rural Zimbabwe and to assess the impact of HIV-1 infection. METHOD: Comparative, cross-sectional, retrospective, demographic survey with 1-year follow-up. Parallel HIV-1 surveillance. Comparison of results with 1992 national cens
Survival with AIDS in Ireland.: AIDS. 1997 Aug;11(10):1281-90. Unique Identifier : AIDSLINE MED/97401108; Dunne MT; Ruskin HJ; Mulcahy FM; Faculty of Computing and Mathematical Sciences, Dublin City; University, Ireland.; OBJECTIVE: To analyse the pattern of survival for patients diagnosed with AIDS in Dublin. METHODS: Data on 193 patients visiting the Department of Genitourinary Medicine of a Dublin Hospital, over a period of 7 years with AIDS, were analysed, and survival patterns were investigated. RESULTS: The cumulative probability
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir [letter]: AIDS. 1997 Aug;11(10):1293-4. Unique Identifier : AIDSLINE MED/97401110; Sadler M; Morris-Jones S; Nelson M; Gazzard BG
Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report [letter]: AIDS. 1997 Aug;11(10):1294-6. Unique Identifier : AIDSLINE MED/97401111; Lenzo NP; Garas BA; French MA
Detection of HIV-1 RNA in vaginal secretions of HIV-1-seropositive women who have undergone hysterectomy [letter]: AIDS. 1997 Aug;11(10):1296-7. Unique Identifier : AIDSLINE MED/97401112; Farrar DJ; Cu Uvin S; Caliendo AM; Costello SF; Murphy DM; Flanigan TP; Mayer KH; Carpenter CC
HIV/AIDS surveillance in Colombia: regional differences in epidemic trends [letter]: AIDS. 1997 Aug;11(10):1297-8. Unique Identifier : AIDSLINE MED/97401113; Garcia-Bernal R; Klaskala W; Castro J; Zhang G; Baum M
No therapeutic advantage from didanosine (ddI) and hydroxyurea versus ddI alone in patients with HIV infection [letter]: AIDS. 1997 Aug;11(10):1299-300. Unique Identifier : AIDSLINE MED/97401114; Simonelli C; Comar M; Zanussi S; De Paoli P; Tirelli U; Giacca M
Hypersensitivity reactions during antiretroviral regimens with protease inhibitors [letter]: AIDS. 1997 Aug;11(10):1301-2. Unique Identifier : AIDSLINE MED/97401116; Bonfanti P; Capetti A; Riva P; Testa L; Quirino T
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir [letter]: AIDS. 1997 Aug;11(10):1302-3. Unique Identifier : AIDSLINE MED/97401117; Pialoux G; Fournier S; Moulignier A; Poveda JD; Clavel F; Dupont B
Macrophage-tropism of HIV-1 isolates of different genetic subtypes [letter]: AIDS. 1997 Aug;11(10):1303-4. Unique Identifier : AIDSLINE MED/97401118; Karita E; Nkengasong JN; Willems B; Vanham G; Fransen K; Heyndrickx L; Janssens W; Piot P; van der Groen G
Airborne pathogens: infection control and tuberculosis--the Singapore scene.: Asepsis. 1997 FIRST QUARTER;19(1):17-21. Unique Identifier : AIDSLINE MED/97449891; Ling ML; Wee M; Department of Pathology, Singapore General Hospital.
Probable transmission of HIV from orthopedic surgeon to patient.: Asepsis. 1997 FIRST QUARTER;19(1):22. Unique Identifier : AIDSLINE MED/97449892; Lancaster AD
[Survey of knowledge, attitudes, and opinions about AIDS expressed by a population of high-school students in Rimini]: Ann Ig. 1996 Nov-Dec;8(6):611-20. Unique Identifier : AIDSLINE MED/97366953; Bergamaschi A; Stampi S; Zanetti F; De Luca G; Chiadini A; Toni F; Ist. di Igiene I Catt., Universita degli Studi di Bologna.
[Trends in the prevalence and geographic distribution of HIV infection among Italian drug addicts in treatment provided by public assistance services during 1990-1994]: Ann Ig. 1996 Nov-Dec;8(6):621-33. Unique Identifier : AIDSLINE MED/97366954; Perria C; Magliocchetti N; Nicoletti G; Pezzotti P; Rezza G; Ist. di Igiene, Universita Cattolica del Sacro Cuore, Roma.
[Prevalence of HTLV-I and HTLV-II infection in Puglia]: Ann Ig. 1996 Nov-Dec;8(6):649-55. Unique Identifier : AIDSLINE MED/97366957; Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S; Ist. di Igiene, Universita degli Studi di Bari.
Nurse practitioners' reactions to persons with HIV/AIDS: the role of patient contact and education.: J Am Acad Nurse Pract. 1996 Sep;8(9):419-26. Unique Identifier : AIDSLINE MED/97450049; Dimick LA; Levinson RM; Manteuffel BA; Donnellan M; Woodruff School of Nursing, Emory University Atlanta, Georgia, USA.; Attitudes about caring for patients with HIV/AIDS (PWAs) were investigated in a survey mailed to all nurse practitioners (NPs) in Georgia. There was a 53% response rate to the survey (286 of 539 questionnaires were returned). It was hypothesized that exposure to continuing education on HIV/AIDS and to HIV-positive pat
Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.: Br J Clin Pharmacol. 1997 Aug;44(2):190-4. Unique Identifier : AIDSLINE MED/97422441; Eagling VA; Back DJ; Barry MG; Department of Pharmacology and Therapeutics, University of Liverpool,; UK.; AIMS: To compare the inhibitory potential of the HIV protease inhibitors saquinavir, ritonavir and indinavir against CYP1A2, CYP2C9, CYP2E1 and CYP3A4 catalysed metabolic reactions in human liver microsomes in vitro. METHODS: Microsomes from six human livers were ut
Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?: Ann Oncol. 1997 Jan;8(1):71-7. Unique Identifier : AIDSLINE MED/97247583; Hernberg M; Muhonen T; Pyrhonen S; Department of Oncology, Helsinki University Central Hospital, Finland.; BACKGROUND: In a randomised trial, patients with renal cell carcinoma (RCC) treated with vinblastine alone or in combination with interferon-alpha (IFN) were monitored for peripheral blood lymphocyte subsets (CD4+ and CD8+) prior to and during treatment to elucidate the influence of IFN on these cells, and the associa
The University of Toronto liver transplant program.: Clin Transpl. 1996;:177-85. Unique Identifier : AIDSLINE MED/97432687; Hemming AW; Cattral MS; Greig PD; Philosophe B; Superina RA; Lilly LB; Levy G; Toronto Hospital, Hospital for Sick Children, Ontario, Canada.; The University of Toronto liver transplant program began in 1985 at a time when the procedure had already evolved from an experimental form of surgery to an accepted treatment for many forms of liver failure. The program was established not only to provide clinical care for patients but also to address academically th
Skewing of TCR V genes to CD4+ and CD8+ subsets of T lymphocytes is not determined by amino acid composition of CDR3.: Int Immunol. 1997 Aug;9(8):1103-10. Unique Identifier : AIDSLINE MED/97408488; Hawes GE; Vietor HE; Kanhai HH; van den Elsen PJ; Department of Immunohematology and Blood Bank, University Hospital; Leiden, The Netherlands.; TCR V genes show differing expression patterns, termed skewing, in CD4+ and CD8+ subsets of T lymphocytes. To determine which elements of the TCR V regions contribute to these observed TCR V gene skewing patterns, we have performed an in-depth analysis, taking advantage of RT-PCR and DNA sequencing, which was focused
IL-2 and IL-7 differentially induce CD4-CD8- alpha beta TCR+NK1.1+ large granular lymphocytes and IL-4-producing cells from CD4-CD8- alpha beta TCR+NK1.1- cells: implications for the regulation of Th1- and Th2-type responses.: Int Immunol. 1997 Aug;9(8):1123-9. Unique Identifier : AIDSLINE MED/97408490; Nishizawa K; Koyasu S; Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical; School, Boston, MA 02115, USA.; Effector functions of CD4-CD8- double negative (DN) alpha beta TCR+ cells were examined. Among mouse DN alpha beta TCR+ thymocytes, NK1.1+ cells expressing a canonical V alpha 14/J alpha 281 TCR but not NK1.1- cells produce IL-4 upon TCR cross-linking and IFN-gamma upon cross-linking of NK1.1 as well as TCR. Productio
gp 120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules.: Int Immunol. 1997 Aug;9(8):1141-7. Unique Identifier : AIDSLINE MED/97408492; Feito MJ; Bragardo M; Buonfiglio D; Bonissoni S; Bottarel F; Malavasi F; Dianzani U; Dipartimento di Scienze Mediche, University of Turin at Novara, Italy.; This work extends our previous finding that lymphocyte treatment with gp120IIIB specifically induces CD4 association with several surface molecules to other molecules and to three other gp120s from different HIV-1 strains. The ability to induce this association was displayed by the four gp120s employed, i.e. gp120IIIB
Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines.: Int Immunol. 1997 Aug;9(8):1213-9. Unique Identifier : AIDSLINE MED/97408500; Taneja V; Hansen J; Smart M; Griffiths M; Luthra H; David CS; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.; Transgenic mice expressing DQA1*0301 and DQB1*0302 (HLA-DQ8) molecules in class II-deficient Ab degree mice are susceptible to collagen-induced arthritis (CIA). To evaluate the role of the H2-E molecule (a homolog of HLA-DR) in DQ-restricted arthritis, the H2-E gene was introduced into DQ8.Ab degree mice to generate D
Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.: Biochemistry. 1997 Sep 9;36(36):10846-56. Unique Identifier : AIDSLINE MED/97454133; Huang X; Barchi JJ Jr; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR; Laboratory of Medicinal Chemistry, Division of Basic Sciences,; National Cancer Institute, Bethesda, Maryland 20892, USA.; We have prepared glycosylated analogues of the principal neutralizing determinant of gp120 and studied their conformations by NMR and circular dichroism spectroscopies. The 24-residue peptide from the HIV-1IIIB isolate (residues 308-331) designated RP135, which contains the immunodominant tip of the V3 loop, was glyco
2',3'-Dideoxycytidine cytotoxicity in human macrophages.: Biochim Biophys Acta. 1997 Aug 21;1358(1):39-45. Unique Identifier : AIDSLINE MED/97441081; Antonelli A; Brandi G; Casabianca A; Magnani M; Institute of Biochemistry G. Fornaini, University of Urbino, Italy.; Human macrophages when cultured for several weeks in the presence of therapeutically relevant 2 ,3 -dideoxycytidine ( ddC ) concentrations show a time-dependent decay in mitochondrial DNA content. This decay is associated with a reduction of Rhodamine 1
[Performance of the IgG avidity test in patients with cytomegalovirus disease]: Enferm Infecc Microbiol Clin. 1997 Apr;15(4):190-5. Unique Identifier : AIDSLINE MED/97323777; Lafarga B; Noguera FJ; Bolanos M; Perez MC; Rodriguez H; Servicio de Microbiologia, Hospital Nuestra Senora del Pino, Las; Palmas de Gran Canaria.; BACKGROUND: IgG antibodies produced early in infection has a low avidity to their respective epitopes, so that an assay to detect those antibodies could be easily used to diagnose a recent primary infection. A prospective study of anti- CMV IgG avidity test in pa
[Otomastoiditis caused by Aspergillus in AIDS]: Enferm Infecc Microbiol Clin. 1997 Apr;15(4):200-2. Unique Identifier : AIDSLINE MED/97323779; Martinez-Berriotxoa A; Montejo M; Aguirrebengoa K; Gonzalez de Zarate P; Aguirre C; Unidad de Enfermedades Infecciosas, Hospital de Cruces, Barakaldo,; Bizkaia.; BACKGROUND: Aspergillus otomastoiditis is an infrequent infection that occurs in most cases in immunocompromised hosts. Although fungal infections are common in AIDS patients, few cases of Aspergillus otomastoiditis have been reported. METHODS: Two clinical cases of AIDS patients with Aspergillus otomastoiditis are re
[Mixed adenitis caused by Mycobacterium avium complex and Mycobacterium tuberculosis complex in patients with HIV infection letter)]: Enferm Infecc Microbiol Clin. 1997 Apr;15(4):225-6. Unique Identifier : AIDSLINE MED/97323786; Terrones R; de Alarcon A; Garcia-Curiel A; Luque JA; Arroyo A
[Histoplasmosis and AIDS (letter)]: Enferm Infecc Microbiol Clin. 1997 Apr;15(4):229-30. Unique Identifier : AIDSLINE MED/97323791; Santos J; Arana C; Rivero A; Garcia-Bravender R
[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents (letter)]: Enferm Infecc Microbiol Clin. 1997 Apr;15(4):231-2. Unique Identifier : AIDSLINE MED/97323793; de Luis DA; Fortun J; Pintado V; Aller de la Fuente R
[Viral infections in solid organ transplant recipients]: Enferm Infecc Microbiol Clin. 1997 May;15 Suppl 2:22-33. Unique Identifier : AIDSLINE MED/97326170; Moreno MA; Servicio de Enfermedades Infecciosas, Hospital Clinic, Barcelona.
Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells.: Hum Gene Ther. 1997 Jul 20;8(11):1375-84. Unique Identifier : AIDSLINE MED/97439576; Hirano N; Takahashi T; Takahashi T; Azuma M; Okumura K; Yazaki Y; Yagita H; Hirai H; Third Department of Internal Medicine, Faculty of Medicine, University; of Tokyo, Japan.; B7 molecules provide an important co-stimulatory signal for T cell receptor/CD3-mediated T cell activation via binding to their cognate receptors, CD28 and CTLA-4. We have introduced B7-1 CD80) into M1 cells, spontaneously occurring mouse myelocytic leukemic cells, and assessed its potential to induce antitumor immuni
Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection.: Eur Cytokine Netw. 1997 Jun;8(2):153-60. Unique Identifier : AIDSLINE MED/97408445; Estaquier J; Marguerite M; Sahuc F; Bessis N; Auriault C; Ameisen JC; INSERM U. 415, Institut Pasteur de Lille, France.; The pathogenesis of infection with the helminth parasite Schistosoma (S) mansoni in mice has been reported to involve a T helper (Th)1 to Th2 cytokine switch, associated with a pathogenic granulomatous response to parasite eggs and to a global defect in Th1-cell effector functions. Here we report that the Th2 cytokine
The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes.: Eur Cytokine Netw. 1997 Jun;8(2):203-13. Unique Identifier : AIDSLINE MED/97408450; Minty A; Asselin S; Bensussan A; Shire D; Vita N; Vyakarnam A; Wijdenes J; Ferrara P; Caput D; Sanofi Recherche, Labege-Innopole, France.; adrian.minty@tis1.elfsanofi.fr; We have compared the production of the related cytokines IL-13 and IL-4 by T lymphocytes, and the effects of the two cytokines on these cells. IL-13 and IL-4 production differ in a number of respects. IL-13 is produced at higher levels than IL-4 by activated T lymphocytes, and its accumulation in the culture medium ca
Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome.: Blood. 1997 Sep 1;90(5):1737-46. Unique Identifier : AIDSLINE MED/97436533; Baiocchi RA; Khatri VP; Lindemann MJ; Ross ME; Papoff G; Caprio AJ; Caprio TV; Fenstermaker R; Ruberti G; Bernstein ZP; Caligiuri MA; Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.; The poor prognosis associated with patients afflicted with the acquired immunodeficiency syndrome and primary central nervous system lymphoma (AIDS-PCNSL) is due in part to the intrinsic resistance of this Epstein-Barr virus (EBV)-associated tumor to conventional antineoplastic therapy. Fas (CD95) is a transmembrane p
Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma.: Blood. 1997 Sep 1;90(5):1787-98. Unique Identifier : AIDSLINE MED/97436538; Bahner I; Kearns K; Coutinho S; Leonard EH; Kohn DB; Department of Pediatrics, University of Southern California School of; Medicine, Children's Hospital Los Angeles 90027, USA.; Patients with human immunodeficiency virus-1 (HIV-1) infection often present with bone marrow (BM) failure that may affect all hematopoietic lineages. It is presently unclear whether this failure reflects a direct viral impairment of the CD34+ hematopoietic progenitor cells or whether the virus affects the BM microenv
Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype.: Blood. 1997 Sep 1;90(5):1920-6. Unique Identifier : AIDSLINE MED/97436552; Hilkens CM; Kalinski P; de Boer M; Kapsenberg ML; Academic Medical Center, University of Amsterdam, Department of Cell; Biology & Histology, The Netherlands.; Dendritic cells (DC) are important initiators of specific primary immune responses because they are the only APC that can efficiently activate naive Th cells. DC have the capacity to produce interleukin-12 (IL-12), a cytokine that plays a pivotal role in the development of Th1-mediated cellular immune responses. The p
CD40 ligand induces an antileukemia immune response in vivo.: Blood. 1997 Sep 1;90(5):1927-33. Unique Identifier : AIDSLINE MED/97436553; Dilloo D; Brown M; Roskrow M; Zhong W; Holladay M; Holden W; Brenner M; Division of Bone Marrow Transplantation and Cell and Gene Therapy; Program, St Jude Children's Research Hospital, Memphis, TN 38105, USA.; Leukemia cells may express tumor specific antigens in association with Class I and II major histocompatability complex (MHC) molecules. However, lack of expression of conventional costimulator molecules means that these cells tend to induce specific T-cell anergy rather than activation. CD40 ligand CD40L) is a costimu
Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.: Blood. 1997 Sep 1;90(5):1977-81. Unique Identifier : AIDSLINE MED/97436559; Loughran TP Jr; Hadlock KG; Yang Q; Perzova R; Zambello R; Semenzato G; Foung SK; Poiesz BJ; Veteran's Administration Hospital and the Department of Medicine,; State University of New York, Syracuse, USA.; Natural killer (NK) cells are CD3- large granular lymphocytes LGL) responsible for immunity against viral infections. A chronic lymphoproliferative disorder of NK cells has been described in which the expanded NK cells display a restricted phenotype and cytotoxic activity. These data raise the hypothesis that prolifer
In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype.: Blood. 1997 Sep 1;90(5):2089-96. Unique Identifier : AIDSLINE MED/97436575; Halverson DC; Schwartz GN; Carter C; Gress RE; Fowler DH; Division of Clinical Sciences, National Cancer Institute, National; Institutes of Health, Bethesda, MD 20892, USA.; We have previously shown that allospecific murine CD8+ T cells of the Tc1 and Tc2 phenotype could be generated in vitro, and that such functionally defined T-cell subsets mediated a graft-versus-leukemia (GVL) effect with reduced graft-versus-host disease (GVHD). To evaluate whether analogous Tc1 and Tc2 subsets might
Bone marrow contains virus-specific cytotoxic T lymphocytes.: Blood. 1997 Sep 1;90(5):2103-8. Unique Identifier : AIDSLINE MED/97436577; Slifka MK; Whitmire JK; Ahmed R; Emory Vaccine Center and the Department of Microbiology and; Immunology, Emory University School of Medicine, Atlanta, GA 30307,; USA.; Immunizing bone marrow donors prior to bone marrow transplant BMT) has the potential for adoptively transferring specific immunity against opportunistic pathogens. Studies have shown that long-term antibody production occurs in the bone marrow and that specific humoral immunity may be transferred from donor to recipie
HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals.: Int J Clin Lab Res. 1997;27(2):111-7. Unique Identifier : AIDSLINE MED/97411303; Howell AL; Groveman DS; Wallace PK; Fanger MW; V. A. Medical Center, Research Service, White River Junction, VT; 05009, USA.; Monocytes and monocyte-derived macrophages play a key role in immune defense against pathogenic organisms. Superoxide anion production is a key mechanism by which phagocytes kill pathogens. We sought to determine whether human immunodeficiency virus-infected monocytes and monocyte-derived macrophages are compromised i
Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions.: Acta Paediatr Suppl. 1997 Jun;421:1-9. Unique Identifier : AIDSLINE MED/97382858; Mofenson LM; Pediatric, Adolescent & Maternal AIDS Branch, Center for Research for; Mothers and Children, National Institute of Child Health & Human; Development, National Institutes of Health, Rockville, MD 20852, USA.; In 1994, the hypothesis that transmission of human immunodeficiency virus (HIV) from mother to child could be interrupted became a reality when it was shown that a regimen of zidovudine given to HIV-infected pregnant women and their newborn infants could reduce the risk of perinatal transmission by two-thirds. An unde
Pregnancy and HIV infection in Europe.: Acta Paediatr Suppl. 1997 Jun;421:10-4. Unique Identifier : AIDSLINE MED/97382859; Newell ML; Thorne C; Department of Paediatric Epidemiology, Institute of Child Health,; London, UK.; Human immunodeficiency virus (HIV) seroprevalence among pregnant women varies between and within countries and is generally higher in urban than in rural areas. In the European Collaborative Study, heterosexual transmission is increasing and most women are asymptomatic, although the overall mean CD4 count is declining
Human immunodeficiency virus infection and mode of delivery.: Acta Paediatr Suppl. 1997 Jun;421:104-6. Unique Identifier : AIDSLINE MED/97382877; Peckham C; Newell ML; Department of Paediatric Epidemiology, Institute of Child Health,; London, UK.; Most children acquire human immunodeficiency virus (HIV) infection vertically from an infected mother. Indirect evidence suggests that a substantial proportion of infection is acquired around the time of delivery, which suggests that this would be an appropriate time to intervene. If intrapartum transmission of HIV oc
Overview of the potential role of vitamin A in mother-to-child transmission of HIV-1.: Acta Paediatr Suppl. 1997 Jun;421:107-12. Unique Identifier : AIDSLINE MED/97382878; Semba RD; Department of Ophthalmology, The Johns Hopkins University School of; Medicine, Baltimore, MD, USA.; Vitamin A is an essential micronutrient for normal immune function. Vitamin A deficiency is common among human immunodeficiency virus (HIV)-infected pregnant women and is associated with higher mother-to-child transmission of HIV-1 and increased infant mortality. The biological mechanisms by which vitamin A deficiency
Breastfeeding and vertical transmission of HIV-1.: Acta Paediatr Suppl. 1997 Jun;421:113-7. Unique Identifier : AIDSLINE MED/97382879; Kreiss J; Department of Medicine, University of Washington, Seattle 98104-2499,; USA.; An estimated one-third to one-half of vertical transmission of human immunodeficiency virus type 1 (HIV-1) worldwide is due to breastfeeding. The exact frequency of breast milk HIV-1 transmission is unknown, but it has been estimated to be 14% in the setting of established maternal HIV-1 infection and 29% in the setti
Epidemiology of HIV/AIDS in women and children in the USA.: Acta Paediatr Suppl. 1997 Jun;421:15-6. Unique Identifier : AIDSLINE MED/97382860; Rogers MF; Epidemiology Branch, Division of HIV/AIDS Prevention, Centers for; Disease Control and Prevention, Atlanta, GA 30333, USA.; In the USA, the AIDS epidemic has shown dramatic increases among women and children in the past decade with more than 70,000 cases in women and 7000 cases in children reported. Acquired immunodeficiency syndrome is the seventh leading cause of death in children aged 1-4 years and the fourth leading cause of death amon
Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group.: Acta Paediatr Suppl. 1997 Jun;421:17-21. Unique Identifier : AIDSLINE MED/97382861; Rouzioux C; Burgard M; Chaix ML; Delamare C; Cirau N; Bouiller B; Cateloy S; Allemon MC; Broyart C; Ciraru N; Floch C; Lelorier P; Lachassine E; Mazy F; Narcy P; Saillant J; Salomon JL; Seaume H; Talon P; Mayaux MJ; Blanche S; Laboratoire de Virologie, Hopital Necker-Enfants Malades, Paris,; France.; Among human immunodeficiency virus-1 (HIV-1) vertically infected children, two patterns of disease progression have been observed: about 25% develop a severe immunodeficiency within the first 2 years of life; the rest experience a slower progression, like adults. We have assessed infectious viral burden in infected ne
Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection.: Acta Paediatr Suppl. 1997 Jun;421:22-8. Unique Identifier : AIDSLINE MED/97382862; De Rossi A; Ometto L; Masiero S; Zanchetta M; Chieco-Bianchi L; Department of Oncology and Surgical Sciences, InterUniversity Center; for Cancer Research, University of Padova, Italy.; Human immunodeficiency virus-1 (HIV-1) primary isolates differ in replicative capacity on peripheral blood mononuclear cells, tropism for primary monocyte-derived macrophages (MDM) and T-cell lines and syncytium-inducing (SI) capability on MT-2 cells in vitro. To assess the role of viral phenotype in mother-to-child H
Antiretroviral resistance and HIV vertical transmission.: Acta Paediatr Suppl. 1997 Jun;421:29-32. Unique Identifier : AIDSLINE MED/97382863; McIntosh K; Division of Infectious Diseases, Children's Hospital, Boston, MA; 02115, USA.; The author reviews the current and potential problem of antiviral resistance in the prevention of vertical transmission of human immunodeficiency virus (HIV) from mother to child. The paper addresses five questions: (i) How often does antiretroviral resistance occur? While this does not appear to be an important probl
Role of placental cytokines and inflammation in vertical transmission of HIV infection.: Acta Paediatr Suppl. 1997 Jun;421:33-8. Unique Identifier : AIDSLINE MED/97382864; Shearer WT; Reuben J; Lee BN; Popek EJ; Lewis DE; Hammill HH; Hanson IC; Kline MW; Langston C; Department of Pediatrics, Baylor College of Medicine, Texas Children's; Hospital, Houston 77030, USA.; In light of new evidence suggesting that maternal human immunodeficiency virus (HIV) infection produces at least a three-fold increase in the number of early spontaneous abortions, it is important to search for factors that may predispose to fetal wastage. Immunological factors are thought to play an important role in
Role of immunity in maternal-infant HIV-1 transmission.: Acta Paediatr Suppl. 1997 Jun;421:39-45. Unique Identifier : AIDSLINE MED/97382865; Jansson M; Orlandi P; Scarlatti G; Moschese V; Romiti ML; Cancrini C; Mancia L; Livadiotti S; Castelli-Gattinara G; Rossi P; Halapi E; Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm,; Sweden.; Factors influencing human immunodeficiency virus type 1 (HIV-1) mother-to-child transmission include both immunological and virological parameters: higher viral loads have been associated with clinical stage of HIV-1-infected individuals as well as higher risk of mother-to-child transmission. Furthermore, we have show
Immunological and virological markers of disease progression in HIV-infected children.: Acta Paediatr Suppl. 1997 Jun;421:46-51. Unique Identifier : AIDSLINE MED/97382866; Munoz-Fernandez MA; Navarro J; Obregon E; Arias RA; Gurbindo MD; Sampelayo TH; Fernandez-Cruz E; Division of Immunology, Hospital General Universitario Gregorio; Maranun, Madrid, Spain.; Polymerase chain reaction (PCR), virus culture and antigen detection assays are useful for early detection of vertically transmitted human immunodeficiency virus type 1 (HIV-1) infection in infants under 12 months of age. Sixty-four children born to HIV-1-seropositive mothers were evaluated. Thirteen children 20.3%) w
Maternal clinical factors influencing HIV-1 transmission.: Acta Paediatr Suppl. 1997 Jun;421:52-5. Unique Identifier : AIDSLINE MED/97382867; Tovo PA; Gabiano C; Tulisso S; Department of Paediatrics, University of Turin, Torino, Italy.; The complex puzzle of maternal factors involved in mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission is being put together. The risk of perinatal infection increases with mother s disease progression, but it remains stable in women seroconverting to HIV-1 during pregnancy and in consecutive preg
Vertical transmission of human immunodeficiency virus type 1: insights from studies of multiple pregnancies.: Acta Paediatr Suppl. 1997 Jun;421:56-9. Unique Identifier : AIDSLINE MED/97382868; Goedert JJ; Viral Epidemiology Branch, National Cancer Institute, USA.; Because twins share an in utero environment and genetic relationships, similarities and differences between them can provide insight into the epidemiology and natural history of infectious agents, especially human immunodeficiency virus type 1 HIV-1). Three projects were summarized: HIV-1 transmission and AIDS-free su
Early spontaneous abortions and fetal thymic abnormalities in maternal-to-fetal HIV infection.: Acta Paediatr Suppl. 1997 Jun;421:60-4. Unique Identifier : AIDSLINE MED/97382869; Shearer WT; Langston C; Lewis DE; Pham EL; Hammill HH; Kozinetz CA; Kline MW; Hanson IC; Popek EJ; Department of Pediatrics, Baylor College of Medicine, Houston, TX; 77030, USA.; The thymus is thought to play a major role in the immunopathogenesis of human immunodeficiency virus (HIV) infection, particularly in maternal-to-fetal HIV transmission. Characteristic lesions of the HIV-infected thymus include a prominent CD4+ CD8+ T lymphocyte depletion at the corticomedullary junction, the region o
Identification of HIV infection in pregnancy: another era.: Acta Paediatr Suppl. 1997 Jun;421:65-6. Unique Identifier : AIDSLINE MED/97382870; Saba J; Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.; In order to be successfully implemented, some interventions to prevent vertical transmission of human immunodeficiency virus HIV) will require prior identification of HIV-infected women. The testing and counselling of pregnant women should therefore be promoted. Promoting testing and counselling within prenatal clinic
Anonymous testing of newborn infants for HIV antibodies as a basis for estimating prevalence of HIV in childbearing women: the 1991-1994 study in Spain.: Acta Paediatr Suppl. 1997 Jun;421:67-71. Unique Identifier : AIDSLINE MED/97382871; Canosa CA; Grady GF; Cabello ML; Comeau AM; Schwerzler ME; Contreras MT; Fraga JM; Gomez de los Terreros I; Pena J; Children's Hospital La Fe, Valencia, Spain.; During 1991-1994, anonymous screening of newborn infants for maternal antibody to human immunodeficiency virus (HIV) was carried out in three regions of Spain : Valencia, Galicia and Sevilla. The newborn infants whose heel-stick blood eluates were satisfactory for HIV antibody tests
The future of prenatal HIV testing.: Acta Paediatr Suppl. 1997 Jun;421:72-7. Unique Identifier : AIDSLINE MED/97382872; Minkoff H; Willoughby A; Department of Obstetrics and Gynecology, SUNY Health Science Center at; Brooklyn, NY 11203, USA.; The use of zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus, as well as continuing advances in our understanding of the determinants of that transmission, and of potential new avenues of intervention augur ever more efficient perinatal prevention strategies in the near futu
Human immunodeficiency virus type 1 infection, clinical trials and ethics in paediatrics.: Acta Paediatr Suppl. 1997 Jun;421:78-85. Unique Identifier : AIDSLINE MED/97382873; de Martino M; Galli L; Guarino Amato A; Vierucci A; Institute of Paediatrics and Obstetrics, University of Chieti, Italy.; Children are not little adults and questions regarding their treatment must be directly addressed to children. Phase I and II trials should closely follow those in adults, integrated by separate studies in infants. Phase III trials should be carried out in a parallel fashion, flexible enough to be modifiable according
Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry.: Acta Paediatr Suppl. 1997 Jun;421:86-8. Unique Identifier : AIDSLINE MED/97382874; White A; Eldridge R; Andrews E; Worldwide Epidemiology Department, Glaxo Wellcome Inc., Research; Triangle Park, NC 27709, USA.; Potential risk of adverse birth outcomes associated with the use of antiretrovirals in human immunodeficiency virus (HIV)-infected women during pregnancy must be assessed. Data through June 1995 are reported from the worldwide Antiretroviral Pregnancy Registry on the incidence of structural birth defects following pre
Reducing the risk of perinatal HIV-1 transmission with zidovudine: results and implications of AIDS Clinical Trials Group protocol 076.: Acta Paediatr Suppl. 1997 Jun;421:89-96. Unique Identifier : AIDSLINE MED/97382875; Mofenson LM; Pediatric, Adolescent & Maternal AIDS Branch, Center for Research for; Mothers and Children, National Institute of Child Health & Human; Development, National Institutes of Health, Rockville, MD 20852, USA.; This paper reviews the rationale for the AIDS Clinical Trials Group (ACTG) protocol 076 design, the study results and the implications of these results, including discussion of the US Public Health Service Task Force recommendations on the use of zidovudine to reduce perinatal transmission and for prenatal human immun
Progress in prevention of perinatal HIV-1.: Acta Paediatr Suppl. 1997 Jun;421:97-103. Unique Identifier : AIDSLINE MED/97382876; Fowler MG; Mofenson L; National Institute of Allergy and Infectious Diseases, Bethesda, MD,; USA.; The findings of a recent human immunodeficiency (HIV-1) prevention trial in the USA demonstrated that administration of an antiretroviral drug, zidovudine, to mothers during the prenatal and intrapartum periods, and to their neonates for 6 weeks, resulted in a two-thirds reduction in risk of perinatal transmission fro
CD8+ T lymphocyte counts as an adjunctive predictor of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.: Intern Med. 1997 Jul;36(7):461-5. Unique Identifier : AIDSLINE MED/97382489; Oka S; Nagata Y; Fujino Y; Yasuoka A; Ishihara M; Ikeda K; Iwamoto A; Shimada K; Mochizuki M; Kimura S; AIDS Clinical Center, International Medical Center of Japan,; Shinjuku-ku, Tokyo.; We encountered a case of cytomegalovirus ( CMV ) retinitis with spontaneous regression in association with an increased number of CD8+ but not CD4+ T lymphocytes in a patient with acquired immunodeficiency syndrome (AIDS). Thus
Coronary artery bypass grafting in patients with human immunodeficiency virus.: J Card Surg. 1997 Mar-Apr;12(2):98-101. Unique Identifier : AIDSLINE MED/97417659; Flum DR; Tyras DH; Wallack MK; Department of Surgery, St. Vincents Hospital and Medical Center, New; York, New York, USA.; The role of surgery in the natural history of HIV disease is in evolution. A review was conducted of 2980 CABG operations taking place between January 1992 and January 1996 at St. Vincents Hospital; four of these patients were known to be HIV-positive prior to the operation. Preoperative work-up, operative course, and
Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients.: Arch Med Res. 1997 Autumn;28(3):391-6. Unique Identifier : AIDSLINE MED/97436973; Silva AA; Camara V; Quirico-Santos T; Department of Pathology, Universidade Federal Fluminense, Rio de; Janeiro, Brazil.; The central nervous system is considered an early and common target for the human immunodeficiency virus type 1 (HIV-1). Serum and cerebrospinal fluid (CSF) from 20 HIV positive patients, including 14 with AIDS- dementia complex (CDC stage IV) and 6 asymptomatic individuals (CDC sta
Prophylaxis after occupational exposure to HIV [editorial]: BMJ. 1997 Sep 6;315(7108):557-8. Unique Identifier : AIDSLINE MED/97448613; Easterbrook P; Ippolito G
Anonymous AIDS testing in Hungary to end [news]: BMJ. 1997 Sep 6;315(7108):567. Unique Identifier : AIDSLINE MED/97448624; Kovac C
Screening for HIV infection should be part of routine antenatal screening [letter]: BMJ. 1997 Sep 6;315(7108):608. Unique Identifier : AIDSLINE MED/97448655; Essex B
Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient.: Leuk Lymphoma. 1997 Jun;26(1-2):205-7. Unique Identifier : AIDSLINE MED/97392594; Mahon FX; Nabera CB; Pellegrin JL; Cony-Makhoul P; Leng B; Bernard P; Reiffers J; Laboratoire Greffe de Moelle Universite, (UMR CNRS 5540 Universite; Bordeaux 2), France.; An asymptomatic HIV-positive patient with Philadelphia chromosome positive chronic myelogenous leukemia (CML) was treated by interferon-a (IFN-a) for four years. A sustained hematological response and major cytogenetic response were achieved. However, a complete cytogenetic remission (100% Ph-negative cells) was obser
Virus load and antigenic diversity.: Bull Math Biol. 1997 Sep;59(5):881-96. Unique Identifier : AIDSLINE MED/97426780; Bittner B; Bonhoeffer S; Nowak MA; Department of Zoology, University of Oxford, England.; In this paper, we analyse mathematical models for the interaction between virus replication and immune responses. We show that the immune system can provide selection pressure for or against viral diversity. The paper provides new insights into the relationship between virus load (=the abundance of virus in an infecte
Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.: Bone Marrow Transplant. 1997 Aug;20(4):317-23. Unique Identifier : AIDSLINE MED/97429909; Pauksen K; Sjolin J; Linde A; Alm G; Andersson B; Lonnerholm G; Ljungman P; Department of Infectious Diseases, Uppsala University Hospital,; Sweden.; In seronegative autologous bone marrow transplanted (ABMT) patients, a sustained cell-mediated immunity (CMI) has been shown to impair the antibody response after measles vaccination. To investigate if this might be caused by a preferential Th1 cytokine response, interferon (IFN)-gamma and interleukin (IL)-10 producti
Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice.: Endocr J. 1997 Jun;44(3):357-65. Unique Identifier : AIDSLINE MED/97425460; Matsuzaki T; Yamazaki R; Hashimoto S; Yokokura T; Yakult Central Institute for Microbiological Research, Tokyo, Japan.; The antidiabetic effects of Lactobacillus casei (LC) on a non-insulin-dependent diabetes mellitus (NIDDM) model, KK-Ay mice, were investigated. The oral administration of LC to male 4-week-old KK-Ay mice, or raising the mice on a 0.05% LC-containing diet significantly decreased the plasma glucose at 8 to 10 weeks of a
New plan to combat indigenous HIV/AIDS [news]: Aust Nurs J. 1997 May;4(10):10. Unique Identifier : AIDSLINE MED/97441217
Adjusting for regression toward the mean when variables are normally distributed.: Stat Methods Med Res. 1997 Jun;6(2):129-46. Unique Identifier : AIDSLINE MED/97405242; Lin HM; Hughes MD; Research Department, United Network for Organ Sharing, Richmond,; Virginia, USA.; Many studies use the same variable, for example blood pressure in studies of antihypertensive treatments, to identify subjects to be included in the study and to evaluate the effects of a treatment. As a consequence, if not properly accounted for, the effect of regression toward the mean can confound the evaluation of
Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation.: Br J Pharmacol. 1997 Aug;121(7):1295-300. Unique Identifier : AIDSLINE MED/97400412; Elimadi A; Morin D; Albengres E; Chauvet-Monges AM; Allain V; Crevat A; Tillement JP; Departement de Pharmacologie, Faculte de Medecine de Paris XII,; Creteil, France.; 1. The effects of zidovudine (ZDV) and zidovudine triphosphate ZDV-3P) on Ca2+-induced mitochondrial permeability transition MPT), respiratory control ratio (RCR) and ATP synthesis have been investigated on isolated rat liver mitochondria. 2. ZDV slightly but significantly decreased RCR and ATP synthesis but was ineff
Control of HIV co-receptor expression: implications for pathogenesis and treatment.: Trends Microbiol. 1997 Aug;5(8):300-2; discussion 302-3. Unique Identifier : AIDSLINE MED/97408885; Rowland-Jones S; Tan R; Molecular Immunology Group, Institute of Molecular Medicine, Oxford,; UK. sarah.rowland-jones@ndm.ox.ac.uk
Endogenous retroviruses and the evolution of resistance to retroviral infection [see comments]: Trends Microbiol. 1997 Aug;5(8):313-8. Unique Identifier : AIDSLINE MED/97408890; Best S; Le Tissier PR; Stoye JP; Wellcome Trust Centre for Human Genetics, Oxford, UK.; sbest@well.ox.ac.uk; The current AIDS epidemic has rekindled interest in the evolution of retroviruses and the development of resistance to infection. Retroviruses and their vertebrate hosts have coexisted for millions of years, during which time a variety of host defence mechanisms has evolved. One repeated strategy is to use endogenous
Influence of microbial infections on the progression of HIV disease.: Trends Microbiol. 1997 Aug;5(8):326-31. Unique Identifier : AIDSLINE MED/97408893; Blanchard A; Montagnier L; Gougeon ML; Institut Pasteur, Dept du SIDA et des Retrovirus, Paris, France.; ablancha@pasteur.fr; HIV infection is associated with immune activation, which in turn stimulates HIV replication. Certain other co-infections cause immune activation and may contribute to an increased viral load. The impact of co-infections by microorganisms such as Mycobacterium tuberculosis can be important for patient survival, partic
Aspects of national health promotion programmes for youth.: Promot Educ. 1997 Jun;4(2):16-8. Unique Identifier : AIDSLINE MED/97436843; Levin D; Coronel G; Department of Health Education, Kupat Holim Clalit Health Insurance; Institution, Tel Aviv, Israel.
Further trends in the etiology of end-stage renal disease in African-Americans.: Curr Opin Nephrol Hypertens. 1997 May;6(3):243-9. Unique Identifier : AIDSLINE MED/97409292; Coresh J; Jaar B; Welch Center for Prevention, Epidemiology and Clinical Research,; Department of Epidemiology, Johns Hopkins Medical Institutions,; Baltimore, USA. coresh@jhu.edu; Publications in the past year have continued to shed light on the etiology of the excess risk of end-stage renal disease end-stage renal disease among African-Americans. Prospective data now show that even mild elevations in blood pressure are associated with an increased risk of end-stage renal disease. The prevalenc
[Experimental study of mechanisms of neuronal death in the course oh HIV infection]: Bull Acad Natl Med. 1997 Apr;181(4):713-24. Unique Identifier : AIDSLINE MED/97416051; Vincent JD; Lannuzel A; Barnier JV; Lledo PM; Tardieu M; Institut Alfred Fessard, CNRS, Gif/Yvette.; The HIV1 virus and its envelope glycoprotein gp120 are toxic for human neurones in vitro. This neurotoxicity is, at least partially, of an apoptotic nature, resulting from the interaction of gp120 with the neuronal membrane which leads to perturbations of intracellular signaling systems. These latter bring about on th
[Prenatal screening for anti-HIV antibodies]: Bull Acad Natl Med. 1997 May;181(5):939-42. Unique Identifier : AIDSLINE MED/97416043; Henrion R
[Tubulo-interstitial nephritis associated with abnormal immune system]: Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):281-3. Unique Identifier : AIDSLINE MED/97423800; Kawaguchi K; Division of Surgical Pathology, Shinonoi General Hospital.
[Antiviral activity of hydroalcoholic extract from Haemanthus albiflos on the Moloney murine leukemia virus and the human immunodeficiency virus]: C R Seances Soc Biol Fil. 1997;191(3):473-85. Unique Identifier : AIDSLINE MED/97441750; Husson GP; Subra F; Lai-Kuen R; Vilagines R; Faculte des Sciences pharmaceutiques et biologiques, Laboratoire; d'Hydrologie, Paris.; We have used a biological test on the microplates of cellular cultures in order to investigate the toxicity and the antiviral properties against different viruses: defective Moloney Murine Leukemia virus (MoMLV) derived from the SVX shuttle and expressing resistance to the G418 antimitotic, and Human Immunodeficiency
Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes.: Immunity. 1997 Aug;7(2):221-31. Unique Identifier : AIDSLINE MED/97429769; Hu Q; Bazemore Walker CR; Girao C; Opferman JT; Sun J; Shabanowitz J; Hunt DF; Ashton-Rickardt PG; Gwen Knapp Center for Lupus and Immunology Research, Department of; Pathology, University of Chicago, Illinois 60637, USA.; To understand how thymic selection gives rise to T cells that are capable of major histocompatibility complex (MHC)-restricted recognition of antigen but are tolerant of self, we directly examined how peptide/MHC ligands expressed on thymic epithelial cells trigger the positive selection of immature thymocytes. We dem
Midwives knowledge of the HIV virus and its implications for their attitude and practice.: Midwives. 1997 Aug;110(1315):190-3. Unique Identifier : AIDSLINE MED/97450091; Grellier R; Health Services Research Unit, Canterbary Christ Church College.
The traffic light model. An approach to HIV infection in maternity services.: Midwives. 1997 Aug;110(1315):194-5. Unique Identifier : AIDSLINE MED/97450092; Chester T; Jervis R; O'Connell T
Antenatal HIV antibody testing. To test or not to test?: Midwives. 1997 Aug;110(1315):196. Unique Identifier : AIDSLINE MED/97450093; McGuinness S; Princess Anne maternity Unit, Bolton.
Aids in Zimbabwe.: Midwives. 1997 Aug;110(1315):198-9. Unique Identifier : AIDSLINE MED/97450094; Hopper MH; University of East Angiia.
Questions & answers in industrial relations.: Midwives. 1997 Aug;110(1315):200. Unique Identifier : AIDSLINE MED/97450095; Shepherd B; RCM Industrial Relations Dept., London.
Bone mineral density in patients with human immunodeficiency virus infection.: Calcif Tissue Int. 1997 Jul;61(1):30-2. Unique Identifier : AIDSLINE MED/97336252; Paton NIJ; Macallan DC; Griffin GE; Pazianas M; Division of Infectious Diseases, St. George's Hospital Medical School,; London SW17 ORE, United Kingdom.; The Object of this study was to determine whether HIV infection is associated with decreased bone mineral density (BMD). BMD was measured by dual-energy X-ray absorptiometry at total body, lumbar spine, and hip in 45 men with HIV infection and compared with sex, age, and weight-matched controls. Repeat scans were perf
Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients.: J Viral Hepat. 1997 Jul;4(4):279-83. Unique Identifier : AIDSLINE MED/97422458; Balayan MS; Fedorova OE; Mikhailov MI; Rytick PG; Eremin VF; Danilova TI; Shevelev BI; Gorbacheva EC; Pankova GY; Institute of Poliomyelitis and Viral Encephalitides, Moscow, Russia.; Antibody to hepatitis E virus of IgG class (anti-HEV IgG) is regularly detected in industrialized countries, where HEV is non-endemic, at levels not exceeding 2-3%; seropositive individuals are often found in certain groups of patients and professionals exposed to an increased risk of blood-borne infections. The prese
Temperature effect on the sensitivity of ELISA, PA and WB to detect anti-HIV-1 antibody and infectivity of HIV-1.: Chung Hua I Hsueh Tsa Chih (Taipei). 1997 Jun;59(6):325-33. Unique Identifier : AIDSLINE MED/97440708; Wang GR; Yang JY; Lin TL; Chen HY; Horng CB; Department of Medicine, Taipei Medical College, Taiwan, R.O.C.; BACKGROUND: This study is designed to resolve the problem of whether temperature or freeze/thaw cycle will have any impact on the sensitivity for detection of anti-HIV-1 antibody by particle agglutination (PA), enzyme-linked immunosorbent assay (ELISA) and western blotting (WB). To reduce potential risk for laboratory
Cleavage of the complement system C3 component by HIV-1 proteinase.: Biol Chem. 1997 May;378(5):439-42. Unique Identifier : AIDSLINE MED/97334334; Kisselev AF; Mentele R; von der Helm K; Max von Pettenkofer-Institute, Munich, Germany.; The C3 factor of the complement system and its C3b fragment are cleaved in vitro by the proteinase of the human immunodeficiency virus, type 1 (HIV PR). The cleavage occurs in the alpha-chain of both substrates at multiple sites yielding a 100 kDa fragment of the C3 alpha-chain and multiple fragments of the C3b alpha-
Pleural disease in patients with AIDS.: Curr Opin Pulm Med. 1997 Jul;3(4):315-8. Unique Identifier : AIDSLINE MED/97404034; Hamm H; Matthys H; Medizinische Universitatsklinik, Abt. Pneumologie, Freiburg, Germany.; Patients infected with HIV are at risk of developing a variety of infectious and malignant pleuropulmonary disorders. The three most common causes of AIDS-related pleural effusions are parapneumonic effusions or empyemas, tuberculosis, and Kaposi s sarcoma. However, the relative frequency of these conditions varies fr
Invasive pneumococcal disease in the immunocompromised host.: Microb Drug Resist. 1997 Fall;3(3):215-32. Unique Identifier : AIDSLINE MED/97417042; Janoff EN; Rubins JB; Department of Medicine, Veterans Affairs Medical Center, University of; Minnesota School of Medicine, Minneapolis 55417, USA.; A normal constituent of the human upper respiratory flora, Streptococcus pneumoniae also produces respiratory tract infections that progress to invasive disease at high rates in specific risk groups. The individual factors that contribute to the development of invasive pneumococcal disease in this distinct minority of
Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.: Microb Drug Resist. 1997 Fall;3(3):277-82. Unique Identifier : AIDSLINE MED/97417050; Bermudez LE; Inderlied CB; Kuzell Institute for Arthritis & Infectious Diseases, California; Pacific Medical Center Research Institute, San Francisco 94115, USA.; KRM-1648 is a new benzoxazinorifamycin with activity in vitro and in vivo against organisms of the Mycobacterium avium complex. We investigated the ability of 14C-KRM-1648 to concentrate within human monocyte-derived macrophages in vitro. KRM-1648 is rapidly taken up by uninfected macrophages, with 90% of the initial
[Study on the level of soluble interleukin-2 receptor, expression of membrane interleukin-2 receptor and T lymphocyte subpopulations in pulmonary tuberculosis]: Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih. 1996 Feb;19(1):44-6. Unique Identifier : AIDSLINE MED/97420959; Liu C; Teng Q; Xing S; Department of Diagnostics, Qingdan Medical College.; OBJECTIVE: To evaluate the significance of soluble interleukin-2 receptor (sIL-2R), membrane interleukin-2 receptor (mIL-2R) and T lymphocyte subpopulations in development of pulmonary tuberculosis. METHODS: The level of sIL-2R, expression of mIL-2R and the profile of T lymphocyte subpopulations in patients with pulmo
Early presentation of dilated cardiomyopathy as a part of seroconversion illness in human immunodeficiency virus infection.: Clin Cardiol. 1997 Aug;20(8):738-9. Unique Identifier : AIDSLINE MED/97403886; Fath-Ordoubadi F; van der Watt MJ; Noble MI; MRC Cyclotron Unit, Hammersmith Hospital, London, U.K.; It has been debated whether dilated cardiomyopathy seen in patients with acquired immune deficiency syndrome is caused by the virus itself or by the combination of other factors such as presence of opportunistic pathogens and/or severe immunosuppression. This paper describes the first reported case of a patient with h
[Clinical characteristics and muscle histopathology in polymyositis positive anti-hepatitis with C virus antibody]: Rinsho Shinkeigaku. 1997 Mar;37(3):208-11. Unique Identifier : AIDSLINE MED/97360394; Ayabe M; Kawamoto M; Ijima H; Hino H; Shoji H; First Department of Internal Medicine, Kurume University School of; Medicine, Japan.; In 14 patients with polymyositis (PM), 5 patients (2 males and 3 females) were positive for anti-hepatitis C virus (HCV) antibody measured by a second generation assay. We analysed the clinical characteristics and histopathological findings of the biopsied muscles from those 5 patients. They aged from 42 to 65 years a
AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease.: Cold Spring Harb Symp Quant Biol. 1996;61:759-70. Unique Identifier : AIDSLINE MED/97389313; Price RW; Neurology Service, San Francisco General Hospital, California, USA.
Decay rates of anti-HIV dideoxynucleotides in tissue culture systems: a simple correction for the effect of cell replication.: Drug Metab Dispos. 1997 Jul;25(7):893-6. Unique Identifier : AIDSLINE MED/97368018; Ahluwalia GS; Dedrick RL; Driscoll JS; Morrison PF; Gao WY; Johns DG; Laboratory of Medicinal Chemistry, Division of Clinical Sciences,; National Cancer Institute, National Institutes of Health, Bethesda, MD; 20892-4255, USA.; Measurement of intracellular drug levels in cell culture systems can be of predictive value in establishing rational clinical dosage schedules. Such in vitro measurements carried out with anti-HIV agents of the 2 ,3 -dideoxynucleoside (ddN) class have shown that many of the pharmacologically active ddNTP metabolites o
Changes in network characteristics and HIV risk behavior among injection drug users.: Drug Alcohol Depend. 1997 Jun 6;46(1-2):41-51. Unique Identifier : AIDSLINE MED/97389364; Hoffmann JP; Su SS; Pach A; National Opinion Research Center, University of Chicago, USA.; Studies indicate that HIV risk behaviors vary greatly among injection drug users (IDUs). The source of such variation is often ascribed to individual differences, but much of it is due to how IDUs are grouped into social networks. Nevertheless, given the turbulent and uncertain lives led by many IDUs, it would not be
[AIDS: early treatment too seldom implemented (news)]: Dtsch Med Wochenschr. 1997 Aug 22;122(34-35):A27. Unique Identifier : AIDSLINE MED/97457821
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)]: Dtsch Med Wochenschr. 1997 Aug 22;122(34-35):1027-32. Unique Identifier : AIDSLINE MED/97441611; Allewelt M; Steinhoff D; Rahlwes M; Vogel-Hartmann H; Hoffken G; Schaberg T; Lode H; Pneumologische Abteilung L, Lungenklinik Heckeshorn, Krankenhaus; Zehlendorf, Berlin. haloheck@zedat-fu.berlin.de; BACKGROUND AND OBJECTIVE: The picture of pneumonia acquired out of hospital is continually changing. Microbial aetiology as well as predisposing factors, course and prognosis of this disease were prospectively analysed over a period of 10 years. PATIENTS AND METHODS: In three prospective studies, undertaken between 19
Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.: East Afr Med J. 1997 Apr;74(4):213-6. Unique Identifier : AIDSLINE MED/97444653; Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO; Department of Medical Microbiology, College of Medical Sciences,; University of Maiduguri, Nigeria.; Before the advent of the Acquired Immune Deficiency Syndrome AIDS), many countries of the world transfused blood without seriously considering the potential risks of transmission of infectious agents. Even after it was shown that the Human Immunodeficiency virus(HIV) could be transmitted through blood and blood produc
HIV infection in malnourished children in Harare, Zimbabwe.: East Afr Med J. 1997 Apr;74(4):217-20. Unique Identifier : AIDSLINE MED/97444654; Ticklay IM; Nathoo KJ; Siziya S; Brady JP; Division of Paediatrics, Harare Hospital.; A descriptive study was undertaken to compare the pattern of socio-demographic features, nutritional profile and presenting features of HIV infected and uninfected children with malnutrition. A total of 140 children aged above 15 months admitted to the paediatric wards, Harare Hospital from December 1993 to February 1
Non infective colitis in infancy: evidence in favour of minor immunodeficiency in its pathogenesis.: East Afr Med J. 1997 Apr;74(4):233-6. Unique Identifier : AIDSLINE MED/97444658; Ojuawo A; Milla PJ; Lindley KJ; Gastroenterology Unit, Institute of Child Health, London.; Forty two infants below the age of two years presenting with chronic non infective diarrhoea and shown to have histologically proven colitis were investigated over a five year period at this hospital. Allergic colitis was the most common cause of colitis accounting for sixty two percent of the cases. Other colitides d
Specificity of a novel red blood cell agglutination assay SimpliRED') for HIV-1/HIV-2 infection.: East Afr Med J. 1997 Apr;74(4):237-8. Unique Identifier : AIDSLINE MED/97444659; Toye P; Riyat MS; The specificity and ease of use of a novel red blood cell assay for detection of HIV-1/HIV-2 antibodies was evaluated on 125 blood donor samples in Nairobi. The specificity was estimated as > 99%. The assay correctly identified five positive samples in the population, and was easy and rapid to perform. The data confir
Relationship between maximal oxygen uptake on different ergometers, lean arm volume and strength in paraplegic subjects.: Eur J Appl Physiol. 1997;76(2):122-7. Unique Identifier : AIDSLINE MED/97417396; Arabi H; Vandewalle H; Pitor P; de Lattre J; Monod H; Laboratoire de Physiologie du Travail et du Sport, Paris, France.; The present experiment was designed to study the importance of strength and muscle mass as factors limiting maximal oxygen uptake (VO2max) in wheelchair subjects. Thirteen paraplegic subjects [mean age 29.8 (8.7) years] were studied during continuous incremental exercises until exhaustion on an arm-cranking ergometer
Moderate and exhaustive endurance exercise influences the interferon-gamma levels in whole-blood culture supernatants.: Eur J Appl Physiol. 1997;76(2):165-9. Unique Identifier : AIDSLINE MED/97417402; Baum M; Muller-Steinhardt M; Liesen H; Kirchner H; Institute of Sports Medicine, University of Paderborn, Germany.; The aim of this study was to investigate whether moderate or exhaustive endurance exercise influences cytokine levels in whole-blood culture supernatants after stimulation. Therefore, eight healthy subjects were first exposed to moderate exercise on a cycle ergometer for 30 min at 70% of their 4-mmol/l lactic acid ana
The FLG motif in the N-terminal region of glucoprotein 41 of human immunodeficiency virus type 1 adopts a type-I beta turn in aqueous solution and serves as the initiation site for helix formation.: Eur J Biochem. 1997 Aug 1;247(3):896-905. Unique Identifier : AIDSLINE MED/97433273; Chang DK; Chien WJ; Cheng SF; Institute of Chemistry, Academia Sinica, Taiwan, Republic of China.; dkc@chem.sinica.edu.tw; NMR and CD studies were carried out on a peptide representing the hydrophobic N-terminal domain of envelope glycoprotein of human immunodeficiency virus type-1 in solutions of varying polarity. It was found that in aquaeous solution the amide proton of glycine in the FLG motif resonated at a considerably high field an
Th1 and Th2 subsets equally undergo Fas-dependent and independent activation-induced cell death.: Eur J Immunol. 1997 Aug;27(8):1858-64. Unique Identifier : AIDSLINE MED/97439463; Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T; Division of Molecular Genetics, Center for Biomedical Science, Chiba; University School of Medicine, Japan.; Stimulation of previously activated T cells results in apoptosis, termed activation-induced cell death (AICD). Recent analysis revealed that the Fas/Fas ligand (FasL) interaction is predominantly involved in AICD of T cells. Furthermore, based on the analysis of various T cell clones and lines, it has been reported th
A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.: Eur J Immunol. 1997 Aug;27(8):1933-41. Unique Identifier : AIDSLINE MED/97439473; Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M; Laboratory of Biochemistry, DCBDC, NCI, NIH, Bethesda, MD 20892, USA.; Major histocompatibility complex (MHC) class II molecules bind to numerous peptides and display these on the cell surface for T cell recognition. In a given immune response, receptors on T cells recognize antigenic peptides that are a minor population of MHC class II-bound peptides. To control which peptides are prese
Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults.: Eur J Immunol. 1997 Aug;27(8):1952-7. Unique Identifier : AIDSLINE MED/97439475; Udhayakumar V; Ongecha JM; Shi YP; Aidoo M; Orago AS; Oloo AJ; Hawley WA; Nahlen BL; Hoffman SL; Weiss WR; Lal AA; Division of Parasitic Diseases, National Center for Infectious; Diseases, Centers for Disease Control and Prevention, Atlanta, GA; 30341-3724, USA. Kumar@FORM-NET.COM; In this study, we have investigated the extent of natural polymorphism in the CD8+ cytotoxic T lymphocyte (CTL) determinant amino acids 368-390) of circumsporozoite (CS) protein of Plasmodium falciparum field isolates from a holoendemic region of Kenya , and determined how this varia
The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission.: Eur J Epidemiol. 1997 Jul;13(5):517-21. Unique Identifier : AIDSLINE MED/97403193; Tanzi M; Bellelli E; Benaglia G; Cavatorta E; Merialdi A; Mordacci E; Ribero ML; Tagger A; Verrotti C; Volpicelli A; Institute of Hygiene, University of Parma, Italy.; The prevalence of antibodies for one or more HCV antigens was 2.3% of 1,347 mothers at childbirth. Compared with the principal factors studied, the presence of antibodies was more frequent in women who were carriers of HIV infection (3/3), in those who had suffered liver diseases (5/37) or who had had transfusion (3/2
A low blood lymphocyte count is associated with an expansion of activated cytotoxic lymphocytes in patients with B-cell chronic lymphocytic leukaemia.: Eur J Haematol. 1997 Aug;59(2):89-99. Unique Identifier : AIDSLINE MED/97438081; Martin AP; Martin ER; Garcia-Suarez J; Arriagada FC; del Puerto Hernandez-Fuentes M; Vilaplana JC; Alvarez-Mon Soto M; Medicine Department, University of Alcala de Henares, Madrid, Spain.; In order to determine the relationships between CD2+ lymphocyte subpopulations and tumour mass, the immunophenotype of natural killer (NK) cells and T lymphocyte subsets was studied in 56 B-chronic lymphocytic leukaemia (B-CLL) patients and 38 healthy subjects. The patients were classified according to their blood lym
Cervical intra-epithelial neoplasia in HIV-positive women and women with AIDS.: Int J Gynaecol Obstet. 1997 Sep;58(3):325-6. Unique Identifier : AIDSLINE MED/97431367; Carreras R; Fuste P; Castellanos ME; Department of Obstetrics and Gynecology, Hospital del Mar, Passeig; Maritim, Barcelona, Spain.
Culturally specific health care model for ensuring health care use by rural, ethnically diverse families affected by HIV/AIDS.: Health Soc Work. 1997 Aug;22(3):172-80. Unique Identifier : AIDSLINE MED/97406698; Goicoechea-Balbona AM; School of Social Work, University of Maryland at Baltimore 21201-1777,; USA. agoicoec@ssw02.ab.umd.edu; This article describes the culturally specific health care model CSHCM). The CSHCM can guide health social workers in assessing and intervening with rural, ethnically diverse families. Such families require specialized and regular health care but generally face many barriers in obtaining that care. The model relies on
Interferon-regulatory factors during development of CD4 and CD8 thymocytes.: Immunology. 1997 Jul;91(3):340-5. Unique Identifier : AIDSLINE MED/97447070; Simon AK; Desrois M; Schmitt-Verhulst AM; Centre d'Immunologie, INSERM-CNRS de Marseille Luminy, France.; Selection events in the thymus occur at the double-positive CD4+ CD8+ (DP) developmental stage leading either to further differentiation of the CD4+ and CD8+ lineages or to deletion. The interferon-regulatory factor IRF-1 has been implicated in signalling for T-cell death and also in CD8+ thymic differentiation. IRF-1
Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.: Immunology. 1997 Jul;91(3):414-20. Unique Identifier : AIDSLINE MED/97447080; Azouaou N; Petrofsky M; Young LS; Bermudez LE; Kuzell Institute for Arthritis and Infectious Diseases, California; Pacific Medical Center Research Institute, San Francisco, USA.; Disseminated infection caused by organisms of Mycobacterium avium complex is common in acquired immune deficiency syndrome (AIDS) patients. M. avium is an intracellular bacterium that multiplies within macrophages. We examined the effect of M. avium infection on the T-helper cell response in C57/BL/6 black mice. At we
Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.: Immunology. 1997 Jul;91(3):493-500. Unique Identifier : AIDSLINE MED/97447091; Kataoka T; Togashi K; Takayama H; Takaku K; Nagai K; Department of Bioengineering, Tokyo Institute of Technology, Yokohama,; Japan.; In our recent studies, an inhibitor of vacuolar-type H(+)-ATPase, concanamycin A (CMA) has been shown to neutralize acidic pH in vacuolar organelles, including lytic granules, and to decrease the perforin content markedly. In the present paper, we have further investigated the role of acidification in perforin storage
Expression of both Th1 and Th2 cytokines correlates with the histological rejection of MHC-matched and MHC-mismatched foetal pancreas allografts in mice.: Immunol Cell Biol. 1997 Jun;75(3):303-9. Unique Identifier : AIDSLINE MED/97387251; Kovarik J; Koulmanda M; Mandel TE; Walter and Eliza Hall Institute of Medical Research, Parkville,; Victoria, Australia.; Foetal mouse pancreatic islet grafts were used to investigate differences in the histological appearance and cytokine expression pattern during acute rejection of fully MHC-mismatched, and MHC-matched but minor histocompatibility-mismatched (mH) allografts. Grafts of foetal islet tissue from non-obese diabetic mice un
Hypothesis: MHC class I, rather than just a flagpole for CD8+ T cells is also a protease in its own right.: Immunol Cell Biol. 1997 Jun;75(3):310-7. Unique Identifier : AIDSLINE MED/97387252; Mullbacher A; Division of Immunology and Cell Biology, John Curtin School of Medical; Research, Australian National University, Canberra, Australia.; Ever since the discovery of MHC class I restriction and the onslaught of the dual receptor hypothesis, MHC class I has been perceived as a passive entity in TCR recognition and the appropriate antigen processing and presentation pathways. However, numerous experimental observations and theoretical considerations are d
Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies.: Immunol Invest. 1997 Jun;26(4):473-89. Unique Identifier : AIDSLINE MED/97389385; Rosenberg JS; Atassi MZ; Verna and Marrs McLean Department of Biochemistry, Baylor College of; Medicine, Houston, TX 77030, USA.; Humoral responses to a protein require T-B cell communication for B cell activation by T cells. Previous studies from this laboratory have mapped the T and B cell recognition sites epitopes) on sperm-whale myoglobin (Mb) and several other proteins. It was found that, five of six regions on Mb recognized by T cells are
Cytokine production during infection with Hymenolepis diminuta in BALB/c mice.: Int J Parasitol. 1997 Jul;27(7):855-9. Unique Identifier : AIDSLINE MED/97425540; Palmas C; Bortoletti G; Gabriele F; Wakelin D; Conchedda M; Istituto di Patologia Sperimentale, Universita degli Studi di; Cagliari, Italy.; Levels of the cytokines IFN-gamma, IL-2 , IL-3, IL-4 and IL-5 were monitored in cells from the mesenteric lymph nodes (MLN) of BALB/c mice infected with Hymenolepis diminuta after stimulation in vitro with Con-A. Infection was associated with an increased production of
Effect of IL-12 on granuloma formation induced by injected Schistosoma japonicum eggs.: Int J Parasitol. 1997 Jul;27(7):861-4. Unique Identifier : AIDSLINE MED/97425541; Yang JQ; Tasaka K; Yoshikawa H; Chuang CK; Minai M; Nakajima Y; Department of Parasitology & Immunology, Yamanashi Medical University,; Japan.; The regulatory functions of IL-12 on granuloma formation by the eggs of S. japonicum in the lungs of BALB/c mice were studied. Mice were injected i.v. with the eggs to induce the pulmonary granuloma. On days 0, 1, 2, 3, 7, 8 after injection, mice were injected i.p. with murine rIL-12 at a dose of 1 microgram day-1 Gro
Testing testing.: Hastings Cent Rep. 1997 Jul-Aug;27(4):22-3. Unique Identifier : AIDSLINE MED/97417648; Schneider CE; University of Michigan, USA.
Yeast Rad7-Rad16 complex, specific for the nucleotide excision repair of the nontranscribed DNA strand, is an ATP-dependent DNA damage sensor.: J Biol Chem. 1997 Aug 29;272(35):21665-8. Unique Identifier : AIDSLINE MED/97413754; Guzder SN; Sung P; Prakash L; Prakash S; Sealy Center for Molecular Science, University of Texas Medical; Branch, Galveston, Texas 77555-1061, USA.; In eukaryotes, nucleotide excision repair of ultraviolet light-damaged DNA is a highly intricate process that requires a large number of evolutionarily conserved protein factors. Genetic studies in the yeast Saccharomyces cerevisiae have indicated a specific role of the RAD7 and RAD16 genes in the repair of transcript
The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity.: J Biol Chem. 1997 Aug 29;272(35):22023-9. Unique Identifier : AIDSLINE MED/97413805; Zhan X; Crouch RJ; Laboratory of Molecular Genetics, NICHD, National Institutes of; Health, Bethesda, Maryland 20892, USA.; Retroviral RNases H are similar in sequence and structure to Escherichia coli RNase HI and yet have differences in substrate specificities, metal ion requirements, and specific activities. Separation of reverse transcriptase (RT) into polymerase and RNase H domains yields an active RNase H from murine leukemia virus (
The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.: J Biol Chem. 1997 Sep 5;272(36):22385-8. Unique Identifier : AIDSLINE MED/97426372; Chen P; Mayne M; Power C; Nath A; Department of Medical Microbiology, University of Manitoba, Winnipeg,; Manitoba, Canada R3E 0W3.; Human immunodeficiency virus (HIV) infection may cause a dementing illness. HIV-mediated dementia is clinically and pathologically correlated with the infiltration of activated macrophages and elevated levels of tumor necrosis factor TNF)-alpha, both of which occur in an environmen
Social and medical factors affecting hospital discharge of persons with HIV/AIDS.: J Community Health. 1997 Aug;22(4):225-32. Unique Identifier : AIDSLINE MED/97391011; Bonuck KA; Arno PS; Department of Epidemiology and Social Medicine, Montefiore Medical; Center/Albert Einstein College of Medicine, New York, USA.; Although outpatient care and pharmaceuticals have rendered community-based care possible, hospitals remain the locus of the most costly and intensive HIV/AIDS care. Little is know, however, about the impact of patients social circumstances upon hospital length of stay. This paper examines the impact of housing status
Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV-positive patients.: J Cutan Pathol. 1997 Aug;24(7):425-8. Unique Identifier : AIDSLINE MED/97418884; Munoz E; Valks R; Fernandez-Herrera J; Fraga J; Department of Pathology, Hospital Universitario de la Princesa,; Madrid, Spain.; Herpetic syringitis has been described as a rare manifestation of herpes virus infection in patients with an immunodeficiency, usually secondary to human immunodeficiency virus (HIV) infection. Eccrine squamous syringometaplasia (ESS) is an infrequent alteration of the eccrine duct epithelium reported in association w
Enhancing motivation to reduce the risk of HIV infection for economically disadvantaged urban women.: J Consult Clin Psychol. 1997 Aug;65(4):531-41. Unique Identifier : AIDSLINE MED/97400668; Carey MP; Maisto SA; Kalichman SC; Forsyth AD; Wright EM; Johnson BT; Department of Psychology, Syracuse University, New York 13244-2340.; mpcarey@syr.edu; This research evaluated a motivation-based HIV risk reduction intervention for economically disadvantaged urban women. Participants completed a survey that assessed HIV-related knowledge, risk perceptions, behavioral intentions, sexual communication, substance use, and risk behavior. A total of 102 at-risk women (76%
Fatalism, current life satisfaction, and risk for HIV infection among gay and bisexual men.: J Consult Clin Psychol. 1997 Aug;65(4):542-6. Unique Identifier : AIDSLINE MED/97400669; Kalichman SC; Kelly JA; Morgan M; Rompa D; Department of Psychology, Georgia State University, Atlanta 30303,; USA. psysck@panther.gsu.edu; This study surveyed 430 men at an urban gay pride celebration to assess fatalism, current life satisfaction, and perceived expected years of life among men who have sex with men. Analyses showed that men who engaged in unprotected anal intercourse outside of exclusive relationships reported a greater fatalistic outloo
Reluctance of paramedics and emergency medical technicians to perform mouth-to-mouth resuscitation.: J Emerg Med. 1997 May-Jun;15(3):279-84. Unique Identifier : AIDSLINE MED/97403405; Hew P; Brenner B; Kaufman J; Department of Emergency Medicine, Brooldyn Hospital Center, New York; University School of Medicine 11201, USA.; Recently, a reluctance of lay and medical personnel to perform mouth-to-mouth resuscitation (MMR) in hospital and community settings has been documented, with 45% of respondents declining to perform MMR on a stranger. In the present study, we examined whether the perceived risk and fear of contracting infectious disea
Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection.: J Immunol Methods. 1997 Jul 14;205(2):163-8. Unique Identifier : AIDSLINE MED/97440291; Beech JT; Bainbridge T; Thompson SJ; Department of Pathology and Microbiology, Medical School, University; of Bristol, UK.; The ability to measure successfully the levels of Th1 or Th2 cytokines during an in vitro antigen-driven, polyclonal T-cell response has proven to be more difficult than expected. Here we describe the development of a highly sensitive cell-based ELISA celELISA) technique for the detection of murine Th1 and Th2 cytokin
A novel, highly efficient peptide-HLA class I binding assay using unfolded heavy chain molecules: identification of HIV-1 derived peptides that bind to HLA-A*0201 and HLA-A*0301.: J Immunol Methods. 1997 Jul 14;205(2):201-9. Unique Identifier : AIDSLINE MED/97440295; Tan TL; Geluk A; Toebes M; Ottenhoff TH; Drijfhout JW; Department of Immunohematology and Blood Bank, Leiden University; Hospital, Netherlands.; A novel cell-free, highly automated peptide-HLA binding assay has been designed during which a mixture of unfolded recombinant HLA heavy chain molecules, beta 2-microglobulin and a fluorescent labeled standard peptide is allowed to form peptide-HLA complexes. The binding of a peptide of interest is monitored as the ab
Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.: J Med. 1997;28(1-2):108-28. Unique Identifier : AIDSLINE MED/97393100; Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y; AJI Pharma USA, Inc., Teaneck, NJ, USA.; This study evaluated tolerance (and possible efficacy) for 21 days of i.v. administration at three dose levels of curdlan sulfate (CRDS) (a semisynthetic sulfated polysaccharide), administered over 30 minutes, in HIV and CMV (in some cases) infected individuals
Effects of repeated hyperthermal stress on blood cells in vivo.: J Med. 1997;28(1-2):55-61. Unique Identifier : AIDSLINE MED/97393094; Kubota K; Kurabayashi H; Take H; Tamura K; Shirakura T; Department of Medicine, Kusatsu Branch Hospital, Gunma University; School of Medicine, Japan.; The effects of repeated hyperthermal stress on blood cells were examined in seven healthy subjects who took three 3-minute 47 degrees C hotspring baths daily for three consecutive weeks. After a 3-minute 47 degrees C bath, the sublingual temperature was transiently increased about 1.8 degrees C, returning to the basel
Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.: J Exp Med. 1997 Aug 29;186(5):757-66. Unique Identifier : AIDSLINE MED/97419193; Itoh Y; Germain RN; Lymphocyte Biology Section, Laboratory of Immunology, National; Institute of Allergy and Infectious Diseases, National Institutes of; Health, Bethesda, Maryland 20892-1892, USA.; T cell receptor (TCR) recognition of peptide-major histocompatibility complex antigens can elicit a diverse array of effector activities. Here we simultaneously analyze TCR engagement and the production of multiple cytokines by individual cells in a clonal Th1 CD4(+) cell population. Low concentrations of TCR ligand e
Primary care in Cuba: low- and high-technology developments pertinent to family medicine.: J Fam Pract. 1997 Sep;45(3):250-8. Unique Identifier : AIDSLINE MED/97445016; Waitzkin H; Wald K; Kee R; Danielson R; Robinson L; Department of Family and Community Medicine, University of New Merico,; Albuquerque 87131, USA. waitzkin@medusa.unm.edu; Cuba s accomplishments in primary care, while controversial, include several developments pertinent to family medicine. These accomplishments involve low-technology and organizational innovations such as neighborhood-based family medicine as the focus of primary care; regionalized systems of hospital services and prof
Bovine herpesvirus-1 infects activated CD4+ lymphocytes.: J Gen Virol. 1997 Sep;78 ( Pt 9):2159-66. Unique Identifier : AIDSLINE MED/97437469; Eskra L; Splitter GA; Department of Animal Health and Biomedical Sciences, University of; Wisconsin-Madison 53706, USA.; Acute virus infections can induce immune deficiencies, as shown by immunosuppression to a variety of antigens and mitogens. Previously we observed that live bovine herpesvirus-1 (BHV-1) induced considerable lymphocyte death in culture, suggesting that the virus infected one or more cell populations. Our goal was to id
Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 protease.: J Gen Virol. 1997 Sep;78 ( Pt 9):2217-24. Unique Identifier : AIDSLINE MED/97437476; Konya J; Stuber G; Bjorndal A; Fenyo EM; Dillner J; Karolinska Institute, Microbiology and Tumorbiology Center, Stockholm,; Sweden.; Identification of in vitro immunogenic T-cell epitopes is important for the design of immunotherapeutics targeted to specific antigenic sites. To identify candidate cytotoxic T-lymphocyte (CTL) epitopes in the protease of human immunodeficiency virus type 1 (HIV-1) strain MN, we synthesized 9-mer and 10-mer peptides c
Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk.: J Gen Virol. 1997 Sep;78 ( Pt 9):2225-33. Unique Identifier : AIDSLINE MED/97437477; Simonon A; Mulder-Kampinga GA; van de Perre P; Karita E; Msellati P; Kuiken C; Goudsmit J; AIDS Reference Laboratory, National AIDS Control Program, Kigali,; Rwanda.; The evolution of genomic RNA of human immunodeficiency virus type 1 (HIV-1), subtype A, was studied in three Rwandan mother-child pairs over a period of 12-30 months. In two pairs a homogeneous subtype A V3 sequence population was observed at seroconversion and the virus populations in the children resembled those in
Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.: J Gen Virol. 1997 Sep;78 ( Pt 9):2235-45. Unique Identifier : AIDSLINE MED/97437478; Veschambre P; Roisin A; Jalinot P; Laboratoire de Biologie Moleculaire et Cellulaire, CNRS UMR49, Ecole; Normale Superieure de Lyon, France.; Tat strongly stimulates transcription of the human immunodeficiency type 1 (HIV-1) provirus by interacting with various cellular transcription factors, including TFIID. The results presented in this report indicate that the effect exerted by Tat also involves an interaction with TFIIB. A direct protein-protein interac
Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B.: J Gen Virol. 1997 Sep;78 ( Pt 9):2247-57. Unique Identifier : AIDSLINE MED/97437479; Pistello M; Cammarota G; Nicoletti E; Matteucci D; Curcio M; Del Mauro D; Bendinelli M; Department of Biomedicine, University of Pisa, Italy.; The genetic diversity of 32 Italian isolates of feline immunodeficiency virus (FIV) was studied. Isolates were obtained from domestic cats living in different areas. Sequence data were obtained from a 308 bp fragment of the p25 region of the gag gene. Phylogenetic relationships among these sequences and previously pub
Augmentation of human T cell leukaemia virus type I Tax transactivation by octamer binding sites.: J Gen Virol. 1997 Sep;78 ( Pt 9):2259-67. Unique Identifier : AIDSLINE MED/97437480; Marriott SJ; Payne K; Connor LM; Division of Molecular Virology, Baylor College of Medicine, Houston,; TX 77030, USA. susanm@bcm.tmc.edu; The human T cell leukaemia virus type I (HTLV-1) Tax protein is an activator of viral and cellular gene expression. Tax does not bind DNA directly, but does interact with cellular DNA binding proteins. These interactions bring Tax to a specific group of promoters and may help to determine the specificity of Tax transa
The emerging recognition of cryptosporidium as a health hazard.: J Community Health Nurs. 1997;14(3):135-40. Unique Identifier : AIDSLINE MED/97427631; Matukaitis JM; University of Delaware, USA.; Cryptosporidium is the leading cause of waterborne disease in the United States . Cryptosporidiosis occurs as a result of this pathogen and is potentially fatal to the immunosuppressed population. Current water treatment standards will not eradicate the pathogen, resulting in a potentia
Thallium-201 uptake in cytomegalovirus encephalitis.: J Nucl Med. 1997 Sep;38(9):1386-8. Unique Identifier : AIDSLINE MED/97438019; Gorniak RJ; Kramer EL; McMeeking AA; Zagzag D; Department of Radiology, New York University School of Medicine, New; York, USA.; A 36-yr-old man with AIDS exhibited intense 201Tl uptake lesion-to-brain uptake ratio 5.38) in a brain lesion previously detected by MRI and CT. The lesion was biopsied and found to contain cells with viral inclusions diagnostic of cytomegalovirus infection, not tumor as the thalli
[Centralized preparation in the pharmacy of dilute solutions of ganciclovir: (Cymevan): work load change and economic potential]: J Pharm Belg. 1997 May-Jun;52(3):105-9. Unique Identifier : AIDSLINE MED/97426761; Teissier R; Lemozit JP; Vabre F; De Bouet du Portal H; Tiravy JJ; Pomies S; Bastide R; Pharmacie CHU Rangueil, Toulouse, France.; The production of ganciclovir doses by a hospital pharmacy having the necessary facilities to reconstitute anticancer drugs would be of the utmost relevance regarding both protection of the nursing staff and therapeutic safety. As this activity is also economically worthwhile a large number of our colleagues would lik
Sun, sex and responsibility. The Lumleian Lecture 1996.: J R Coll Physicians Lond. 1997 Jul-Aug;31(4):425-33. Unique Identifier : AIDSLINE MED/97409612; Adler MW; Department of Sexually Transmitted Diseases, University College London; Medical School.
Chemoattractant factors (IP-10, MIP-1alpha, IL-16) mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques.: J Med Primatol. 1997 Feb-Apr;26(1-2):19-26. Unique Identifier : AIDSLINE MED/97415386; Cheret A; Le Grand R; Caufour P; Neildez O; Matheux F; Theodoro F; Boussin F; Vaslin B; Dormont D; Centre de Recherches du Service de Sante des Armees Emile Parde,; Commissariat a l'Energie Atomique, DSV/DRM, Institut Paris-Sud sur; lesCytokines, Fontenay aux Roses, France.; We have used semiquantitative RT-PCR to monitor the expression of mRNA encoding chemoattractant factors IP-10, MIP-1alpha, and IL-16 in freshly isolated peripheral blood mononuclear cells PBMCs), lymph node mononuclear cells (LNMCs), and mononuclear cells obtained after bronchoalveolar lavages (BALMCs) of two cynomolg
SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque.: J Med Primatol. 1997 Feb-Apr;26(1-2):3-10. Unique Identifier : AIDSLINE MED/97415384; Trichel AM; Roberts ED; Wilson LA; Martin LN; Ruprecht RM; Murphey-Corb M; Tulane Regional Primate Research Center, Covington, LA 70433, USA.; The primary mode of human immunodeficiency virus (HIV) transmission worldwide is by exposure to the virus at vaginal, rectal, and oral mucosal surfaces. To understand HIV/simian immunodeficiency virus (SIV) transmission events at mucosal portals of entry, we used the SIV-macaque model to determine if mucosal surfaces
Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells.: J Med Primatol. 1997 Feb-Apr;26(1-2):34-43. Unique Identifier : AIDSLINE MED/97415388; Almond N; Corcoran T; Hull R; Walker B; Rose J; Sangster R; Silvera K; Silvera P; Cranage M; Rud E; Stott EJ; National Institute for Biological Standards and Control, Potters Bar,; Herts, UK.; Attenuated simian immunodeficiency virus (SIV) induces potent protection against infection with wild-type virus, but the mechanism of this immunity remains obscure. Allogeneic antibodies, which arise within animals as a result of SIV infection, might protect against challenge with exogenous SIV grown in allogeneic cel
Immunization of Macaca mulatta with aroA attenuated Salmonella typhimurium expressing the SIVp27 antigen.: J Med Primatol. 1997 Feb-Apr;26(1-2):44-50. Unique Identifier : AIDSLINE MED/97415389; Steger KK; Pauza CD; Department of Pathology and Laboratory Medicine, University of; Wisconsin-Madison, 53706, USA.; Attenuated bacteria expressing foreign antigens stimulate both systemic and mucosal immune responses to the recombinant protein. We studied the infection of rhesus macaques with an attenuated Salmonella typhimurium expressing the simian immunodeficiency virus p27 capsid protein. Juvenile rhesus macaques were inoculate
A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys.: J Med Primatol. 1997 Feb-Apr;26(1-2):51-8. Unique Identifier : AIDSLINE MED/97415390; Cole KS; Rowles JL; Murphey-Corb M; Clements JE; Robinson J; Montelaro RC; Department Molecular Genetics and Biochemisry, University of; Pittsburgh School of Medicine, PA 15261, USA.; Studies using live attenuated virus vaccines in the simian immunodeficiency virus (SIV) rhesus macaque model have demonstrated broad protection against experimental challenge. Protection in these studies was found to be critically dependent on the length of time postvaccination, suggesting that protective immunity inv
Expression of the gibbon ape leukemia virus receptor-1 in rhesus macaque tissues.: J Med Primatol. 1997 Feb-Apr;26(1-2):59-62. Unique Identifier : AIDSLINE MED/97415391; Wong SW; Swanson RM; Bergquam EP; Division of Pathobiology and Immunology, Oregon Regional Primate; Research Center, Beaverton 97006, USA.; A cDNA fragment specific for the rhesus macaque gibbon ape leukemia virus (GaLV) receptor (Glvr-1) was isolated by polymerase chain reaction (PCR) amplification and oligonucleotide primers specific for human Glvr-1 and a cDNA library derived from rhesus macaque brain. Sequence analysis of the fragment revealed the pol
Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates.: J Med Primatol. 1997 Feb-Apr;26(1-2):63-81. Unique Identifier : AIDSLINE MED/97415392; Warren JT; Levinson MA; The EMMES Corporation, Potomac, Maryland 20854, USA.
Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.: J Mol Biol. 1997 Aug 15;271(2):278-93. Unique Identifier : AIDSLINE MED/97415761; Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL; Laboratory of Immunobiology Dana-Farber Cancer Institute, Harvard; Medical School, Boston, MA, 02115, USA.; The molecular interactions between the CD8 co-receptor dependent N15 and N26 T cell receptors (TCRs) and their common ligand, the vesicular stomatitis virus octapeptide (VSV8) bound to H-2Kb, were studied to define the docking orientation(s) of MHC class I restricted TCRs during immune recognition. Guided by the molec
Can we define the mechanism of antitumor response observed during clinical adoptive immunotherapy? [letter]: J Natl Cancer Inst. 1997 Sep 17;89(18):1380. Unique Identifier : AIDSLINE MED/97452295; Merrouche Y; Negrier S; Puisieux I; Favrot M
AIDS in women in the United States. Recent trends.: JAMA. 1997 Sep 17;278(11):911-6. Unique Identifier : AIDSLINE MED/97445955; Wortley PM; Fleming PL; Division of HIV/AIDS Prevention, National Centers for HIV, STD, and TB; Prevention, Centers for Disease Control and Prevention, Atlanta, Ga; 30333, USA.; CONTEXT: The effect of the acquired immunodeficiency syndrome AIDS) epidemic on women is substantial and warrants an updated analysis. OBJECTIVE: To describe AIDS incidence trends in women. DESIGN: We analyzed national surveillance data on women 13 years of age and older with AIDS reported through June 1996. Data were
Recent advances in the management of human immunodeficiency virus infection.: Mayo Clin Proc. 1997 Sep;72(9):854-8; quiz 859. Unique Identifier : AIDSLINE MED/97440226; Temesgen Z; Wright AJ; HIV Clinic, Mayo Clinic Rochester, Minnesota 55905, USA.; Major advances during the past 2 years have resulted in an unprecedented optimism regarding the perception of human immunodeficiency virus (HIV) infection. An improved understanding of the pathogenesis of HIV infection coupled with the availability of assays to measure HIV-1 RNA and the approval of new antiretroviral
Satisfaction with inpatient acquired immunodeficiency syndrome care. A national comparison of dedicated and scattered-bed units.: Med Care. 1997 Sep;35(9):948-62. Unique Identifier : AIDSLINE MED/97443222; Aiken LH; Sloane DM; Lake ET; Center for Health Services and Policy Research, School of Nursing,; University of Pennsylvania, Philadelphia 19104-6096, USA.; OBJECTIVES: This study sought to determine whether there were differences in acquired immunodeficiency syndrome (AIDS) patients satisfaction with inpatient nursing care on dedicated AIDS units compared with conventional, multidiagnosis medical units. METHODS: Interview data were collected from more than 600 consecuti
[Hemophilia and infection (editorial; comment)]: Med Clin (Barc). 1997 May 3;108(17):658-62. Unique Identifier : AIDSLINE MED/97328601; Tusell JM
[HTLV-1 infection in a prisoner: the first case in Spain letter)]: Med Clin (Barc). 1997 May 3;108(17):677-8. Unique Identifier : AIDSLINE MED/97328605; Dronda F; Gutierrez M; Alonso-Sanz M; Soriano V
Group A streptococcal bacteremia. A 10-year prospective study.: Medicine (Baltimore). 1997 Jul;76(4):238-48. Unique Identifier : AIDSLINE MED/97425280; Bernaldo de Quiros JC; Moreno S; Cercenado E; Diaz D; Berenguer J; Miralles P; Catalan P; Bouza E; Department of Microbiology and Infectious Diseases, Hospital General; Universitario Gregorio Maranon, Universidad Complutense de Madrid,; Spain.; In this paper we present a prospective evaluation of 100 patients with Group A Streptococcal (GAS) bacteremia evaluated in our hospital over a 10-year period. Sixty-two patients were intravenous drug users (IVDU); all but 1 of these had an obvious cutaneous portal of entry related to the injection of illicit drugs. Tw
Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection. Report of 2 cases and review.: Medicine (Baltimore). 1997 Jul;76(4):249-55. Unique Identifier : AIDSLINE MED/97425281; Mylonakis E; Rich J; Skolnik PR; De Orchis DF; Flanigan T; Department of Medicine, Miriam Hospital, Brown University School of; Medicine, Providence, RI 02906, USA.; Aspergillus sinusitis is an uncommon complication of advanced human immunodeficiency virus (HIV) infection. We describe 2 patients with AIDS who developed histologically proven invasive Aspergillus sinusitis. We also review the findings of 14 histologically documented and 5 probable cases of invasive Aspergillus sinus
Musculoskeletal infections in patients with human immunodeficiency virus infection.: Medicine (Baltimore). 1997 Jul;76(4):284-94. Unique Identifier : AIDSLINE MED/97425284; Vassilopoulos D; Chalasani P; Jurado RL; Workowski K; Agudelo CA; Emory University School of Medicine, Atlanta, Georgia, USA.; Musculoskeletal infections constitute an unusual clinical manifestation in patients with human immunodeficiency virus (HIV) infection. Available information about patients characteristics and their clinical course has been obtained mainly from case reports and small retrospective studies. Our retrospective study is t
Identification of cytotoxic peptide as possible mechanism for neurotoxicity of HIV viral envelope and AIDS pathogenesis.: Med Hypotheses. 1997 Jun;48(6):463-8. Unique Identifier : AIDSLINE MED/97391078; Sangster B; LaMond Institute, Huntington Beach, CA 92646, USA.; A major segment of acquired immunodeficiency syndrome (AIDS) patients suffer from neurological complications, including impairments in concentration and motor functions. This neuronal injury, although related to the human immunodeficiency virus HIV), occurs even though the neurons themselves are not infected by the vi
Bartonellosis and human immunodeficiency disease (AIDS): L-forms as persisters, activating factors, and mechanism of disease.: Med Hypotheses. 1997 Jun;48(6):511-5. Unique Identifier : AIDSLINE MED/97391088; Sood FH; Phatak VD; Chaudhari MS; Bartonella, genus Proteus, can cause immunodepressive disease. The organisms, in parasitized red blood cells, may invade the brain and every other system and space in the human body. Bartonella henselae is proposed to have a role in the pathogenesis of acquired immunodeficiency syndrome (AIDS) encephalopathy. Bartonel
The viral envelope in the evolution of HIV: a hypothetical approach to inducing an effective immune response to the virus.: Med Hypotheses. 1997 Jun;48(6):517-21. Unique Identifier : AIDSLINE MED/97391089; Ngu VA; Cancer Research Laboratory, Faculty of Medicine and Biomedical; Sciences, Yaounde, Cameroon.; The human immunodeficiency virus (HIV) is perceived by the host immune system as partly-self because of the presence of host cell wall membrane on the viral envelope. This perception leads to an ineffective immune response to the virus. It is proposed that only viral core antigens without the envelope will be percei
The Maginot Line and AIDS vaccines.: Med Hypotheses. 1997 Jun;48(6):527-9. Unique Identifier : AIDSLINE MED/97391091; Stricker RB; Goldberg B; Department of Medicine, California Pacific Medical Center, San; Francisco, USA.; Despite extensive and costly efforts, attempts to develop a vaccine against human immunodeficiency virus (HIV), the causative agent of the acquired immunodeficiency syndrome (AIDS), have been unsuccessful. Using the Maginot Line as a metaphor, we discuss the reasons why an antibody-based vaccine strategy against HIV h
Zinc-controlled Th1/Th2 switch significantly determines development of diseases.: Med Hypotheses. 1997 Jul;49(1):1-14. Unique Identifier : AIDSLINE MED/97391093; Sprietsma JE; Functional, excessive-possibly temporary-deficiencies of the trace element zinc can change immune functions prematurely from predominantly cellular Th1 responses to humoral Th2 responses. T helper (Th1) cells produce cytokines such as interleukin-2 ( IL-2 ) and interfero
Human immunodeficiency virus-1 proviral gene disruption by targeted gene therapy: a hypothetical technique for the elimination of provirus from the infected cells.: Med Hypotheses. 1997 Jul;49(1):35-9. Unique Identifier : AIDSLINE MED/97391098; Batchu RB; Hinds T; Department of Medicine: Hem/Onc, Arkansas Cancer Research Center,; University of Arkansas for Medical Sciences; Little Rock 72205, USA.; A hypothetical technique is proposed for the elimination of all the integrated human immunodeficiency virus-1 provirus from infected cells, based on the developing technology of selective gene excision through homologous recombination. In this technique, a recombinant retroviral packaging cell-line which would produce
A hypothesis to explain the role of the suppressor and helper T cells in the immunologic selection of highly related human immunodeficiency virus isolates found in infected patients.: Med Hypotheses. 1997 Jul;49(1):77-9. Unique Identifier : AIDSLINE MED/97391105; Barnett E; Barnett N; Department of Medicine, University of Southern California School of; Medicine, Los Angeles, USA.; It is proposed that specific human immunodeficiency virus determinants in seropositive individuals are capable of evoking very strong suppressor T cell responses which inactivate certain helper T cells. This helper T cell suppression may be sufficient to inhibit the cytotoxic T cell recognition of these specific retro
Ethical complexities of conducting research in developing countries.: N Engl J Med. 1997 Oct 2;337(14):1003-5. Unique Identifier : AIDSLINE MED/97441026; Varmus H; Satcher D; National Institutes of Health, Bethesda, MD 20892-0148, USA.
Mandatory HIV testing for the mentally ill [letter]: N Engl J Med. 1997 Oct 2;337(14):1014-5. Unique Identifier : AIDSLINE MED/97441036; Cournos F; Bakalar N
[Update of the treatment of HIV infection (editorial)]: Pathol Biol (Paris). 1997 Apr;45(4):261-3. Unique Identifier : AIDSLINE MED/97441853; Molina JM
An interferon-gamma (IFN-gamma) based whole blood assay to detect T cell response to antigens in HIV-1 infected patients.: Pathol Biol (Paris). 1997 May;45(5):400-3. Unique Identifier : AIDSLINE MED/97441873; Benyoucef S; Hober D; De Groote D; De La Tribonniere X; Vilain V; Lion G; Bouzidi A; Wattre P; Laboratoire de Virologie, Centre Hospitalier et Universitaire de; Lille, France.; Recently it has been reported that cytokine production by T cells in response to antigens may be more sensitive test than lymphoproliferation. T cell reactivities to antigens is usually performed on isolated PBMCs, however whole blood is being used frequently for cytokine production studies. A whole blood assay is des
[Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients]: Pathol Biol (Paris). 1997 May;45(5):441-4. Unique Identifier : AIDSLINE MED/97441882; Reynes J; Montes B; Delmas B; Vendrell JP; Janbon F; Segondy M; Service des Maladies Infectieuses et Tropicales, Hopital Gui de; Chauliac, France.; 25 HIV-infected antiretroviral-naive adults were included in a 24-week study to evaluate the efficacy and the tolerability of a zidovudine/didanosine combination therapy in which didanosine was administered once daily (200 mg if weight 60 kg
[Bone marrow changes in HIV-positive patients (clinical, cytological, histological, and ultrastructural study of 57 cases)]: Pathologica. 1997 Feb;89(1):36-43. Unique Identifier : AIDSLINE MED/97367173; Oddi G; Rebeck L; Storniello G; De Blasio A; Papetti C; De Laurenzi A; Modesti A; Modica A; Servizio di Anatomia Citologica ed Istologia Patologica, Ospedale C.; Forlanin, Roma.; The authors take into consideration clinical, cytological, histological and ultrastructural pattern of 57 HIV+ patients. They want to quantify bone marrow alterations and research their relation with haematological pattern of these patients. They think that peripheral haematological deficit is related with cellular an
Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents.: Pediatr Infect Dis J. 1997 Aug;16(8):754-9. Unique Identifier : AIDSLINE MED/97417087; Bohler T; Baumler C; Herr I; Groll A; Kurz M; Debatin KM; Department of Hematology/Oncology, Children's Hospital,; Ruprecht-Karls-University, Heidelberg, Germany.; BACKGROUND: Increased apoptosis in infected as well as noninfected cells has been invoked in CD4+ T helper cell depletion during HIV-1 infection. A strong increase in the expression of CD95 (APO-1/Fas) and CD95 ligand, key regulators of apoptosis in normal T cells, has previously been described in freshly isolated T c
Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review.: Pediatr Infect Dis J. 1997 Aug;16(8):807-11. Unique Identifier : AIDSLINE MED/97417096; Zaknun D; Zangerle R; Kapelari K; Fischer H; Sailer M; McIntosh K; Department of Pediatrics, University of Innsbruck, Austria.; John.zaknun@uibk.ac.at
Cognitive functioning in school-age children with human immunodeficiency virus.: Percept Mot Skills. 1997 Aug;85(1):267-72. Unique Identifier : AIDSLINE MED/97439133; Frank EG; Foley GM; Kuchuk A; Department of Pediatrics, New York University Medical Center, NY; 10016, USA.; The number of pediatric AIDS cases continues to rise. This study focused on 27 HIV-positive children aged 6 through 17 and attending public schools. Cognitive functioning and the relation between this domain of functioning and stage of disease, drug therapy, mode of transmission, and caretaker were examined. IQs and v
Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.: Nucleic Acids Res. 1997 Sep 1;25(17):3445-50. Unique Identifier : AIDSLINE MED/97402535; Yamamoto R; Koseki S; Ohkawa J; Murakami K; Nishikawa S; Tai